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Abstract
In order to improve upon stem cell therapy for osteoarthritis, it is necessary to understand the molecular
and cellular processes behind bone development and the differences from cartilage formation. To further
elucidate these processes would provide a means to analyze the relatedness of bone and cartilage tissue by
determining genes that are expressed and regulated for stem cells to differentiate into skeletal tissues. It
would also contribute to the classification of differences in normal skeletogenesis and degenerative conditions
involving these tissues. The three predominant skeletal tissues of interest are bone, immature cartilage and
mature cartilage. Analysis of the transcriptome of these skeletal tissues using RNA-seq technology was
performed using differential expression, clustering and biclustering algorithms, to detect similarly expressed
genes, which provides evidence for genes potentially interacting together to produce a particular phenotype.
Identifying key regulators in the gene regulatory networks (GRNs) driving cartilage and bone development
and the differences in the GRNs they drive will facilitate a means to make comparisons between the tissues
at the transcriptomic level.
Due to a small number of available samples for gene expression data in bone, immature and mature
cartilage, it is necessary to determine how the number of samples influences the ability to make accurate
GRN predictions. Machine learning techniques for GRN prediction that can incorporate multiple data types
have not been well evaluated for complex organisms, nor has RNA-seq data been used often for evaluating
these methods. Therefore, techniques identified to work well with microarray data were applied to RNA-
seq data from mouse embryonic stem cells, where more samples are available for evaluation compared to
the skeletal tissue RNA-seq samples. The RNA-seq data was combined with ChIP-seq data to determine
if the machine learning methods outperform simple, correlation-based methods that have been evaluated
using RNA-seq data alone. Two of the best performing GRN prediction algorithms from previous large-scale
evaluations, which are incapable of incorporating data beyond expression data, were used as a baseline to
determine if the addition of multiple data types could help reduce the number of gene expression samples.
It was also necessary to identify a biclustering algorithm that could identify potentially biologically relevant
modules. Publicly available ChIP-seq and RNA-seq samples from embryonic stem cells were used to measure
the performance and consistency of each method, as there was a well-established network in mouse embryonic
stem cells to compare results. The methods were then compared to cMonkey2, a biclustering method used
in conjunction with ChIP-seq for two important transcription factors in the embryonic stem cell network.
This was done to determine if any of these GRN prediction methods could potentially use the small number
of skeletal tissue samples available to determine transcription factors orchestrating the expression of other
genes driving cartilage and bone formation.
Using the embryonic stem cell RNA-seq samples, it was found that sample size, if above 10, does not have
a significant impact on the number of true positives in the top predicted interactions. Random forest methods
outperform correlation-based methods when using RNA-seq, with area under ROC (AUROC) for evaluation,
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but the number of true positive interactions predicted when compared to a literature network were similar
when using a strict cut-off. Using a limited set of ChIP-seq data was found to not improve the confidence
in the transcription factor interactions and had no obvious affect on biclustering results. Correlation-based
methods are likely the safest option when based on consistency of the results over multiple runs, but there
is still the challenge of determining an appropriate cut-off to the predictions. To predict the skeletal tissue
GRNs, cMonkey was used as an initial feature selection method to identify important genes in skeletal tissues
and compared with other biclustering methods that do not use ChIP-seq. The predicted skeletal tissue GRNs
will be utilized in future analyses of skeletal tissues, focussing on the evolutionary relationship between the
GRNs driving skeletal tissue development.
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Chapter 1
Introduction
Osteoarthritis is caused by the degeneration of articular cartilage and subchondral bone. It is the most
prevalent form of arthritis, affecting over 10% of the Canadian population and roughly 50% of people over
the age of 60 [2]. This figure is on the rise as the population ages and weight related influences become
increasingly common. As the population becomes older as a whole, this issue will place increased financial
burden upon healthcare systems as well as having indirect costs from lost wages, and a lower quality of
life due to pain and reduced physical functioning [3]. The burden of osteoarthritis is exacerbated by the
inadequacies of current therapies. However, recently adult mesenchymal stem cells, which have the ability to
differentiate into cartilage or bone, have emerged as a candidate cell type with great potential for cell-based
articular cartilage repair technologies [4]. To shed light on the mechanisms behind degeneration of bone and
cartilage, it is first necessary to describe normal skeletal tissue development by examining what and how
various cellular and molecular components are involved.
The challenge is to determine the genes involved and how they specify differentiation of mesenchymal
cells into three main types of skeletal tissue: bone, immature and mature cartilage [5, 6, 7]. Comparing
these skeletal tissues may provide insight as to how the process of bone formation differs from the formation
of cartilage. One way to approach analysis of these tissues is to look at the transcriptome, which contains
the total RNA present inside a cell. The dynamic properties of the transcriptome allows information to
be obtained about the gene activity in a particular cell or a number of cells under particular conditions.
Important gene activity includes the expression of transcription factors, which regulate the expression of
other genes, and ultimately influences the development of each tissue. A gene regulatory network (GRN)
consists of genes identified as potential regulators, and the target genes of these regulators. Expression of
the regulators influence the expression of the target genes of that particular regulator. The number of genes
in a GRN may vary from only two genes to full genomic networks.
A goal of this thesis is to uncover the GRNs underlying skeletal tissue formation. Two main transcription
factors are required for skeletal tissue formation. Sox9 is required for immature cartilage development,
while Runx2 is required for bone development [5]. Sox9 is hypothesized to be the main transcription factor
controlling the GRN active in immature cartilage, and Runx2 is hypothesized to be controlling the GRN
active in bone [8]. Since both these transcription factors need to be expressed in order for mature cartilage to
form, this thesis hypothesizes that these two GRNs interact in order for mature cartilage to develop. For two
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GRNs to interact, genes in one network are also influenced by genes or the transcription factors active in the
other network. The alternative to this is that the GRNs are not interacting, but both networks are present in
mature cartilage. The GRNs active in mature cartilage could include equal activity of the Sox9 and Runx2
GRNs, more activity in one GRN compared to the other due to the expression level of both transcription
factors. The Sox9 and Runx2 GRNs and the level of interaction occurring between them in mature cartilage
remains unknown.
A wide variety of technologies are available for constructing GRNs [9]. Genes of importance have been
discovered in these skeletal tissue networks using microarrays, RNA-seq and ChIP-seq, which is used to
analyze protein interactions with DNA that contribute to regulating gene expression [10, 11]. However, it
is of interest to determine whether current knowledge about the genes regulated by Sox9 and Runx2 gives
an accurate representation of the GRNs that are active when these three tissues differentiate. It is also of
interest to uncover genes whose expression has not been measured and associated with skeletogenesis, the
process of skeleton formation. One method of detecting patterns of gene expression in high-dimensional
data is to use a clustering technique where genes are grouped together based on similar expression patterns,
implying they are more likely to be functionally related [12]. In this thesis, bioinformatic analyses including
differential expression and clustering are performed using RNA-seq, which quantitates transcript abundance
as a means to measure gene expression, in skeletal tissue. These analyses may contribute to determining the
extent that these GRNs may be interacting, if they interact at all, during mature cartilage development. The
results of the analyses are compared to what is currently known in the literature about these networks. The
comparison is done to determine if what is found agrees with what is currently known in literature about the
genes regulated by Sox9 and Runx2, or if there is disagreement with what is in the literature about genes in
the Sox9 and Runx2 networks. These results are necessary to determine if it is best to predict new Sox9 and
Runx2 GRNs.
A typical GRN construction algorithm predicts GRNs with hundreds of expression samples [13]. A major
problem is that the small sample size of typical transcriptome data is a significant limiting factor in gene
regulatory network prediction. Expression data tends to have high dimensionality (thousands of genes)
versus a limited number (from one to hundreds) of samples implying that there could be many equally
good solutions when predicting a GRN. Researchers may not have access to large amounts of data, for in
vivo studies in particular, due to cost and time constraints or limited resources in publicly accessible gene
expression repositories depending on their research area. The number of samples necessary at minimum
to form an acceptably accurate network in vertebrates has not been reported in the literature for RNA-
seq. For a network to be considered acceptably accurate, it must be useful for further biological predictions
and hypothesis testing with minimal false positive interactions. Furthermore, the number of false negative
interactions should be low when using a method to discover a new network. It is often necessary to reduce
the number of genes used to predict a GRN as well as to combine expression data from multiple experiments
[12]. It is not known if the number of samples may be reduced if supplemented with other types of data,
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including protein-protein interaction, knock-out gene expression or ChIP-seq data. Indeed, more information
used for the construction of GRNs is considered best if it is available [14]. Since there are many genes present
in GRNs functioning in vertebrates, and the genes in these networks are usually not well-defined, there are
a lot more genes that need to be considered for prediction compared to simpler organisms, which will likely
also increase the number of samples required. Limiting the genes expressed to a smaller sets of genes of
interest is necessary if there is no established group of genes to predict interactions between. This is relevant
to this project as the sample size of bone, immature and mature cartilage from mouse is small. In order
to successfully construct a GRN from this data, an unsupervised method of categorizing gene expression
is necessary to discover underlying GRNs. Furthermore, data from another source is required to test if
combining data types increases confidence in the networks.
The algorithms currently available to predict GRNs are increasingly accurate if they are also able to
incorporate information from many of these sources including knock-out gene expression, ChIP-seq, data
already available for the transcription factors in the pathway or biological annotation [14]. Previous studies
have been done with microarray data to show different estimations of the necessary number of samples to
generate a GRN that has an accuracy above random [15]. These algorithms are typically evaluated using
synthetic data or gold standard networks, usually from Escherichia coli. Although there is currently no
network considered a gold standard available for mammals, such as mouse, there are small well-established
model networks [16]. Therefore, before predicting the GRNs present in cartilage and bone, this thesis will
determine how sample size changes the ability for GRN prediction algorithms to accurately construct a GRN
using a model network in mouse, where more samples are available for testing. This information will allow us
to determine if it could be useful to apply these GRN prediction methods to the skeletal tissue RNA-seq data
available for this thesis, which only contains 9 samples in total. This thesis will also attempt to determine if the
number of RNA-seq samples required can be small when combining ChIP-seq data with RNA-seq to predict
a model GRN in mouse. A random forest method, that has been found to outperform other GRN prediction
methods using microarray data, will be compared with methods capable of incorporating ChIP-seq data
as well as simple correlation-based methods with no integration capabilities. A clustering technique called
biclustering is also evaluated, which can be used to detect gene expression patterns in groups of genes that
are unique to a single tissue as well as pattern across all tissues. Biclustering is also used as a means of feature
selection to minimize the number of genes potentially in the Sox9 and Runx2 GRNs. Using biclustering to
minimize the number of genes will allow the consideration of all genes expressed in RNA-seq gene expression
data, which could potentially identify genes that have not been associated with Sox9 or Runx2 before. It
could also be used in the future to identify other important transcription factors possible regulating Sox9 and
Runx2. How another data type, in particular ChIP-seq, improves GRN prediction accuracy when combined
with RNA-seq is not known, nor is whether using a small number of samples is possible if data from other
sources are combined.
The interactions present or absent in each predicted GRN for a model mouse network were compared
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when using different methods to make the predictions. Also, the predicted interactions using only one method
were compared to determine the consistency of the results for each method. Each GRN was compared to
a well characterized GRN in mouse to determine how many “known” interactions each method identified
in their top predicted interactions. It is assumed that the more of these interactions a method is able to
identify earlier in their lists of predicted interactions, the better the method is able to perform. However, it
is difficult to determine a cut-off for predictions most likely to be true positives without also including almost
all possible interactions for particular transcription factors of interest. Furthermore, using biclustering does
not allow for the same evaluations that can be done with other machine learning methods since all possible
interactions are unlikely to be predicted. Therefore, another means of comparison was to determine the
consistency of the top predicted interactions from the different techniques. These evaluations may provide
other means of evaluating biclustering methods with other GRN prediction methods. Furthermore, it will
provide insight into how integrating data types changes the resulting network and how different approaches
to data integration changes results. If a more complete gene network driving skeletal tissue development can
be uncovered in this thesis, this may be compared in the future in various organisms at the genomic level
using homology-based studies to determine conserved portions of the networks across species in the future.
By obtaining an initial estimate of what the Sox9 and Runx2 GRNs in these tissues look like, it will be
possible to further evaluate the predicted GRNs from an evolutionary perspective at the transcriptomic and
genomic level.
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Chapter 2
Research Objectives and Thesis Outline
The first objective of this thesis is to test the hypothesis that two specific GRNs are the main drivers
of cartilage and bone development with evidence that the GRNs interact. Furthermore, the GRNs are
hypothesized to both be necessary for the development of mature cartilage. How much influence each GRN
has in the development of each skeletal tissue is also unknown. For example, since there are genes, such as
Sox9, required for any type of cartilage development, these genes are likely expressed in both immature and
mature cartilage. As such, the GRNs driving development of both tissues may also interact. This can be
observed by applying basic bioinformatics techniques including differential expression and global clustering
to determine how similar or different these tissues are from each other in terms of gene expression. This
analysis tests the hypothesis that there are two transcription factors, Sox9 and Runx2, which are the main
drivers of the GRNs controlling differentiation of cartilage and bone. What is currently known about the Sox9
and Runx2 networks from the literature was compared to analyses generated from RNA-seq data from bone,
immature and mature cartilage. Based on these comparisons it was determined that it would be necessary to
construct a new prediction of these GRNs. Therefore, a second objective was to identify competent methods
to predict Sox9 and Runx2 GRNs and whether certain techniques would be more appropriate with few data
samples in a complex vertebrate like mouse.
Chapter 3 introduces gene regulatory networks as well as a literature review of current methods used to
infer them including their limitations when used with small sample sizes of gene expression data. Then, it
provides a background explaining what is currently known about the Sox9 and Runx2 networks, which is
important to compare to the initial analyses performed with RNA-seq data from bone, immature and mature
cartilage in Chapter 5. Chapter 4 describes the RNA-seq data used in this thesis to predict the GRNs in
skeletal tissues and the methods used to test the accuracy of the currently described networks in the literature.
Results of differential expression, clustering and comparisons to the current literature networks for Sox9 and
Runx2 are presented in Chapter 5. Chapter 6 describes the methods used to evaluate machine learning
methods that are able to incorporate multiple data types to infer GRNs and discusses how these results will
be used to defend choices made to build preliminary skeletal tissue Sox9 and Runx2 networks. In Chapter
7, preliminary biclustering evaluations are conducted to select a method for feature selection to minimize
the genes used for GRN prediction. Chapter 8 presents results of the GRN evaluations for correlation-based
methods and machine learning methods with different sample sizes and types by comparing consistency of
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predicted interactions and accuracy when compared to a model network. From this, a Sox9 and Runx2
network is predicted using ChIP-seq and RNA-seq data currently available from mouse. Chapter 9 discusses
results of the evaluation of integrative GRN prediction methods focused on in this thesis. It also includes a
discussion of initial network predictions for the skeletal networks, with caveats. Finally, future directions are
proposed to further improve the current predictions of the main gene regulatory networks in skeletal tissues.
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Chapter 3
Background
3.1 Gene Regulatory Networks
Computationally, gene regulatory networks (GRNs) are generally represented as a (usually undirected)
graph, where the nodes of the graph represent genes. The edges connecting nodes of the graph of a GRN
indicate interactions or regulatory relationships between the genes, as shown in Figure 3.1. Nodes that have
a high number of edges connected to other nodes are referred to as hubs. Hub genes tend to have many
edges leading to various nodes of the network and are often transcription factors that directly or indirectly
coordinate the expression of a large number of other genes [12, 17]. What genes qualify as hub genes
varies, although recent hub gene identification has defined hub genes as the top 5% of the highest-degree
nodes in a network []. A transcription factor is responsible for controlling expression of genes by binding to
promoters or enhancers to promote or block gene expression. The bound transcription factors are able to
collect the genetic machinery necessary for gene transcription, and can increase or decrease the production
of mRNA for particular genes depending on where the transcription factor is able to bind [18]. A network
with directed edges can also be referred to as a Transcription Regulatory Network (TRN) as opposed to
a GRN [12]. When directed edges go in both directions between two vertices (sometimes represented by
undirected edges), this may indicate that genes are co-expressed or co-regulated. These types of relationships
between genes are predicted using correlation or mutual information, which are discussed later. These
edges may also be weighted, depending on the confidence of the interaction [19]. Possible reasons for co-
regulation include that they are active in the same pathway, share a common biological function, location
or process. It is also possible that their protein products directly bind to one another, or assemble into the
same complex, while a directed edge between genes may also be used to represent a step in a metabolic
pathway, signal transduction cascade, or stage of development [20]. Therefore, GRNs are important in
development, differentiation and for responding to environmental cues, and can provide good evidence for
differences between tissues. However, identifying — for each gene — a small number of regulators among
thousands of genes using a very limited number of samples in each experiment remains a challenge due to
inherent and observational noise in expression data.
Transcription is regarded as a major control mechanism of gene expression [18]. GRN discovery is im-
proving in part by advances made in high-throughput technologies, which enables the measurement of global
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Figure 3.1: Graphical representation of a GRN/TRN
gene expression in biological systems [21]. Using these data alone does not produce a complete or accurate
GRN for each skeletal tissue of interest, but integrating different types of “omics” data including genomic,
transcriptomic and proteomic data may improve the quality of GRNs reconstructed [21]. Methods currently
used to predict GRNs use data including microarrays, RNA-seq, ChIP-chip/ChIP-seq, proteome, metabolome
and biological annotations. These data types are discussed in the following subsections.
3.1.1 Microarrays
A DNA microarray is a collection of spots affixed to a solid support, where each spot contains DNA,
referred to as probes, representing some feature of interest such as a gene. DNA or cDNA (DNA complemen-
tary to RNA) generated from a sample that is able to bind to a particular position on the microarray can be
detected [22]. Further, the quantity of bound DNA at each spot can be partially measured to obtain gene
expression information. However, microarrays do not include the entire transcriptome (unknown/uncharac-
terized transcripts etc.) and tend to have higher noise at lower expression levels (limited dynamic range)
and so do not provide a complete picture of the transcriptome [23]. This is because the probes present on
a microarray have to be designed and therefore all the probes on a microarray must be identified and char-
acterized before being added to a microarray. Microarray technology is also limited largely to well-studied
organisms as these are the only species microarrays are available for, which limits evolutionary studies that
need to compare many species. Furthermore, splice variants are not taken into consideration with this tech-
nology as genes can be transcribed to produce variants of a single gene from combinations of coding regions
for a particular gene. Microarray gene expression data still remains the most frequently used type of data
for GRN construction even with RNA-seq as a feasible option [24].
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3.1.2 RNA-seq
Both RNA-seq and microarray technology follow similar practices for analysis and interpretation of the
data they produce, but the technologies have some differences. Next generation sequencing techniques, used
for RNA-seq, can be utilized to obtain a more accurate gene expression profile when compared to traditional
microarrays, providing increased coverage of DNA sequences and the ability to measure high and low gene
expression accurately. RNA-seq is able to provide quantitative approximations of the abundance of target
genes in the form of counts for all of the RNA present in a sample, including genes that are novel and would
otherwise be excluded from microarrays [23]. Using RNA-seq, a sample of RNA is converted to a library of
complementary DNA (cDNA) fragments with identifying adapters attached and sequenced from one (single)
or both (paired) ends of each sequence. The resulting sequence reads are aligned with a reference genome or
transcriptome (if available) instead of characterized probes on a chip. Since RNA-seq is able to utilize all the
RNA in a sample for sequencing, it can detect new transcripts. Furthermore, since RNA-seq does not require
probes, it does not have issues with noise due to cross-hybridization where the DNA from a sample pairs with
the DNA of a probe that does not match [23]. Microarrays also do not have the dynamic range as high as
RNA-seq, since RNA-seq counts correlate with the number of sequences obtained and are not relative amounts
as with microarrays [25]. To take advantage of the dynamic range of RNA-seq, read depth is important to
consider. If an experiment is performed to discover new transcripts or quatify transcripts that are relatively
lowly expressed, than having higher read depth will provide an advantage [26]. It is usually recommended to
have about 10M reads, but this may be reduced depending on how well annotated the reference genome is as
well as the number of replicates and variation in the data [27]. The number of replicates required depends on
the amount of technical or biological variability in the samples [26]. Generally for both microarray and RNA-
seq data, there are GRN prediction methods that work best with gene expressions from perturbation and
time-series experiments, which often provide more insights on the directionality or the causality of regulatory
relationships [24]. There have been recent studies indicating that RNA-seq and microarray de novo network
discovery tend to complement each other. However, there are genes with “extreme” expression levels, which
RNA-seq tends to identify more than microarray, that change the topology of the resulting GRNs [28, 29].
3.1.3 Sequence Data ie. ChIP-chip/seq
The analysis of sequence data includes the investigation of transcription factor binding motifs, the aim
being to detect potential links between sequence motifs and tissue specific gene expression. In ChIP-on-chip
(chromatin immunoprecipitation) experiments, DNA fragments that are isolated using a particular protein
like a transcription factor are applied to a microarray chip for analysis [30]. This generates a global picture
of where the protein binds. However, there are limitations once again by the microarrays available for a
genome of interest. ChIP-seq combines ChIP with Next Generation Sequencing such as RNA-seq. With
ChIP-seq, analysis assays direct physical interactions between a transcription factor and the DNA to which
9
the transcription factor binds. A sample of DNA is fractionated and an antibody for a particular transcription
factor is used to bind to the transcription factors in the sample, which are cross-linked to binding sites on
the fractionated DNA. Once these bound fragments are precipitated, the sections of DNA the transcription
factor was able to bind to are sequenced using next generation sequencing, which is then analyzed for
possible binding sites. Experimentally, transcription factor interactions with DNA are determined by ChIP-
seq resulting in p-values of interactions, which are inversely correlated to the probability of an edge being
present in a GRN [31]. This data is also used as an evaluation method as they tend to be used on their own to
generate many GRNs considered gold standard networks [14]. However, there are limitations depending on
the availability of ChIP-seq data for each transcription factor. This type of data has been recently integrated
with methods for GRN prediction by enriching results for gene sets, which are expected to include additional
evidence for co-regulation [19]. When GRN discovery is transformed into a sparse optimization problem,
small transcription factor sets that control the network can be found by solving a least absolute shrinkage
and selection operator (LASSO) type problem using transcription factor perturbation sequencing as well as
ChIP-chip/seq [32]. It can also be used as the first step to determine potential target genes in the network
and calculating correlations between the transcription factor binding data and other gene expression data
[33].
3.1.4 Proteome, Metabolome Data and Biological Annotation
Protein interaction and the metabolites produced by protein catalyzing reactions were some of the first
commonly used data used to construct networks, but they quickly lose effectiveness when larger, global net-
works need to be predicted [9, 21]. Protein-protein interaction data can be used to refine gene networks
estimated from expression data using Bayesian networks and are particularly useful for predicting the topo-
logical structure of a network and the functions of neighbouring genes [34]. It is also possible to integrate
functional gene information such as from Gene Ontology, Proteome and KEGG. Gene Ontology (GO), for ex-
ample, is a controlled vocabulary that describes the attributes of genes and their products including functional
characteristics and where they are located in a cell [21]. This type of information alleviates the functional
interpretation of genes participating in a GRN.
3.2 Key Transcription Factors in Skeletal Cells
The most abundant tissues in vertebrate skeletal tissues are bone, immature cartilage and mature cartilage.
Immature cartilage and mature cartilage differ where immature cartilage will not mineralize, but instead
persist over an organism’s lifetime and mature cartilage will mineralize and is typically degraded when
replaced by bone [6]. Bone is a unique tissue to vertebrates and may develop through two different processes.
One of these processes is endochondral ossification, which begins with differentiation of loosely associated
cells called mesenchymal cells into chondrocytes. This can persist as cartilage or become gradually replaced
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by bone. These mesenchymal cell fates are dictated by skeletal cell GRNs. Due to the similarities observed
in the functional, embryonic and histological properties of these tissues, it has been hypothesized that the
GRNs driving their development share a similar GRN across the tissues [8]. However, bone and cartilage
also have properties distinct to each tissue in these categories as wel,l suggesting that there are distinct parts
to the GRNs driving cartilage and bone development.
Figure 3.2: How the Runx2 network may be related to the Sox9 network present in immature
cartilage. Genes in the Sox9 network are indicated by the red objects. Runx2 is hypothesized to
be the main regulator of the networks driving mature cartilage and bone formation. Genes in the
Runx2 network are represented by the green objects. The introduction of Runx2 and genes regulated
by Runx2 to the Sox9 network could allow for the development of mature cartilage. Therefore gene
expression in mature cartilage is represented as a mixture of gene expression observed in immature
cartilage (driven by Sox9) and bone (driven by Runx2).
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Sox9 and Runx2 are candidate transcription factors driving the GRNs responsible for cartilage and bone
development respectively. Sox9 is the earliest indicator of mesenchyme differentiating into chondrocytes
producing cartilage [5, 6] while Runx2 is considered a master regulator of bone development [35]. Consistently
high levels of Sox9 will commit cells to chondrogenesis to produce cartilage, whereas higher levels of Runx2
will push them toward osteogenesis or bone development [5]. The type of tissue that results after immature
cartilage development depends upon additional transcriptional control by Sox9 or Runx2. Expression of
Runx2 and other transcription factors, such as Sp7, will lead to development of mature cartilage that can
be invaded by vasculature, resulting in bone development. Continued action of Sox9 may produce persistent
cartilage. In mature cartilage, Sox9 ultimately must become down regulated in order to trigger the maturation
of the cartilage. This is required since Runx2 activity is repressed with Sox9 interaction and is hypothesized
to be regulated by a wide range of cofactors [36]. Therefore, if both transcription factors are being expressed
together it is possible for cells to preferentially differentiate into cartilage.
It is of interest to determine similarities as well as differences in the GRNs of bone and cartilage tissues.
If genes in the Runx2 GRN overlap and interact with the genes in the Sox9 network, it will be interesting
to determine the extent of the overlap between the GRNs observed in mature cartilage since both Sox9
and Runx2 are required for mature cartilage development. This observation could indicate if the gene
expression observed in mature cartilage behaves more like a mixture between the Sox9 and Runx2 networks,
if it is more similar to gene expression in one tissue or the other. The combination of the two GRNs also
could produce synergistic gene expression where their cooperation leads to gene expression not observed in
immature cartilage or bone. It is important to note that Sox9 is dominant to Runx2, so other transcription
factors and/or genes may be required for the down-regulation of Sox9 in order for the other skeletal cells to
differentiate. This also means that in immature cartilage, the Runx2 GRN is likely to have very little activity
or influence. In order for bone development to occur, Sox9 must be down-regulated, which likely means that
genes expressed due to Sox9 activity must also become down-regulated or silenced. The alternative to this
scenario is that the Runx2 network and the Sox9 network are not both influencing development of mature
cartilage, meaning that one of these GRNs could have very little impact in the development of this tissue.
This could also mean that, for example, the GRN driving immature cartilage development has very little
activity in bone, or no activity at all. The predicted GRNs in this scenario possibly have less overlapping
genes and gene expression seen between the skeletal tissues. Mature cartilage could also have gene expression
that is a lot more similar to either immature cartilage or bone, depending on the GRN that is most active
in the tissue.
Skeletal tissue GRNs have been explored using techniques such as transcriptional profiling and genome
wide binding studies [10, 11]. A list of currently known important genes in the Runx2 network has been
obtained using microarray data available in the literature, but may still exclude genes participating in the
network [10]. The currently known list of genes in the Sox9 network has also been determined from RNA-seq
data from the literature using analysis of fold change in expression after Sox9 silencing discussed in Section
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3.3 below [11]. The Sox9 study only compares fold change between single replicates of a control and Sox9
silenced sample, which does not allow for statistical measurements of significance. However, it also makes
use of ChIP-seq data to make inferences of important genes controlling cartilage development.
3.3 Differential Expression and GRN Prediction
One of the most common uses of transcriptome data is to discover differentially expressed genes that
contribute to different phenotypes. When a gene is differentially expressed, it shows differences in expression
level between conditions. Since all of the genes in all cells is identical, differential expression of this DNA
is one way different cell types develop [37]. For example, different tissue types may have different levels of
gene expression or a tissue may have genes expressed that are not expressed in other tissues. The genes
that are not utilized still have the potential to be expressed, but may be suppressed by other gene activity
and regulatory machinery, or the tissue may lack what is required for the genes to be expressed. Detecting
differential expression involves the pairwise comparison of conditions. One of the more simple comparisons
tests the null hypothesis that the conditions with a proportion of counts for some gene among two samples
is the same as that of the remaining genes. In order to obtain a list of differentially expressed genes with
statistical significance it is typically recommended that each condition has at least three replicates, but at
least six if preferable to identify differentially expressed genes [38].
Differential expression is one means to establish a prediction for interactions influenced by a single gene,
but may not be indication that an accurate GRN can be created from the samples used. It is reliant on a
statistical cut-off of confidence of differential expression, which may result in co-regulated modules being left
out that could be contributing to a GRN. This also means gene interactions that may be in common among
the samples will not be picked up as differentially expressed since a single gene is likely the focus of the study.
However, when studying the a GRN in different tissues it is not only imperative to analyze differences, but
also similarities between the different networks. Genes in the Sox9 and Runx2 GRNs may be part of both
networks and influenced by both transcription factors, so genes may not be differentially expressed between
the networks, yet they are important for both networks.
The literature networks available for Sox9 and Runx2 were reported using differential expression and ChIP-
seq analysis to identify genes potentially influenced by the transcription factors [10, 11]. Both experiments
effectively silenced expression of either Sox9 or Runx2 in chondrocytes and an osteoblast cell line, respectively,
and compared to a control. The predicted Sox9 network was generated using expression of Sox9 that was
decreased more than 8-fold and compared to a control sample of mouse chondrocytes, as well as focusing on
55% of the genes identified from ChIP-seq data. One limitation of this dataset is that there was only one
replicate for each condition, which does not allow for any statistical confidence with the differential expression
the authors report, although results are strengthened slightly with the ChIP-seq data. The Runx2 network
was predicted using shRNA to silence Runx2, and this identified 159 genes responsive to Runx2 silencing.
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Although successful in identifying novel genes potentially regulated by Runx2, the number of probes present
on the microarray limits the dataset. Furthermore, it is difficult to measure the quality of this data as it leaves
out genes that are known to be regulated by Runx2 such as Col10a1. Combining ChIP-seq with differential
expression also does not take advantage of the gene expression data as a whole to include a larger portion of
genes with correlated expression.
Furthermore, differential expression can help to establish whether a gene is upstream of other genes in
the GRN, but will not help to determine if the relationship between this gene and others is likely direct
or indirect. An indirect relationship can occur if the expression of one gene influences other genes which
are responsible for direct regulation of others and so forth [39]. The genes downstream of this cascade are
indirectly influenced by the expression of the first gene. Differential expression will not allow for prediction
of other transcription factor influences in a single experiment although predictions can be made with co-
expression networks from the gene expression data. One method of obtaining all the genes a transcription
factor could be interacting with is collecting the locations where it is able to bind and the gene translation
start site (TSS) closest to these binding sites. ChIP-seq is one method to obtain this information.
It is predicted that RNA-seq and ChIP-seq do not influence GRN prediction results in the same way,
as ChIP-seq should include the part of the network influence by a transcription factor, not including the
type of interaction. The issue with building networks exclusively from ChIP-seq data is the large number
of false positive interactions. This is due to many binding events being non-functional [40]. This is where
expression data may aid to reduce some of the spurious interactions. It also limits the type of interactions
to transcription factor binding events. However, the number of RNA-seq or microarray samples necessary to
begin eliminating these spurious interactions from the predicted network is unknown.
Using ChIP-seq may allow for less RNA-seq samples to be used to predict a GRN. However, it is unknown
how many samples of expression data are necessary to predict a network when a researcher also has access
to other data that can provide an initial hypothesis or prior of what the GRN could look like and reduce the
number of genes possibly in the network. This thesis will determine if it allows for less samples of RNA-seq
to retrieve the same predictions consistently with current integrative GRN prediction methods.
3.4 Computational Methods for de novo GRN Discovery
3.4.1 Clustering
A traditional method of statistical analysis of expression data is to use clustering methods, which relies
on the “guilt by association” principle, where genes with similar functional properties tend to interact and
exhibit similar expression patterns in a network. Clustering is an unsupervised learning method that can
group either the genes or the conditions of an expression matrix, which has a row for each gene, a column for
each sample, and has entries that give discrete counts for each gene in each sample. For example, a higher
count for a particular gene is seen as a possible indication of higher expression levels of that gene. Clustering
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is able to group similar patterns of expression across tissue types, conditions, or time steps (the columns),
identifying either expression across all tissues with minimal variance or similar changes in expression at
different magnitudes. Key features can be explained by grouping these genes or conditions in terms of similar
expression patterns across either the genes or conditions being clustered [5]. Genes grouped together based
on expression implies they are more likely to be functionally related. Clustering provides a global analysis of
the expression data, reflecting expression levels across all conditions, which is an oversimplified view of genes
that display expression over select conditions. An example of this type of clustering is discussed further in
Section 4.3.1.
Some of the most simple similarity measures used to cluster gene expression data are Euclidean distance
and correlation-based methods. Euclidean distance calculates the distances between the expression values of
two genes x and y as √∑
c∈C
(exc − eyc)2
where exc is the expression level of gene x under condition c, and C is the set of all conditions [41]. This
measure is sensitive to scaling and differences in average expression level, whereas correlation is not. Corre-
lation is an association measure, which is used to estimate the relationships between two variables. Pearson
correlation measures the extent of a linear relationship. It is calculated using
1−
∑
c∈C(exc − e¯x)(eyc − e¯y)√∑
c∈C(exc − e¯x)2
∑
c∈C(eyc − e¯y)2
where e¯x is the mean expression of gene x [41]. Another measure, Spearman correlation, is based on ranks
measuring the extent of a monotonic relationship between x and y. All correlation coefficients take on
values between −1 and 1, where negative values indicate an inverse relationship. A correlation coefficient is
an attractive association measure since it can be easily calculated, allows for calculating significance levels
(p-values), and the sign (+/-) allows one to distinguish between positive and negative relationships. For
GRN prediction, close relationships have been found between mutual information and correlation based co-
expression networks. Mutual information is discussed further in Sections 3.5 and 3.6. It has been observed
that mutual information is often highly related to the absolute value of the correlation coefficient and when
they disagree, the correlation findings appear to be more plausible statistically and biologically [42, 43]. It
is an attractive method of GRN prediction as well as clustering, since it is possible to estimate correlation
with few observations and it does not depend on other parameter choices.
Analyses of RNA-seq data beyond differential expression, such as clustering, are important topics but
lack rigorous methodological development with most methods designed with microarray data in mind, which
has a different distribution of expression values. Recently, a model-based clustering approach was used to
identify co-expressed genes in RNA-seq, which employs either a Poisson or negative binomial mixture model
to postulate the over-dispersed gene count data [44]. This algorithm works by alternating between computing
probabilities for assignments of each gene to each cluster and updating the cluster means and covariance based
on the set of genes predominantly belonging to that cluster [7]. The effectiveness of this clustering method
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was measured by its ability to cluster genes into clusters with minimal similarities between separate clusters.
The method was evaluated in terms of biological significance, as it is required to contribute to elucidating
biological processes.
3.4.2 Biclustering Algorithms
There are limitations to GRN prediction using clustering. First, it cannot be presumed that genes that
show similar expression profiles are co-regulated as part of the same regulatory pathway. This is because in
clustering, all conditions are given equal weights in the computation of gene similarity; thus some conditions
may increase the amount of background noise, where there are higher numbers of non-informative variables
(genes). Furthermore, each gene can only be assigned to a single cluster even though biologically the gene
could be involved in different regulatory pathways depending on the conditions it is acting under. For example,
a set of genes could have similar expression levels between two tissues, but they could vary significantly within
a third tissue. With clustering, the similarity in the first two tissues would not be identified. Also, it is not
possible for a gene, or set of genes, to be present in more than one cluster. To address these concerns, localized
clustering methods, or biclustering, was created. The first biclustering algorithms were proposed in 2000 and
were called two-way clustering algorithms. This type of algorithm seeks homogeneous subsets of genes and
samples by performing a one-way clustering in an iterative manner [45]. To do this, it searches for biclusters
with high correlation between the genes by imposing the condition that the mean square residue is below
some cut-off value. The Coupled Two-way Clustering (CTWC) algorithm was produced around the same
time, which aims to find a set of genes together with a subset of conditions, such that a single cellular process
is the main contributor to the expression of the gene subset over the condition subset [46]. This two-way
clustering algorithm repeatedly performs one way hierarchical clustering on the rows and columns of the data
expression matrix using stable clusters of rows as attributes for column clustering and vice versa. A second
type of biclustering algorithm particularly important to this project is probabilistic generation methods,
which implement probabilistic techniques in order to discover genes that are similarly expressed across a
subset of samples and vice versa [6]. Although biclustering performs better than traditional methods when
picking out local gene expression patterns, most biclustering problems have exponential time complexity in
the number of rows and columns of the dataset. Consequently, algorithms have to depend on heuristics, so
their performance is never optimal. These algorithms are also more often used for feature selection as they
are capable of generating lists of related genes, but are unable to infer the types of relationships present in a
list of genes without other techniques. In Chapter 7, a performance review and evaluation is performed with
the RNA-seq data from skeletal tissues available for this thesis, and a summary of results is provided.
3.4.3 Review of Performance Evaluation of Biclustering Algorithms
Comparative studies have been previously done for both traditional clustering and biclustering methods
[47, 48, 49, 50, 51]. A comparison of both clustering and biclustering algorithms is difficult due to most
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algorithms performing well for the particular tasks assigned yet when further analysis is done, they fail in
other areas. Some of the algorithms have been found to be data dependent and so performance relies heavily
on the type of data being analyzed [48]. Studies have been done to judge an algorithm’s ability to detect
biclusters when they do, and do not, overlap using artificial data while others such as Chia and Karuturi
used a differential co-expression framework to compare algorithms on real data [52]. Previous performance
evaluation of multiple biclustering algorithms tends to involve the introduction of a new biclustering technique
in parallel to the evaluation, as a demonstration of the new methods superiority where datasets used for
evaluation are either artificially created datasets, or real biological datasets. The synthetic datasets only
have the ability to reflect certain aspects of biological reality, but their complexity can be adjusted manually
and the solutions are known beforehand making performance analysis a lot easier. Still, biological data tends
to hold more sway when judging the performance of a biclustering algorithm.
A common method used to judge biological relevance is the number of Gene Ontology (GO) enriched
terms and p-values based on the significance of the GO annotations identified within the data [47]. GO
terms are a controlled vocabulary that describe biological properties of gene products. These terms may
be used to annotate gene products with various biological processes, cellular components and molecular
functions associated with them. In a study evaluating five biclustering algorithms [48], these two methods
were argued to be inappropriate, as the number of GO terms and the significance levels of enriched GO terms
are dependent on bicluster size. In addition to GO annotations, they considered protein-protein interaction
networks. Biclustering algorithms have also been evaluated by defining a scoring method, called gene match
score, which uses a clustering method, Bimax, as a reference to test the effects of bicluster overlap and
experimental noise [51]. This research suggested that it might be more useful to use multiple algorithms in
conjunction, starting with a method to find all possible biclusters before applying another. Other scoring
methods that have been used include weighted enrichment (WE) scoring and protein-protein interaction
(PPI) network scoring. The algorithms were evaluated by the number of biclusters, ranking of the biclusters
generated based on WE scores and ranking of the biclusters based on PPI scores. The results suggested
that combining gene expression data with pathway maps within a biclustering framework could be useful to
focus on specific gene groups. Identifying particular pathways within gene expression data will play a key
role when evaluating the biclustering performance for this project. These studies demonstrate a movement
from performance analysis using ideal datasets and using more real data as a means to judge performance.
Performance evaluations are discussed further at the beginning of Chapter 7.
3.5 Beyond Feature Selection for GRN Discovery
The Dialogue on Reverse Engineering Assessment and Methods (DREAM) uses crowdsourcing challenges
to address fundamental questions in biology including how well current methods are able to describe interact-
ing molecules. One of the more recent projects, DREAM5, performed blind assessments of 35 GRN discovery
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methods, 29 of which had predicted networks from microarray data submitted by researchers in the com-
munity while the other 6 were common ready-to-use methods [14]. The predicted networks were compared
against binary gold standard networks. They were assessed by the precision vs. recall curve (AUPR) and
the AUROC, which shows the true positive rate vs. 1 minus the false positive rate of interactions between
genes. The methods evaluated included combinations and variations of linear regression, correlation, mu-
tual information, Bayesian networks as well as novel techniques put forth by researchers in the community.
Regression methods select transcription factors by target gene-specific sparse linear regression or by data
resampling techniques. Each gene is considered individually from the others and the expression value for
that can be represented as a linear function of all other gene expression levels and of all polymorphisms
[53]. The DREAM5 project found that the strategy used for resampling is important in these cases, as
the worst performing methods employed no data resampling or bootstrapping technique. These models can
also be combined with Bayesian linear regression models or learned using Markov models [14, 54]. Mutual
information methods such as context likelihood relatedness (CLC) [13] and Algorithm for the Reconstruction
of Accurate Cellular Networks (ARACNE) [55] have an advantage over correlation-based methods such as
Pearson Correlation since they do not assume monotonic relationships and so are able to detect non-linear
and irregular dependencies. These methods were outperformed by many independent contributors in the
DREAM5 project, but perform well when recovering feed-forward loops. Feed-forward loops have three
genes with three interactions between those genes. Gene A influences gene B, which will then influence gene
C expression (A → B → C) and gene A influences C (A → C). However, these methods had many false
positives for linear cascades [56]. The authors found methods such as Relevance Networks and Bayesian
Networks were better at predicting linear cascades as they are more likely to select regulators that indepen-
dently contribute to target gene expression. However, it is likely these methods are highly dependent on how
carefully the data is discretized in order to avoid any loss of information. Furthermore, if data resampling
techniques were applied to these techniques, they would likely only be applicable to smaller networks due
to performance constraints involved in heuristic searching. It is important to note that these methods were
used to measure global dependencies so any local dependencies within subsets of conditions may be missed.
Edge detection methods that are able to do this are comparable to other correlation based methods although
they may discover slightly more true positive localized relationships between genes [57].
One of the best performing algorithms reported in the DREAM5 project used a non-parametric, non-
linear correlation coefficient that is based on Analysis of Variance (ANOVA) [58]. The method performed
best when compared to the gold standard Escherichia coli network, but was unable to discover a higher
proportion of genes in the gold standard network for the eukaryotic species Saccharomyces cerevisiae as the
way the gold standard network was developed was strictly using ChIP-seq data. Data on physical binding
alone can result in false positive interactions unless complemented with a conservation-based motif discovery
algorithm [58]. Therefore, the authors speculate that many false positives are present in the gold standard for
Saccharomyces cerevisiae that GRN discovery methods would never identify based on the expression data used
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in the evaluations. GENIE3 was another top performing method, which uses tree-based ensemble methods to
calculate how important a predictor gene is with respect to a target gene, where greater importance signifies
a likely interaction or regulatory link between both genes [59]. GENIE3 decomposes the network discovery
task into separate regression problems for each gene in the network. The expression values of a particular
target gene are predicted using all other genes as possible predictors. The combination of multiple methods
also performed strongly though the quality of the networks was dependent on the information required by
each combination. The more limitations with information other than gene expression, the less accurate the
networks were. From these results, the project concludes that it is best to exploit direct transcription-factor
perturbations, employ strategies like data resampling to avoid overfitting, and develop better approaches to
differentiate between direct and indirect regulation.
Compared to GRN discovery using microarrays, little has been done to evaluate GRN discovery using
RNA-seq. There are several studies that have been conducted on RNA-seq data for gene network discovery
to compare it with generating GRNs using microarray data, but nothing done beyond observing changes in
the topology of the GRNs. Pearson’s Correlation of the gene expression data has been used as a similarity
measure in order to perform hierarchical clustering [60]. Pearson’s Correlation has also been applied using
a significant correlation threshold, called the Weighted Gene Co-expression Analysis (WGCNA) method,
which ranks the edges of a network based on variants of correlation [61]. The results are clustered based on
the topological overlap measure, which combines the adjacency of two genes and the connection strengths
these two genes share with other genes. It is recommended that 15 samples at a minimum including controls
are used to generate significant results, but the authors state more than 20 is ideal [62]. Both studies
compared RNA-seq expression data results to similar samples from studies using microarrays, and evaluated
the preservation of the network modules across the datasets. This was done by measuring properties of the
networks including pairwise relationships between genes, overlap between the networks discovered using each
technology and how similar the connectivity was between genes of both networks. It was concluded in both
studies that increased dynamic range of expression values and the accuracy of deep sequencing in RNA-seq
allowed for better estimation of these network properties. Higher correlation between some genes were found
in RNA-seq, which was concluded to be a consequence of genes with relatively low counts, which are not
picked up in microarrays due to high background noise. These interactions may result in a more accurate
network, although choosing an appropriate cut-off for low counts in RNA-seq studies is also important to
minimize false positive correlations.
Recent experiments with RNA-seq data have shown mutual information methods such as CLC and
ARACNE are outperformed by even simple correlation strategies such as Pearson or Spearman Correlation
[28]. Simple correlation strategies also outperformed methods like WGCNA in these experiments. WGCNA
has also been outperformed by regression-based methods like Sparse PArtial Correlation Estimation (SPACE)
in evaluations using microarray data [63]. When comparing RNA-seq network results to microarray, hub genes
were dissimilar between the two aggregate networks generated. Furthermore, highly correlated genes using
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one technology were not always well correlated using the other, though Gene Ontology (GO) term results
were similar across both networks. This was also the case for the individual networks. Recent consensus
measures have provided a cut-off for transcript expression estimates. If expression counts are under the
cut-off, they are not reliable in a RNA-seq pipeline, with the bottom one third of transcripts being a major
threshold [64]. Using this threshold, the authors determined the genes in the networks that would fall below
this threshold. They found that the genes under the threshold tended to have high node degree in GRNs
discovered using microarray experiments while RNA-seq experiments resulted in nodes with less edges. These
genes contributed many hub genes to the microarray GRNs, which is likely due to lack of sensitivity when
faced with noisy expression. One limitation of this evaluation is that machine learning algorithms were not
included in this study as a means to generate GRNs, only as an evaluation of the discovered networks using
correlation based and mutual information methods. Machine learning algorithms were only used when com-
paring GRNs generated from RNA-seq to evaluate how similar biological annotations from KEGG, GO and
Reactome were related to the connections between genes.
Another recent study used 72 samples of RNA-seq from Drosophila using a method based on Pearson
Correlation as well as one of the top performing methods in the DREAM5 project, GENIE3, to compare
the discovered networks to the gold standard transcription factor motif for eye development [65]. Although
comparisons between the networks discovered by each technique are limited, both the correlation and GENIE3
methods yield gene sets that represent candidate transcription factor targets, being a mixture of direct and
indirect targets. They recovered many known regulators and cis-regulatory elements, but a large part of the
predicted network has not yet been explored. This study along with the evaluation of current GRN discovery
methods applied to RNA-seq stresses the importance of large sample sizes. From RNA-seq evaluations, it
has been concluded that more than 20 experiments each with more than 10 samples of moderate read depth
( 10M reads for each sample) are required to produce accurate results although this conflicts with suggestions
made by the creators of WGCNA, for example [28, 65].
The general consensus of all of these evaluation studies is to construct consensus networks using multiple
GRN discovery methods to produce more accurate networks [14, 63, 28, 12]. Given the biological variation
among organisms and the experimental variation among gene-expression data sets, it is difficult to determine
which methods will perform optimally for reconstructing an unknown regulatory network without testing
many strategies. One method proposed, Network Inference using Multiple Ensemble Feature Importance
algorithms (NIMEFI), is to weight the results using all the GRN discovery methods to construct a network
based on their influence in constructing the final network. Combinations of importance algorithms as used in
GENIE3, for example, were also combined [66]. Another option is to combine results from the same methods
using various datasets to have more confidence in a GRN discovered. This has been done when comparing
multiple species to infer the evolution of a GRN [67]. Pairs of genes whose expression is significantly correlated
are identified in multiple organisms indicating co-expression is conserved across evolution. Pearson correlation
is traditionally used with microarray analysis for comparing expression profiles between every pair of genes
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for each organism. All of the genes are ranked according to the Pearson Correlation values to calculate the
probability of observing a particular configuration of ranks across different organisms by chance. There are
also options of combining information about interaction types present in the data [17]. One of the most
successful integrative approaches has been to overlay networks with molecular profiles to identify modules.
Molecular profiles include transcriptomic, genomic, proteomic, epigenomic and other cellular information,
which are becoming increasingly accessible. However, predicting molecular networks remains under-explored
at the systems level, as interaction data are typically measured under single conditions.
Module based inference methods such as clustering and biclustering are an appropriate starting point
if the set of expression data is large or heterogeneous compared to more direct query driven methods [12].
These methods are useful when there is no gold standard network or there is little annotation and sequence
information available. If a particular section of an already established network needs to be revisited, the
already reconstructed network can be used as a starting point to generate a GRN or expand upon a particular
piece of it. Biclustering was not involved in any of the method comparisons described previously, but it has
been used as a means to infer GRNs using it in combination with other information such as transcription
factor binding motif sequences [68]. Although using ChIP-seq data to complement the expression data can
allow for a more accurate reconstruction of a GRN, accuracy depends on how much information is available
about the transcription factors in the network. If only select transcription factors have this information
available, it can bias results to include more interactions involving these transcription factors when trying to
derive a GRN [12]. One method using this information is DISTILLER, which uses itemset mining combined
with ChIP-on-chip interaction data to search for evidence of co-regulation [69]. Other methods that employ
biclustering, such as cMonkey, employs Markov chains to model the biclusters while making use of upstream
sequence information as well as association networks and searches for over-represented de novo-detected
motifs to further support gene co-regulation and report sequence features responsible for the co-regulation
[68]. It has been reported that it is possible to identify co-expressed gene-sets in the subgroups of breast
tumour samples using this method [47]. Unfortunately, these methods have not been selected for any of the
major evaluation studies carried out including the BicAT toolbox, as cMonkey requires sequence binding
motif information and was not appropriate to make comparisons to other biclustering methods [70]. Due
to this response in the community, an updated version of this method was published earlier last year called
cMonkey2 claiming to improve its usability and it can also take other types of information as input such as
protein-protein interactions and ChIP-seq [19].
The BicAT toolbox is a means to compare the performance of biclustering algorithms and evaluated
methods based on GRN prediction [70]. After obtaining the biclusters, a Bayesian network method was used
to learn the subnetworks from the biclusters found and these subnetworks were then combined to make a final
GRN. Experiments conducted on datasets using the introduced tool revealed that biclustering algorithms
in general have advantages over the conventional clustering ones. To examine whether the performance on
the datasets is typical of all network reconstruction methods and is not particular to Bayesian networks
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with biclustering, the authors compared results with a linear regression method (LASSO). They found the
biclustering methods performed consistently regardless of the network reconstruction algorithm used. Current
evaluations using this toolbox have found there is no single algorithm that is able to discover all interesting
patterns so integrating results based on the enrichment of the output biclusters with gene ontology functional
categories is recommended in this case as well. However, they avoided evaluations of many biclustering
algorithms due to other information required to run them.
One final integrative biclustering method specifically for GRN prediction is COALESCE (combinato-
rial algorithm for expression- and sequence-based cluster extraction). COALESCE is a nondeterministic
greedy algorithm that seeks biclusters representing regulatory modules in genetics [71]. It finds up-regulated
and down-regulated biclusters starting with a pair of correlated genes, updating selected columns by two-
population z-test, motifs by a modified z-test, and then selects rows by posterior probability. Although the
algorithm was proposed to work on microarray data together with sequence data as well, sequence data has
not been used in evaluations [49]. Biclustering methods such as these and other Bayesian network methods
that fit a model to the entire dataset are less sensitive to noise, which is identified by a lot of methods
that only seek localized patterns. cMonkey2 has been evaluated by the authors against these integrative
techniques.
3.6 Limitations of Small Sample Sizes
Methods that are used to predict GRNs tend to be limited in accuracy when only a small number of
sampling points are available. When trying to predict interactions in a complex system, it is better to have
many more measurements than states, otherwise the system is largely under-constrained and can have many
solutions [72]. This is generally referred to as the curse of dimensionality and remains a challenge in GRN
prediction. Although integrating data types has been done with some success, there are still challenges as-
sociated with it as these various data types do not tend to be directly compatible. Indeed, even combining
microarray data across different platforms is difficult. When validating techniques for GRN discovery, re-
searchers tend to utilize samples in the hundreds [13]. One method to combat this may be feature selection,
where a much smaller subset of genes is selected from which a GRN can be predicted. Most commonly,
feature selection is performed using some method of clustering or using differential expression information
[31].
There are select studies that use only a handful of samples from there own research, but either validate
or incorporate information external to the studies [73, 74]. One study collected 4 time-series samples at
day 4, 8, 11, and 14 with 2 replicates of each in order to infer a network responsible for the differentiation
of one type of cell to another in humans [74]. However, they also had access to 52 microarray datasets
appropriate for weighting the gene pairs generated in their GRN prediction algorithm in order to determine
likely interactions. With prior information of genes more likely to function as transcription factors in humans,
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the accuracy of the predicted GRN improved further since they were able to restrict the number of possible
regulators. Generally, having data in different states allows for sample reduction as opposed to using steady-
state samples. Simulation studies artificially generating microarray data from artificial networks also indicate
that random perturbations contain more information about gene regulatory interactions compared to single
time series with an equivalent data size, even with a higher sampling rate [15].
Also, extensive information is available for the number of samples required depending on the type of
GRN an individual wished to predict [72]. However, these numbers are based on how each GRN prediction
method behaves theoretically. Currently the number of samples required has been studied for microarrays
and the number of data points required is known for simulated time-series data. Experimental performance
of ARACNE, SPACE, and WGCNA has been measured in relation to the number of simulated microarray
samples provided for each method. With 20 samples and 1344 genes, all of the methods performed better
than random, based on area under the ROC curve (AUROC) results, which measures the performance of
the algorithm across all sensitivity and specificity ranges [63]. Results continued to improve as more samples
were added.
Other research suggests an estimated 64 samples should be enough for researchers to obtain the best
possible predictions if considering precision, suggesting that any samples above this is superfluous [75]. These
results were observed with networks with sizes ranging from 100 to 1000 on synthesized time series and steady
state data as well as one real network from Escherichia coli of size 1146 and only with the C3NET algorithm.
C3NET works by trying to eliminate nonsignificant connections among gene pairs by testing the statistical
significance of pair-wise mutual information values [76]. C3NET can never predict more edges than genes as
the maximization step only allows a single edge to another gene so at most the number of edges will be equal
to the number of genes used for prediction. Therefore, a connection between two genes will correspond to the
maximum mutual information value between a gene and all its neighbours, which will also have the lowest
p-value. The author admits these results may not generalize to other methods, one reason possibly being
the study was limited to information-theory based algorithms that do not require only the gene expression
data with mutual information values and a cut-off for these values in order to eliminate non-significant
edges. Also, only one real microarray dataset was tested as well on a relatively simple organism with a
well studied network, which means the study may not be applicable to highly complex organisms, such as
vertebrates. Precision is used to evaluate C3NET since it is unable to predict more edges than genes present,
which increases the number of false negatives. However, this limitation is not a factor in this thesis because
only two transcription factors are focussed on, which will require more than a single connection from these
transcription factors to two other genes. Precision of a real network may not be more indicative of method
performance, as typically with real networks all of the actual interaction taking place within a network are
not known, which may inflate the number of false positives. Regardless of the precision of the network (time
series alone resulted is poorer performance compared to the steady-state data), the data converged around
the same number of samples and increasing this number did not further improve the networks.
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The number of samples necessary when combining data from various sources is not well established. There
is a question of whether data from other sources each count as a single data point depending on how the
data is integrated together (before or after initial network construction). It is also difficult to determine
accuracy of large scale GRNs in mammalian systems, as there is no gold standard to compare to presently
[77]. Currently for mouse datasets, the smallest found in the literature predicted a GRN with 21 samples,
which were only used to compare module conservation with microarray data [61].
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Chapter 4
Methodology for Analysis of Gene Expression in Skele-
tal Tissues
This chapter introduces the methods required for the bioinformatics analysis of RNA-seq data to determine
what evidence from gene expression may be observed to suggest that there are two GRNs driving development
of bone, immature and mature cartilage. The RNA-seq data from skeletal tissues, referred to throughout
the thesis, is introduced as well as how transcript quantitation, normalization and clustering analysis are
performed. The results are presented and discussed in Chapter 5.
4.1 Dataset Overview
RNA-seq data provides discrete counts of gene transcripts. There are generally a high number of genes
with very low expression counts (in terms of the number of transcripts), and expression levels of fewer
transcripts are characteristically high. There have been two underlying distributions proposed to model
RNA-seq data [44]. The first is the Poisson distribution, which tends to be used when analyzing technical
replicates. Therefore, to decrease the potential false positive rates due to underestimation of sampling error,
a negative binomial distribution is generally used to model data containing biological replicates, which tend
to contain an overdispersion or more variance in expression levels. In a Poisson distribution, the variance
should be similar to the mean, which is too restrictive for data containing biological replicates [1].
Nine samples with three replicates for bone, immature and mature cartilage from mouse, with a total
of 13302 genes, will be kept for clustering purposes. The genes selected for clustering were not necessarily
differentially expressed in one tissue when compared to the others, but had to be considered expressed over
a cut-off in at least one of the tissues. In order to confirm the distribution within the RNA-seq data for this
thesis, the samples were sorted by expression levels seen from lowest to highest and the density of expression
levels observed are displayed in Figure 4.1. The distribution of average log2 expression across three replicates
of each tissue was determined, producing three bimodal distributions. It is common practice to filter out
counts that are either close to zero across all samples as well as transcripts expressed at a low level as this
may be due to artifacts [78]. It is likely that these genes were expressed without any functional consequence
of interest. The initial peak represents genes with a very small number of counts that cannot be attributed
to any phenotypic characteristics. The second peak is indicative of a smaller number of genes that have
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Figure 4.1: Distribution of counts in immature cartilage before and after cut-off of 25 counts was
applied. The y-axes show the density of different amounts of gene counts. There is a higher number of
low gene counts and a smaller number of genes with high gene counts. Although these genes with low
counts could be informative, many are also likely to be un-informative, which could cause problems
with downstream analyses. Since the higher gene counts are likely more accurate, the minimum of
the bimodal distribution was selected as a cut-off, and the more highly expressed genes were kept for
further anlysis. For immature cartilage, the cut-off was 25 counts on average across all three replicates.
expression levels capable of influencing traits of each tissue. An appropriate cut-off to limit biological and
technical noise was determined by calculating the minimum value between these peaks before the peak of
significantly expressed genes.
Once low counts were filtered out, each expression profile had a distribution that looked closer to either
a Poisson or negative binomial distribution. Next, the mean of each gene for all samples was plotted against
variance to determine if the data had means similar to variance as in the Poisson distribution or if there
is overdispersion in gene expression. From Figure 4.2, a negative binomial distribution appeared best to
model the count data, as a negative binomial distribution can account for larger variance [44]. Therefore,
the expression levels within each tissue type is likely a mixture of this probability distribution.
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Figure 4.2: Plots of the mean expression of each tissue compared to the variation observed between
the samples for each tissue. The plots show a larger amount of variation than what would be expected
with a Poisson distribution.
4.2 RNA-seq Analysis Pipeline and Comparison to Sox9 and Runx2
Literature Networks
4.2.1 Mapping and Transcript Quantification
Paired-end RNA-seq data from mouse is available as raw transcript sequence reads obtained from Illumina
1.9 sequencing of bone, immature and mature cartilage tissues. These raw sequence reads were assessed using
FastQC [79] to check for low quality reads as well as over-represented reads from primer or adapter sequences
used in Illumina sequencing. Trimming was applied using the Java application Trimmomatic [80] to filter
out low quality sequences as well as possible adapters and primers present. This step resulted in forward and
reverse read fastq files. Any unpaired reads were discarded before aligning the reads to a reference genome.
The origin of each read was identified using the mapping and alignment programs called Tophat2 (version
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2.0.13) and Bowtie2 (version 2.1.0) respectively [81, 82]. Tophat is a commonly used spliced alignment
program that can be used for RNA-seq. Bowtie is the program that acts as the alignment engine for Tophat.
Tophat begins by aligning reads using a reference genome in order to construct the transcriptome. The
reference genome contains annotation in order to establish the position of the reads along the reference
sequence. There is a low tolerance for mismatches, as the reads may not be truncated at the ends if they
do not align. Bowtie2 is responsible for extracting the transcript sequences from the annotated reference
genome and if there are reads that do not align to this transcriptome construct, they are then mapped to
the original genome. The mm10 version of the mouse genome annotation files from Ensembl were used as a
reference. Once mapped, the files were sorted by read names to count the reads per gene. Mapping-based
assembly is done in order to obtain transcript counts to construct gene expression matrices. The Python
program HTSeq [83] was used to obtain discrete transcript counts for each sample, which is a deviation from
the traditional workflow using the Tuxedo suite of tools including Bowtie2 and Tophat2. HTSeq produces
raw transcript counts, where Cufflinks, the third program in the Tuxedo suite, produces counts that have
already been normalized to obtain FPKM (Fragments Per Kilobase per Million mapped reads) values [84].
However, there is some speculation as to how effective this normalization method is for comparisons to be
made across samples and it may be best used for within-sample comparisons of genes [85]. FPKM corrects
raw counts based on the transcript lengths as well as the sequencing depth and this correction is not affected
by results of any other sample. Therefore, it was decided that access to the raw counts would be necessary
for other normalization methods as well as to give more flexibility when determining differential and fold
change expression levels. In this case, trimmed mean of M-values (TMM) normalization was used to correct
for library size as comparison between samples in this case does not require normalization due to different
transcript lengths. HTSeq locates the exons where the aligned reads overlap and groups the overlapping
counts based on gene ID.
4.2.2 Venn Diagrams of Genes Expressed in Skeletal Tissues
Venn diagrams will be generated using gplots in R with lists of genes considered expressed above back-
ground in each tissue. The genes that are unique to each tissue will be determined by selecting the genes that
are grouped in the outer portions of the Venn diagram. These are the genes that had counts high enough
to be considered expressed in only a single tissue. In the other tissues the counts have to fall below each
tissue-specific expression level cut-off. To determine the section of the diagram a gene should be grouped,
the cut-off minimum for each tissue was 18, 24 and 25 for bone, mature and immature cartilage respectively
from Section 4.1. These are the same cut-offs determined from the bimodal distributions representing each
tissue. This is why no gene will be left out of the Venn diagram using these thresholds. Although these genes
may be considered expressed in at least one tissue type, they are not necessarily differentially expressed when
compared to expression levels of the same genes in the other tissues. For example, some genes may have
similar expression, although in one tissue expression of the gene falls just below the cut-off.
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4.2.3 Normalization and Differential Expression
Differential expression can be used to identify genes that are expressed in significantly different quantities
when comparing groups of samples. The counts were normalized with TMM (trimmed means of M values)
using edgeR from Bioconductor, which is a batch normalization technique dependent on the total counts
across all samples and is not designed for single sample normalization as with FPKM [86]. It has performed
well when compared to other normalization methods that also attempt to resolve isoform expression levels [4].
Pairwise differential expression will also be performed in this thesis using edgeR, a tool containing methods
for the normalization of raw count data collected from HTSeq. This tool is capable of handling data that
follows a negative binomial distribution such as what is obtained from RNA-seq with biological replicates. It
is recommended that genes with small counts across all conditions be removed before performing differential
expression [7]. Therefore, genes considered for differential expression analysis were filtered using the cut-offs
used to construct the Venn diagrams to remove genes considered unique. The most up-regulated and down-
regulated genes in bone, immature and mature cartilage will be determined from the pairwise comparisons
by selecting genes in one tissue that were up-regulated compared to both other tissues or down-regulated
compared to both. These gene lists will be compared to the genes present in the Sox9 and Runx2 literature
networks using set operations in R.
4.3 Model-Based Clustering
One method of detecting patterns of gene expression in high-dimensional data is to use a clustering tech-
nique where genes are grouped together based on expression, implying they are more likely to be functionally
related. A model-based clustering approach will be used to identify co-expressed genes in RNA-seq datasets,
which employs either a Poisson or negative binomial mixture model to postulate the over-dispersed gene
count data. Current methods available for model-based clustering for RNA-seq data including biological
replicates involve a modified Expectation Maximization (EM) algorithm called MBCluster.Seq [1]. The ex-
pectation maximization (EM) algorithm allows for the estimation of probabilistic model parameters when
not all data is known. In the context of clustering, the data considered incomplete is the gene assignments
to each cluster. The EM algorithm requires one step to compute probabilities for each possible completion
of the gene-to-cluster assignments using what is currently known. This creates a weighted training set to
provide updated model parameters such as the means and covariance of the genes currently assigned to each
cluster.
4.3.1 Algorithm Description for Model-based Clustering
Each number in a RNA-seq expression matrix represents a discrete RNA transcript count representing
the gene expression level for every gene. It was necessary to obtain the expression profiles that are the
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log-fold-change (log-FC) values in order to determine whether a gene is up-regulated, down-regulated or has
close to a neutral difference in expression. This measures the expression level of gene g in treatment i relative
to the overall mean expression of that gene across all tissues. Due to high dimensionality (# of genes) within
gene expression data, grouping genes of interest using clustering algorithms is a useful method of detecting
possible patterns in expression across tissue types.
To take advantage of the underlying mixture of distributions in the skeletal tissue data, model-based
clustering will be used to detect patterns in the RNA-seq data. The method below uses the EM-algorithm
where:
Observed data x: RNA-seq measurements of expression
z: unobserved latent factors which are the assignments of the gene clusters
θ: parameters of means and covariance matrix of the negative binomial distributions representing
expression patterns for each cluster.
Responsibility of each cluster k = p(z=k|θ)p(x|z=k,θ)∑
k′ p(z=k′|θ)p(x|z=k′,θ) , where k
′ is over all clusters.
A more detailed version of model-based clustering specific to gene expression is described in [1], is briefly
explained here and is utilized from the MBCluster.Seq R package. Currently, this is the only method available
for clustering RNA-seq data specifically by taking into account the distribution of the data, which is different
than microarray data. In order to cluster using the EM algorithm, presented for this method, with the
data for this project, k = 10 cluster centers were selected, represented by µk = (µk1, ..., µkI). Each µk is
a expression profile of a single gene, and I is the number of conditions or treatments represented by the
samples.
The negative binomial model the algorithm uses has two parameters. One is the mean, which is calculated
as logλgij = αg + βgi where αg is the geometric mean gene expression of gene g, and βgi is the expression
level of gene g in treatment i relative to the overall mean expression. The second parameter estimated by
the algorithm is the overdispersion φg, which will compensate for increased variance in the model compared
to the mean where V ar(Ngij) = λgij + φgλ
2
gij .
The density of the negative binomial distribution or the likelihood of gene g belonging to the kth cluster
for all genes being clustered can be represented as
∏
g
∑
k pkf(Ngij |αgk, βg = µk), which can be based on
the negative binomial distribution in this case. Ngij is the count of reads mapped to gene g for replicate
j of treatment i and pk is the weight of a class (
1
K ) or how likely an observation belongs to cluster k,
where K is the total number of clusters. For this algorithm, the authors assumed independence among the
genes although this is likely not the case. However, it is not practical to model and estimate the correlation
among thousands of variables such as genes with only several replicates and no prior knowledge about the
relationship between the variables.
Instead of choosing the cluster center genes uniformly at random from all genes and using their expression
profiles as the initial cluster centers, the program only selected one cluster center uniformly at random and
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then set the additional centers gradually by selecting genes based on the distance between each gene and
each of the selected centers. The likelihood f(Ngj |αgk, µk(1)) is maximized with respect to the geometric
mean expression (αgk) for each combination of gene g and cluster k.
Once the cluster centers are selected, they are passed manually to the method containing the EM algo-
rithm. The EM algorithm is composed of an E step to calculate the expected complete data log-likelihood
that each gene g is in a cluster k. The next step is to maximize f with respect to αgk for each gene g
combined with each cluster k. For this algorithm, the responsibility, or Zgk, is the variable indicating if gene
g if in cluster k. It equals 0 if g does not belong to the kth cluster and 1 if it does belong. All of the indicator
variables in this case are treated as unknown data (Z = Zgk : g = 1, . . . , G, k = 1, . . . ,K). The following
portion of the algorithm will then iteratively calculate conditional expectations of Z and update the model
parameter estimates.
The EM algorithm consists of the following steps:
1. E step: Calculate the conditional expectation of Zgk given the parameter values from the previous
iteration, where m is the iteration number. In other words, given all the current values of the model
parameters, determine the cluster k, that gene g will fit best in, to obtain a distribution describing
class/cluster k.
Z
(m)
gk =
p
(m)
k f(Ngij |αgk, µ(m)k )∑
l p
(m)
l f(Ngij |αgl, µ(m)l )
2. M step: Update the parameter estimates of the model.
µ
(m+1)
k = argmax
∑
g
Z
(m)
gk logf(Ngij |αgk, µ(m)k )
p
(m+1)
k =
∑
g Z
(m)
gk
G
α
(m+1)
gk = argmaxαgkf(Ngij |αgk, µ(m+1)k )
3. Repeat until the change in the log likelihood is small.
4.4 Differentially Expressed and Unique Isoforms
In order to generate a transcript count table as opposed to a gene count table, RSEM will be used in
order to predict which RNA-seq reads come from each isoform [87]. Genes can be transcribed beginning
at different sites, include different coding regions (exons) and different end points, which results in different
mRNA sequences, thus potentially changing how the gene functions. These variations of the same gene are
referred to as isoforms, as opposed to genes, which encompasses all variations of the gene. Using RNA-seq as
opposed to microarray allows the potential to estimate expression of different gene isoforms. A gene could
have multiple isoforms with some up-regulated while other isoforms of the same gene are down-regulated. At
the gene level, this differential expression could be masked if the up-regulated and down-regulated isoforms
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cancel each other out or it could result in up-regulation or down-regulation overall for the gene even if the
opposite is true for select isoforms, which could lead to misleading results or conclusions.
Using a workflow that has been published for RSEM [87], a transcription reference and index files for
Bowtie2 are constructed using the reference genome for mouse from Ensembl. Next, the reads are aligned
to the transcriptome using Bowtie2. Since isoforms of a gene normally share a significant portion of their
sequences, the read mapping uncertainty increases dramatically. Thus, the first command, rsem-generate-
ngvector clusters isoform sequences into 3 clusters according to each isoform’s hardness of being mapped
uniquely [87]. Then, EBSeq estimates the mean and variance parameters separately for each cluster [88].
It is important to note that estimated counts are not the same as raw counts and therefore common
differential expression software such as DeSeq and edgeR are not recommended to calculate differential
expression [88]. After the estimated counts, rsem-generate-data-matrix extracts the estimated expected
counts from each sample and then generates a count matrix GeneMat.txt that can be used by EBSeq to
perform differential expression of isoforms.
After differential expression is performed using EBSeq, controlling false discovery rate at 0.05, the posterior
fold changes between tissues were converted to log2 fold change values and significant differential expression
was considered to be above 2 or below -2 fold changes. Isoforms will be separated based on up-regulation
and down-regulation to determine the isoforms that are only up-regulated in a single tissue. The cut-offs for
the isoforms will be set to the original values from Section 4.1 (gene counts: IMM=25, MAT=24, BON=18)
using the same strategy as for gene counts to determine if there are particular isoforms most likely dominant
to others for a particular gene, although there will also be more genes falling below these cut-offs if the counts
are divided among multiple variants.
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Chapter 5
Results of Applied Bioinformatics Analysis to RNA-
seq Data from Skeletal Tissues
This chapter covers analysis of the similarities and differences between bone, immature and mature
cartilage based on the gene expression information obtained using RNA-seq data. The purpose is to test
the hypothesis of two GRNs driven by Sox9 and Runx2, and to determine how the extent these GRNs may
be interacting with each other in each of the tissues. One method used to analyze the differences between
the three tissues will be to analyze genes only expressed in one of the tissues. The reason unique genes are
important is that they can help provide evidence for or against the hypothesis of a completely additive GRN.
If mature cartilage has gene expression which is a complete mixture of what is found in the other two tissues,
then there should not be any genes considered unique. Furthermore, they can help identify genes that are
more likely to be under control of Sox9 and Runx2. Each tissue’s gene expression profile will also be analyzed
using differential expression and clustering to observe to what extent they share similar gene expression in
order to determine if it is more likely the GRNs driving development are interacting.
5.1 Comparison of RNA-seq Data to Literature Networks for Sox9
and Runx2
5.1.1 Venn Diagrams of Genes Expressed in Skeletal Tissues
Genes identified in RNA-seq as uniquely expressed in either bone, immature or mature cartilage will be
used to determine the number of genes present in the Sox9 and Runx2 networks available in the literature.
The literature networks come from two publications discussed earlier in Section 3.3, which use silencing of
Sox9 and Runx2 to determine genes that could potentially be up or down-regulated by these transcription
factors. A large portion of genes are considered unique in the RNA-seq dataset that do not appear in the
differentially expressed gene lists from the publications. The genes in the Runx2 literature network was
limited to the genes that appear in the microarray data. How genes were defined as unique to a tissue is
further described in Section 5.1.2.
The Venn diagram, showing gene expression overlap of bone, immature and mature cartilage in Figure
33
5.1, indicates that mature cartilage has a lot fewer genes that are uniquely expressed compared to the other
two tissues. Only 321 genes are considered uniquely expressed in mature cartilage compared to 639 in bone
and 513 in immature cartilage. Furthermore, the majority of gene expression is above cut-off in all three
tissues (10239). Mature cartilage and bone have more overlapping genes expressed above cut-off (857) than
bone or mature cartilage have overlapping with immature cartilage (228 and 505, respectively). In particular,
bone has the least number of expressed genes in common with immature cartilage, due to the small number
of genes above cut-off in only these two tissues (228). There is minimal overlap in the genes present in the
literature networks for Sox9 and Runx2 and the genes expressed above cut-off in at least one tissue. More
genes overlap with those present in the Sox9 literature network likely due to the number of genes in the
network (849) compared to the 200 genes in the Runx2 literature network. However, a higher number of
genes considered to be in the Runx2 network are present in the overlapping genes between bone and mature
cartilage (17, with 8 up-regulated) compared to bone and immature cartilage (1). The single gene from the
Runx2 network in the overlap of genes expressed in bone and immature cartilage is also down-regulated.
More up-regulated genes in the Sox9 network are also present in the overlap between immature and mature
cartilage (51) compared to bone and mature cartilage (33). There is also a higher number of genes from the
Sox9 literature network that are down-regulated, but still expressed above cut-off in both bone and mature
cartilage (26) compared to immature and mature cartilage (1).
The unique genes expressed in each tissue also have a small portion of overlapping genes with the literature
networks as shown in Figure 5.2. In immature cartilage, there is only 1 down-regulated gene from the Runx2
network and 29 overlapping with the Sox9 literature network. The genes considered unique in mature cartilage
and bone samples also have a higher number of genes overlapping with the Sox9 literature network, although
with a few more that are down-regulated. However, bone and mature cartilage also has more genes that are
considered down-regulated in the Runx2 literature network than up-regulated genes.
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Figure 5.1: Venn diagram of genes expressed in bone (BON), immature (IMA) and mature (MAT)
cartilage. Genes are divided into differentially expressed genes also in the literature networks for Sox9
and Runx2. The red indicates genes in the RNA-seq data for bone, immature and mature cartilage
also in the literature networks that were reported as down-regulated. The green numbers are genes in
the literature network that were repoted as upregulated. The numbers at the center are genes present
in both networks as well as whether they are up-regulated or down-regulated in the Sox9 (left) and
Runx2 (right) networks.
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Figure 5.2: Venn diagram of genes uniquely expressed in bone, immature and mature cartilage
showing overlapping genes with the literature networks. Genes are divided into differentially expressed
genes in the literature networks for Sox9 and Runx2. The red indicates genes down-regulated in the
literature networks while green indicates genes up-regulated.
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A higher amount of overlap between mature cartilage and the other two tissues may be indication that
mature cartilage has genes being expressed in a similar amount to one tissue or another with fewer genes
being expressed only in mature cartilage. Also, since bone and immature cartilage have a lot fewer genes
expressed that are not expressed in mature cartilage, it is likely their gene expression is the least similar.
This suggests that the GRN active in immature cartilage does not have the same influence in bone as there
are less genes expressed above threshold in both tissues. From these results it also seems that the current
literature networks may not be an accurate depiction of the genes in the Sox9 and Runx2 networks present
in these skeletal tissues. It may also be that the RNA-seq data available for bone, immature and mature
cartilage is not appropriate for determining potential Sox9 and Runx2 networks accurately. However, the
smaller number of unique genes expressed in mature cartilage, as well as the large overlap between genes
expressed in all three tissues may be evidence that the GRNs functioning in these tissues share a lot of
similarities. Mature cartilage, in particular, has gene expression similar to either bone, immature cartilage
or both, more often than having uniquely expressed genes. Further analysis to explore these trends is done
using model-based clustering in Section 5.2. Another benefit of using RNA-seq is that, potentially, isoforms
can be identified that contributes more or less to the expression of a gene as a whole. An initial exploration
of splice variants is performed in Section 5.3.
5.1.2 Differential Expression
Genes that are considered unique, as described in Section 5.1, are not automatically considered differen-
tially expressed in the following analysis. A unique gene is defined as a gene with counts above a cut-off in
only one tissue, meaning it is only considered expressed in that tissue. If a gene is considered uniquely ex-
pressed, or below cut-off for unique expression in all three tissues, it is also not considered to be differentially
expressed. A gene can only be categorized as differentially expressed if it is expressed above cut-off, and
considered expressed in more than one tissue. This way, unique genes and differentially expressed genes are
separated into distinct groups for analysis. The genes that were differentially expressed in one tissue versus
the other two tissues were determined and the number, for each tissue, appears in Figure 5.3. The mature
cartilage RNA-seq samples have fewer genes that are considered up or down-regulated compared to immature
cartilage and bone with only 41 genes up-regulated compared to both bone and immature cartilage and only
1 down-regulated gene. Of the up-regulated genes, only one gene in the mature cartilage RNA-seq data is in
the Runx2 literature network and 2 genes are in the Sox9 network. The down-regulated gene, Selenbp1 in
the RNA-seq data, does not overlap with either network. The tissue with the most overlapping genes with
the Runx2 and Sox9 network is bone. The Sox9 literature network contains 19 genes that are up-regulated
by Sox9 and down-regulated in the RNA-seq bone samples. Genes that are up-regulated in bone include
6 genes down-regulated by Sox9 in the literature network as well as 3 that are up-regulated by Sox9. In
the immature cartilage RNA-seq samples, 8 genes apparently up-regulated by Sox9 in the literature network
were down-regulated in the immature cartilage RNA-seq samples. Over all, not many genes in the literature
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networks overlapped across any of the tissues.
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Figure 5.3: Number of genes significantly differentially expressed in one skeletal tissue compared to
both other tissues. The number of genes overlapping with the literature Sox9 and Runx2 networks
are shown above each bar. Red numbers indicate genes that are down-regulated by Sox9 or Runx2
and those in blue indicate genes up-regulated by Sox9 or Runx2. Genes with significantly different
expression: up-regulated >2 or down-regulated <-2 log2-fold change was used as a cut-off.
These results suggest that not only is mature cartilage gene expression similar to the gene expression
driving immature cartilage formation, but it is also very similar to bone gene expression. Since mature
cartilage does not have many genes that are differentially expressed compared to bone and immature cartilage,
it suggests that the majority of the gene expression is similar in some way to either immature cartilage or
bone. Furthermore, the genes that are differentially expressed in mature cartilage compared to both tissues
are almost all up-regulated with only one gene considered down-regulated. Therefore, the GRN driving
mature cartilage formation may produce some synergistic effects. It is hypothesized that they would have
opposite influence on gene expression where Sox9 down-regulates a gene and Runx2 up-regulates the gene
or vice versa. This is because Sox9 is dominant to Runx2 so it has to be suppressed if Runx2 is going to
influence gene expression. However, perhaps both transcription factors are able to up-regulate some of the
same genes, leading to higher expression in mature cartilage compared to both immature cartilage and bone.
This is further discussed in Section 5.2. The tissues where Runx2 should have the most influence on gene
expression, bone and mature cartilage, have very few overlapping genes with the Runx2 network (6 and 1
respectively). These results further highlight limitations with either the current network, the RNA-seq data
or both due to the lack of overlap between genes in both networks as well.
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5.2 Model-based Clustering
Model-based clustering of gene expression patterns across the skeletal tissues is performed to determine
if there is evidence that the 2 GRNs driving bone and cartilage development interact with each other in
mature cartilage. Principle component analysis (PCA) was performed on the data using prcomp from the
stats library in R to determine if the biological replicates of each tissue separated into distinct groups based
on gene expression variance. The covariance matrix of the data was also calculated using R in order to
determine the eigenvectors and eigenvalues present, which are explained by Abdi et al. [89]. The largest
eigenvalues were present in the first two eigenvectors and they explain the majority of the variance in the
data. The first component explained 52.3% of the variation while the second component explained 18.8% of
the variation. The bone replicates contain a lot less variation compared with the other tissues and overlap
with the 95% confidence ellipse of the mature cartilage samples. This suggests that mature cartilage and
bone have genes that vary from immature cartilage, but are similar to one another. It may be an indication
of the genes that are distinct from the Sox9 GRN in immature cartilage that make mature cartilage and bone
distinct tissues with GRNs that possibly include regulatory control by Runx2. The variation seen in bone
also varies orthogonally to mature cartilage and immature cartilage in coordinate space.
The algorithm from 4.3.1 was used to perform global clustering on the gene expression profiles across
all three tissues. Each cluster was analyzed by comparing average expression levels in each cluster, which
clusters had genes from the Sox9 and Runx2 literature networks and where Sox9 and Runx2 are located in
the clustering results.
5.2.1 Results
The algorithm from MBCluster.Seq 1.0 package in R, was used to cluster genes based on expression
profiles into 10 clusters as specified manually shown in Figure 5.5 [1]. Figure 5.5 shows gene expression that
has been clustered according to similar patterns observed in expression across all three skeletal tissue. The
clustering was visualized using the hybrid-hierarchical clustering capabilities provided, which begins from an
initial partitioning of the genes, then merges the smaller clusters repeatedly to obtain a tree structure. We
hypothesize that the majority of mature cartilage gene expression is a mixture of both immature cartilage
and bone expression, which is supported upon visual inspection of Figure 5.5 [8]. The average gene counts
for each cluster in Figure 5.5 show most clusters have an average expression for mature cartilage, across all
genes in the cluster, that is between the average expression of immature cartilage and bone. The exceptions
are cluster 1 and cluster 8, which have higher gene count averages in mature cartilage than the other two
tissues. The expression in cluster 1 is higher in mature cartilage due to several mitochondrial genes that were
placed in this cluster and have much higher expression in mature cartilage compared to all the other genes
grouped in this cluster. Therefore, overall, this cluster appears to have higher expression observed across all
the genes inside the cluster for immature cartilage, while there is more variability in gene expression observed
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Figure 5.4: PCA of biological replicates for bone, immature and mature cartilage. This was done
to visualize any strong patterns of variation within the dataset. It appears that mature cartilage and
bone may have more similar gene expression patterns to each other compared to immature cartilage.
Bone also appears to have less variation across biological replicates.
in mature cartilage.
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Figure 5.5: Visualization of model-based clustering with bone, immature and mature cartilage using
MBCluster.Seq [1]. The gene expression was transformed to have a mean entered at zero. Expression
higher than the mean is indicated by red, while yellow and white are lower than the mean expression
across all three tissues. Bone expression is indicated by the first row of expression values followed
by mature cartilage in the second row and immature cartilage in the final row. Each column (line of
colour) indicates expression for a single gene, with the tissue type depending on the row. The numbers
from 1 to 10 along the bottom indicate the cluster number.
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Table 5.1: Average gene counts for each tissue, in each cluster
Cluster 1 2 3 4 5 6 7 8 9 10
Immature 9192.00 995.53 18.90 444.79 34.96 514.65 502.30 9869.25 579.42 277.52
Mature 14020.66 560.53 332.52 569.25 756.54 282.58 498.84 34719.66 487.39 535.05
Bone 455.35 156.61 382.13 865.47 5539.89 234.91 329.71 1717.56 614.86 1219.93
Sox9 and Runx2 are present in clusters 1 and 3, respectively. Cluster 1 has 55/423 genes from the Sox9
literature network while only 1 gene from the Runx2 network, which is down-regulated. This seems to
indicate most genes in this cluster might be associated with the Sox9 network. However, it should also be
noted that genes from the network are present in every cluster with cluster 4 having the greatest number
from the network, while also being one of the largest clusters. Cluster 3 has 9/86 genes from the Runx2
network, with the highest number of genes from the Runx2 literature network present in cluster 4.
Table 5.2: Number of genes from Sox9 and Runx2 literature networks separated by up and down-
regulation. Sox9 is in cluster 1 and Runx2 is in cluster 3.
Cluster 1 2 3 4 5 6 7 8 9 10 Total
# in Sox9 network 55 (0,55) 47 (4,43) 41 (19,22) 82 (14,67) 22 (7,15) 33 (4,29) 55 (6,49) 25 (4,21) 38 (7,31) 25 (5,20) 423
# in Runx2 network 1 (1,0) 9 (4,5) 9 (5,4) 17 (10,7) 7 (1,6) 5 (5,0) (7,8) 5 (5,0) 6 (1,5) 12 (7,5) 86
# in cluster 327 1208 485 3699 263 1314 2133 382 2584 907 13302
% in Sox9 network 16.8 3.9 8.5 2.2 8.4 2.5 2.6 6.5 1.5 2.8
% in Runx2 network 0.3 0.7 1.9 0.5 2.7 0.4 0.7 1.3 0.2 1.3
*Sox9 *Runx2
If the proportion of genes is normalized using the total genes in each cluster, shown in Table 5.2, cluster
1 contains the largest proportions of genes from the Sox9 literature networks when compared to the size of
each cluster with 16.8% of the genes overlapping. This cluster has similar gene expression in immature and
mature cartilage, with lower expression in bone. Therefore, the genes clustered with Sox9 are likely genes
from the Sox9 network that do not interact, or are not influenced by, genes in the Runx2 network. The
clusters with the most overlapping genes from the Runx2 literature network are in cluster 3 and cluster 5
with 1.9% and 2.7% of overlapping genes, respectively. Cluster 3 contains Runx2 and both of these clusters
follow a gene expression pattern of lowest expression in immature cartilage and highest expression in bone
and mature cartilage. These genes are more likely to be influenced only by the network driven by Runx2,
with little influence due to Sox9 expression. The clusters where Runx2 and Sox9 are clustered support that
there are parts of each network that are present and active in mature cartilage, but these parts of the GRN
are not interacting with each other to influence the expression of these genes. If genes in mature cartilage
are sorted into categories of having expression closer to immature cartilage or bone or if expression is closer
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to an average between the two, 4667 genes have expression more similar to immature cartilage, 4015 genes
are more an average of both tissues while 4620 have expression more similar to bone. Cluster 8 appears to
have many genes that are up-regulated only in mature cartilage.
The results of model-based clustering have provided several clusters containing monotonic relationships,
where genes differ in expression across all tissues in a by increasing or decreasing if analyzing a gene’s
expression across immature cartilage, mature cartilage and bone, respectively. This may help to identify
genes that distinguish mature cartilage from the other tissues, not necessarily up or down-regulated, but
that have different expression in mature cartilage compared to the both immature cartilage and bone. If
these genes have not been used as probes in microarray studies to characterize mature cartilage than it could
demonstrate the benefits of this RNA-seq method in comparison and provide more genes to classify that
tissue type.
One reason for establishing a list of genes possibly in the Sox9 and Runx2 networks is to determine how
they overlap and if gene expression in one GRN has an effect on the gene expression in another. From visual
inspection of the clusters it looks like mature cartilage is usually an average of the gene expression present
in the other two tissues for each gene. However, further inspection shows that there is a large portion of
the genes in mature cartilage that either share more similar expression levels with one of the other tissues.
This appears to occur almost evenly between immature and bone tissue. This seems to support the idea that
mature cartilage, although a distinct tissue, has independent regulation of these genes by one GRN. Some
gene expression in mature cartilage is an average of expression in immature cartilage and bone indicates the
suggests some interaction between both GRNs in the same tissue. When mature cartilage has gene expression
more like immature cartilage, these genes are likely from the Sox9 GRN and those genes that express similarly
in bone might be from the Runx2 GRN. For example, cluster 1, which contains Sox9 has genes in mature
cartilage that are more similar to expression in immature cartilage as opposed to an overall average. Further,
cluster 3, containing Runx2, has genes with expression in mature cartilage more similar to bone. The only
genes in cluster 1 showing higher expression in immature cartilage overall compared to immature cartilage
are mt-Rnr1 and mt-Rnr2, which skews the overall expression average and is not indicative of the pattern
observed with the other genes in the cluster. As both of the networks driven by these two transcription
factors drive the formation of bone and immature cartilage when acting independently of each other, mature
cartilage shows similar gene expression with one tissue or the other instead of a mixture. Therefore, these
clusters may contain many genes that show the most differences in expression between the two GRNs as
opposed to the genes that may be present in both networks.
5.3 Preliminary Analysis of Splice Variants
Mature cartilage has 293 isoforms that are considered up-regulated with log2 fold changes greater than
2 compared to bone and immature cartilage. Immature cartilage and bone have 442 and 492 up-regulated
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isoforms respectively. This mirrors results for genes as well, where mature cartilage has the least number of
genes up-regulated only in mature cartilage. The genes that have a dominant isoform or have only particular
isoforms differentially expressed between tissues could show genes that are not considered differentially ex-
pressed when the sum of counts across all isoforms are considered, but there is differential expression among
the isoforms when analyzed individually. Examples of these genes in mature cartilage, for example, would
be Lmo7-002, which has a log2 fold change of 1.5 (indicating no significant differential expression using our
cut-offs) when comparing genes across immature cartilage and bone, but is not picked up as differentially
expressed in mature cartilage. There are also genes that do not show up as differentially expressed genes, but
have up-regulated isoforms like Mybph-201. In the future it will be necessary to determine if this information
is due to different isoform expression in the unique genes or if it can be attributed to differences between
EBSeq and edgeR methods of detecting differential expression.
5.3.1 Unique Isoforms
This chapter concludes with a preliminary analysis of unique isoforms found in the RNA-seq dataset.
The normalized dataset without a set cut-off contains 103,639 isoforms. Using the same cut-offs applied in
Section 5.1.1, results in a total of 20,664 isoforms. Of these isoforms, there are 12,746 genes, with 8,681 of
these genes only have a single isoform expressed above the cut-off in at least one tissue. Table 5.3 shows the
number of genes with a number of isoforms. There are very few genes that have expression level high enough
that more than 10 isoforms have expression levels above cut-off. Sox9 only has a single isoform, which is
expressed above cut-off where Runx2 has 2 out of 13 expressed above cut-off. Figure 5.6 shows that mature
cartilage has the smallest number of uniquely expressed isoforms compared to bone and immature cartilage,
much like what is seen in Section 5.1.1. There is also still less isoforms expressed above cut-off between bone
and immature cartilage compared to the isoforms in common between bone and mature cartilage as well as
mature and immature cartilage.
Table 5.3: Distribution of genes by number of isoforms above cut-off
Number of isoforms 1 2 3 4 5 6 7 8 9 greater than 10
Number of genes 8681 2617 1060 437 161 77 38 20 4 8
5.3.2 Conclusion
The limited knowledge currently available describing the regulation of skeletal development could be
further elucidated with the accurate measure of gene expression using RNA-seq technology. In order to utilize
this data, the genes expressed in each tissue was plotted as a Venn digram. This showed a large number
of genes expressed in all three skeletal tissues suggesting that the tissues require a lot of the same genes to
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Figure 5.6: Venn diagram of all isoforms expressed above cut-off in bone (BON), immature (IMM)
and mature (MAT) cartilage.
be expressed in order to develop. Furthermore, mature cartilage has the least number of uniquely expressed
genes, with most gene expression that is above cut-off shared with either bone or immature cartilage. This
supports the idea that the GRNs in immature cartilage and bone do not have as much interaction as in
mature cartilage. This is also supported by fewer genes being expressed above cut-off that are shared only
between immature cartilage and bone. The literature networks for Sox9 and Runx2 that were compared to
have little overlap with all three tissues. However, there were more genes from the Runx2 literature network
that overlapped with bone and mature cartilage compared to immature cartilage. This suggests that the
Runx2 network has more influence on bone and mature cartilage development. The differential expression
results also did not have much overlap with the literature networks, but also show that mature cartilage
shares a lot more gene expression with the other two tissues, which have more genes that are differentially
expressed. Using model-based clustering on RNA-seq data specifically is a relatively new concept that may
be capable of grouping expression trends present across different tissue types. RNA-seq data from cartilage
and bone tissue in mouse was appropriately modelled using a mixture of negative binomial distributions.
Therefore this data appeared appropriate for evaluating the performance of this clustering algorithm and its
ability to separate the different molecular processes occurring in each skeletal tissue. The transcription factors
of interest were clustered into distinct groups and show evidence of the potential relationship between the
Sox9 and Runx2 GRNs. Identifying a proficient means of analyzing expression data from skeletal tissue could
contribute to further study of skeletal development using comparison across multiple species and ultimately
comparisons being made between the molecular mechanisms of normal tissue development and degenerative
skeletal conditions.
It will be of interest in the future to determine gene isoforms that play a dominant role in influence
expression compared to the other isoforms of that same gene and if these isoforms are also differentially
expressed when comparing bone, immature and mature cartilage. This could help to determine if there is a
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large portion of isoforms that are not identified as differentially expressed when considering gene expression
of all isoforms together. It is unlikely that genes such as these would have been considered in analyses before
if they have not been picked up in typical differential expression analysis. This data may also be used in the
future to add more detail to GRN prediction using skeletal tissues, but this is currently outside of the scope
of this thesis. In order to add this information, a comparison of edgeR and EBSeq differential expression
results will have to be done beforehand.
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Chapter 6
Methodology for GRN performance Evaluations for
RNA-seq Data
This chapter describes the methodology that will be used to compare several biclustering algorithms,
which is one method that can be used to predict GRNs, capable of grouping genes and conditions based
on gene expression patterns. The biclustering algorithms are described as well as the metrics used to make
comparisons. The results for biclustering comparison using RNA-seq data from skeletal tissues is presented
in Chapter 7. This chapter also describes the methodology used to compare other machine learning methods
for GRN prediction. This will involve using a well-described network in mouse, with available datasets, in
order to have a gold-standard network to compare to GRN prediction results produced by each method. The
results of GRN prediction methods compared to a literature network available is presented in Chapter 8.
6.1 Comparison of Biclustering Methods for GRN Discovery
In order to choose an algorithm to handle similar, yet functionally distinct tissue types, an analysis of
the SAMBA, Plaid and FABIA algorithms handling RNA-seq data from mouse will be performed. These
three algorithms were selected because of their accessibility as well as to test algorithms that have differences
in performance when handling different tissue samples in previous studies as discussed in Chapter 7. Each
algorithm tested can be used with RNA-seq data, though previous studies had only tested their ability to
handle microarray results.
A comparison will be made between these three methods, and how they divide the biclusters based on
tissue type, to determine if one, or any, provided a better solution to addressing differences between these
skeletal tissues. The biclustering algorithms will be judged based on two criteria. First, based on their ability
to differentiate various sample types, and second, based on how the groups of genes discovered by the methods
are annotated using GO enrichment analysis to measure the biological relevance of the biclusters produced
by all of the biclustering methods. The biological relevance of the biclusters will also be measured using
what is currently known about the gene networks involved in skeletogenesis, with focus on the transcription
factors Sox9 and Runx2 and the biclusters that contain them. It is possible that other genes within the
same biclusters as these transcription factors are candidates for further studies on the molecular basis for
skeletogenesis.
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6.1.1 Biclustering Programs
Plaid The Plaid algorithm uses a series of additive layers over the gene expression matrix to try and
explain the underlying structure [90]. Each layer is similar to a two-way Analysis of Variance (ANOVA)
model between genes and conditions that represent different biclusters. There is also a background layer
containing all the genes not currently in a bicluster. Samples and genes are located within a layer if they
have a strong expression pattern that cannot be explained by the background layer. The algorithm fits
this model using binary least squares to iteratively update cluster membership parameters of the genes and
conditions to minimize the variance of expression levels within the current layer or bicluster.
SAMBA SAMBA [91] models gene expression data as a bipartite graph where each condition and gene
is represented as a node of the graph while probabilistically assigned weighted edges connect them if a
gene responds under the condition. Genes that have a degree of difference over a certain size, meaning
their expression levels differ past the point of a selected threshold, are ignored. The subgraphs with more
connectivity than the overall graph correspond to biclusters with a high likelihood.
FABIA FABIA involves Factor Analysis, which will take gene expression data and attempts to explain it
with a smaller set of parameters or factors [50]. The program uses a variation of the Expectation Maximization
(EM) algorithm in order to iteratively estimate the noise of the observations, in this case expression values,
and the most likely weight of the connections between the observations and the factors, or biclusters. This
version of the algorithm used a Laplacian prior in order to enforce sparseness, meaning that weak connections
between observations and a bicluster will have weights that quickly drop to zero. Once a good estimate of the
parameters is found, the biclusters are ranked based on information content or the weights of the connections
found in each bicluster. More connections and higher weights suggest high information content within a
bicluster.
Plaid and FABIA are available in R in Bioconductor packages biclust and fabia respectively [50, 92].
SAMBA is an open access Java program available in a package called EXPANDER that can be run with the
Windows operating system [93]. The parameters required by each algorithm vary from thresholds set for the
number and size of biclusters to the number of iterations for each particular algorithm. The parameters are
left at the default values except for the number of biclusters generated, which is the number each algorithm
was able to create with the highest tissue separation without causing an error on a 2012; Mac with 3.1 GHz
dual core processor and 16 GB of RAM based on initial testing. The biclusters each program generates will
be selected for analysis of tissue differentiation and biological significance. Each program will be run 20 times
with a different number of set biclusters. The number of biclusters with the highest average tissue separation
score (defined below) will be selected for analysis and the run that results in the highest tissue separation
score will be selected to compare across the biclustering methods.
48
6.1.2 Evaluation Metrics for Plaid, SAMBA and FABIA
Plaid, SAMBA and FABIA will undergo preliminary evaluations to determine how well each tissue could
be identified based on gene expression patterns as well as how distinct both the groupings of functional
annotations and the transcription factors are between each bicluster.
Tissue type differentiation A biclustering metric was implemented, described in the recent evaluation
performed in [47], in order to determine how well distinct expression patterns in a tissue were grouped
together. This metric was used as an indication of how well each algorithm was able to identify each tissue
type correctly, which required the tissue type replicates that were present in each bicluster. The tissue
replicate names present in each of the biclusters were extracted and the level of overlap was calculated
between each bicluster and a list containing all the replicates of each tissue type. The formula is as follows.
f(bicluster, tissue) = 2
Tissues in bicluster ∩ Total replicates tissue
Total number of tissues in both lists
This should give a result of 1 if the tissue types in a bicluster all match the three replicates from a single tissue
with no extra samples. The quality measurement was calculated using this matrix by finding the maximum
value in the matrix, saving it in a vector and deleting the row and column it was present in. This procedure
continued until the matrix was empty and produced a vector of maximum values. The overall quality score
is the mean of all the values in this vector.
Gene Ontology Enrichment Analysis The biological relevance of clustering using actual data can also
be inferred from GO enrichment analysis, which is one of the most widely used gene-based benchmarks for
biclustering methods [94]. This benchmark provides an estimate of the quality of the biclusters by assessing
the genes contained in each. It indicates how significantly the sets of genes discovered by a biclustering
method are enriched with a similar GO category provided by the Gene Ontology Consortium. Genes are
assigned to bins of GO terms, which can be as general as “biological process” to more specific terms such as
“apoptosis” or a location based on functional characteristics. Not all genes are annotated with specific terms
as their functional characteristics may still be unknown, but it can provide an indication of what types of
functional roles these genes may play by reexamining the other genes with which they are grouped together.
GO enrichment analysis will be performed using a web-based program FuncAssociate 2.1, which reports
GO terms that appear more frequently than would be expected by chance when examining the set of terms
annotated to the input genes [95]. The program has up to date associations available from mouse, downloaded
from the Gene Ontology Consortium with 14633 associations available to the 9132 genes clustered in this
dataset. In this program, a Fisher’s exact test is used to estimate a p-value describing the probability of a
term being equally or more frequently observed in another group of genes in the background set. In order to
ensure results from this analysis were statistically significant, the genes chosen for the background comparison
set includes all of the genes in the RNA-seq dataset and not all genes that could possibly be observed in
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mouse. If the background set were to contain all genes in mouse, then the significance would be artificially
increased for groups of genes associated with skeletal cell development, possibly even for biclusters containing
two or three of these genes. With microarray studies, having a background that includes all genes in the
genome may increase the number of enriched terms as the microarray dataset is limited to specific probes or
genes. With RNA-seq, there is the potential that any gene could be picked up as expressed, so there may
be an argument there to keep all genes in the background set, but limiting to just what is expressed means
a researcher can be more confident in the enriched terms found. The p-value will be adjusted using 1000
re-samplings of these genes and a p-value cut-off of 0.05 for every GO term. This method can also contribute
to the discovery of other pathways of interest depending on the process in which the bulk of genes found in
each bicluster are known to be involved.
6.2 Performance Evaluation of GRN Prediction Methods in Mouse
Selected machine learning algorithms using random forest, biclustering techniques and correlation-based
methods will also be compared in their ability to retrieve true positive interactions from a complex mammalian
GRN using RNA-seq data with varying sample sizes, in comparison to microarrays. There will also be some
exploration as to whether the addition of ChIP-seq could improve prediction for parts of the networks.
Biclustering will then be applied as a means of feature selection to RNA-seq datasets from skeletal tissue
and ChIP-seq datasets for the main transcription factors Sox9 and Runx2 proposed to be the genes driving
expression throughout the rest of the GRNs in cartilage and bone respectively. The GRN selected for
evaluations using different numbers of samples was the embryonic stem cell (ESC) network with ChIP-seq
from two of the main transcription factors characterizing this cell type.
6.2.1 Na¨ıve Embryonic Stem Cell (ESC) Gene Regulatory Network
Currently, no gold standard GRN is available for complex organisms including mammals such as mouse
[77]. As such, it remains difficult to evaluate GRN prediction methods for complex organisms. However,
cases of well-described networks such as pathways to control pigmentation, tooth, eye and heart development
are described [77, 96, 97]. Another commonly studied GRN used for testing GRN prediction methods is the
ESC self-renewal and pluripotency network [32, 98, 99]. Mouse ESCs are pluripotent cells derived from the
inner cell mass of early blastocysts. They can be maintained in vitro for extended periods without loss of
their capacity to contribute to all cell lineages when re-implanted back into a blastocyst [100].
The literature-based stem-cell network is a regulatory network extracted from low-throughput studies
reported in the stem-cell literature [101]. The network is created by combining data from 271 publications,
and it contains cell-signaling and gene-regulatory links that can be direct or indirect. The networks have been
updated in the Embryonic Stem Cells Atlas of Pluripotency Evidence (ESCAPE), but have not been used
in this case as ESCAPE uses ChIP-seq and RNA-seq/microarray samples and learn the predicted networks
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Figure 6.1: Embryonic stem cell transcription factors Pou5f1 (Oct4) and Nanog direct interactions
for comparison to ChIP-seq interactions and integration.
to include more interactions. The microarray data used to predict the ESCAPE interactions will also be
used for evaluations in this thesis where ESCAPE does not use the RNA-seq being evaluated. Therefore, the
more gene expression or ChIP-seq samples similar to those used to predict the ESCAPE networks, the more
“accurate” the network may be, which may cause the microarray data to give much better predictions. There
are 146 genes, 249 unique interactions in the list and of these, 97 are transcription factor binding interactions
that could theoretically be identified using ChIP-seq. 62 of these interactions should be possible to infer
from the RNA-seq available alone, and more if ChIP-seq is also considered. For example, only 5 TF-binding
events can be inferred for Pou5f1 using the RNA-seq data as the other genes were not in the data. However,
there are a total of 17 TF-binding events reported for this gene in the known literature interactions, more of
which are contained within the ChIP-seq data.
GRN prediction methods have been evaluated using high-throughput data from ESC [32, 98]. However,
the datasets currently used for evaluation are microarray time-course, silencing or overexpression studies
although there are several studies available for RNA-seq data with a large enough sample size to attempt
GRN prediction tests. Additionally, many data samples are available for single cell RNA-seq, which were not
selected to evaluate these methods due to the noise inherent in these datasets, but are an option if hundreds
of samples are required for GRN prediction. They require different normalization methods and more samples
to obtain accurate gene counts and therefore any conclusion made using this data may not be applicable to
our own RNA-seq data if these datasets have a different level of accuracy.
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In order to compare to results obtained using microarray datasets, two experiments were selected from
Array Express E-MTAB-3234 and E-MTAB-2830, containing 48 samples and 30 samples respectively, to give
a total of 78 samples to use for testing GRN prediction methods for consistency and accuracy based on
sample size used to predict the GRNs. It should be noted that if single-cell RNA-seq is not used to generate
samples, experiments with a large number of samples are usually from in vitro studies, which are artificial
by nature, as opposed to in vivo as it is much more difficult. It can be time consuming, and possibly even
impossible depending on the species, to generate a large number of samples. This number was determined to
be appropriate based on other simulated measures of sample size generally being between 60-70 samples that
allow for performance above random [76]. The researchers originally collected these samples with different
miR-142 levels due to Cas9 silencing in embryonic stem cells starting from before differentiation and then
through the process of differentiating to an endoderm precursor. Pluripotency-associated genes are in charge
of regulating this specification of cells [102]. Therefore, it is a combination of time-series and perturbation
data.
Besides forming the regulatory circuit, the three core transcription factors Oct4, Nanog and Sox2 con-
tribute to the hallmark characteristics of ESCs by activation of target genes that encode pluripotency and
self-renewal mechanisms and repression of signalling pathways that promote differentiation [102]. Focus-
ing on Oct4 and Nanog, two of the commonly studied transcription factors, will be done to determine the
effect on the specificity of this part of the network, and to determine if RNA-seq is able to contribute to
information about this part of the network as well as being used to predict interactions without direct in-
fluence of these transcription factors. The silencing of Oct4 makes it impossible for cultured embryos to
form stable cell lines. Both of these transcription factors are necessary to maintain pluripotency [103]. The
other important transcription factors are not included in evaluations due to lack of good quality samples.
Furthermore, it mirrors the focus of Sox9 and Runx2 in skeletal tissue. It is highly unlikely these are the
only two transcription factors that are important for skeletal tissue development, but these are the only two
being utilized for GRN prediction. In most cases of GRN discovery, knowledge of all important transcription
factors might not be known. We would like to determine if the top performing algorithm outlined in the
DREAM5 project, GENIE3, is improved using ChIP-seq data provided that not all transcription factors in
the data have ChIP-seq data available. Therefore, using the output of these programs, the objective is to
determine if using ChIP-seq improves the true positive rates of these methods, where true positives are the
predicted interactions currently known to occur. It was also necessary to determine which method predicts
the most true positives and the least false positives with a network of equal size to the literature ESC net-
work. If no method is able to predict interactions correctly for an already reduced subset of 126 genes, then
there is not much hope of current methods to predict accurate GRNs for complex organisms where little
may be known about what genes are involved in these networks. Open source programs available with the
potential to incorporate ChIP-seq data in different styles were selected for testing against all of GENIE3,
Pearson and Spearman correlation. One biclustering method specific to GRN prediction will be tested as
52
well as a random forest method extended from GENIE3, but both are able to make use of RNA-seq and
ChIP-seq data without integration of other data types. cMonkey2 has the potential to be compared to the
other biclustering algorithms evaluated in Chapter 7, which currently are unable to utilize ChIP-seq data
within the biclustering process.
6.3 Random Forest
Random forest is an ensemble method for classification, or regression in this case, where weaker models
are combined to create a stronger model [104]. Assume the number of samples in the training set is N . A
randomly selected subset of N samples with replacement is used for training to grow a decision tree. Many of
these decision trees are made to model a response variable, each based on a randomly selected subset. What
decides how the samples are split into children nodes in the tree is chosen randomly from a set of predictors
that are available to select based on their ability to decrease the nodes impurity. Individual decision trees
tend to overfit the data, so averaging over multiple decision trees is done.
6.3.1 GENIE3
GENIE3 first generates a sample where the expression profile of gene j is the output and the expression of
all other genes in the sample is the input. Genes that are strong predictors for gene j expression profiles are
considered the genes regulators. A decision tree is constructed for each gene j 1000 times (using bootstrapped
samples) where the root of the tree contains all observations which are split into subsets that are more similar
than those in the parent node, which is shown in Figure 6.2. These trees are averaged in order to get the
most likely genes regulating gene j. The importance score (IM) is described as the total decrease in node
impurity due to the splitting based on gene j. If D is a node in a tree, the IM is calculated as follows:
IM(D) = Samples(D) * Var(genes D) - #Samples(D leftchild) * Var(genes leftchild) - #Samples(D rightchild) * Var(genes rightchild) .
The importance measure in higher when there is a high number of nodes with low variance in the par-
ent compare to its children once the genes are split again [106]. Using gene k as a predictor for gene j:
IM(gk) is equal to the sum of all nodes with split on gk importance measure divided by the total number of
trees.
6.4 ChIP-seq Data Integration
Integration of ChIP-seq will be done using ChIP-seq available for Oct4 (Pou5f1) and Nanog from Whyte
et al. as sequence quality scores after trimming were high without removing a large portion of the sequences
for mapping [107]. Alignment and normalization of the RNA-seq data from ESC was performed as described
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Figure 6.2: Diagram of random forest method used by GENIE3. Part A shows the target gene g
expression ratios as well as three other genes potentially influencing g. There are three experiments, or
samples. In order to determine how to split the data to begin constructing a tree, GENIE3 attempts
to minimize the variance of gene g expression values, which should group the samples into groups that
show similar responses for gene g (shown in Part B). A visualization of the tree after the first split
is shown in Part C. In this case, a threshold of 0.5 was selected to split the samples into two groups.
This pattern continues to create more splits in the tree until no more splits can be made [105].
in Chapter 7, Section 4.2.1. ChIPseeker 1.8.3 in R will be used to annotate the peaks found with Model-based
Analysis of ChIP-Seq (MACS) 1.4.2 and only peaks found within 3000 base pairs of a transcription start site
(TSS) of a gene were kept for integration purposes with the methods below. In this thesis, the main GRN
prediction methods that are focussed on are correlation-based methods, random forest and biclustering.
6.4.1 iRafnet
One limitation of GENIE3 is that it is unable to incorporate data other than microarray and RNA-seq
in order to make interaction predictions. Recently, iRafnet adapted GENIE3 with the potential to adapt
and incorporate other sources of heterogeneous data [108]. The method uses a weighted sampling strategy
where the gene expression data is considered the main input data to make inferences using the random forest
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technique as with GENIE3, but also utilizes other data, such as protein-protein interactions (PPI), knockout
or ChIP-seq data to derive prior information before incorporating the gene expression data. This prior is an
indication of how likely an interaction occurs between two genes. At each node of the random forests that
are generated to model the expression value of gene g as a function of potential regulators, a random set of
data is selected and N potential regulators are sampled according to the prior information, or weights, for
that data.
The authors claim that this integrative method can be adapted for information including transcription
factor (TF)-DNA-binding, which can be obtained from ChIP-seq [108]. However, it has not been implemented
to work with the program to generate an appropriate weight matrix to calculate weights, nor was a description
to generate the weight matrix for this particular data included in the paper. It is also possible a researcher
may wish to focus on increasing accuracy of the network for particular transcription factors of interest when
they likely do not have access to data on all the predicted transcription factors in the network or the resources
to generate the data for all transcription factors. It is also not known if biasing to the random forest algorithm,
which averages results across many trees, will pick up a select few transcription factors.
As iRafnet does not describe how to integrate ChIP-seq, an attempt was made here. In order to bias
iRafnet to a smaller set of transcription factors, every gene that does not appear in Nanog or Oct4 ChIP-
seq data, but has the potential to regulate other genes, are weighted evenly. All genes that do have these
transcription factors potentially influencing them gets a different weight, which is dependent on how close
the genes are to the binding sites of the transcription factors. A probability is adapted from MACs, which
reports a p-value indicating the likelihood a transcription factor is influencing gene expression of a particular
gene based on where in the genome it is binding to influence transcription. This allows all genes to have the
possibility of being part of the larger network, for future exploratory work or formulating hypotheses, but
should give more confidence to the genes regulated by the transcription factors that appear in the ChIP-seq
data. A benefit of integrating ChIP-seq in this manner is that every gene can still take part in the network
if there is enough evidence from the expression profile that it is a part of it, while focusing on increasing the
accuracy of the network for transcription factors of interest. The algorithm used within iRafnet to accomplish
this is given in Algorithm 5.1.
Algorithm 6.1: Adaptation of iRafnet step A1 calculations for all target genes
r ← number of potential regulators (all transcription factors possibly in the network)
n ← number of samples
imp ←matrix(0,p,p) #p by p matrix to store importance
p ← total number of genes
For(j in 1:p){
#matrix zj of expression profiles of potential regulators (n by r)
zj ← expression matrix[TF names, ]
#matrix xj containing expression profile of target gene j
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xj ← expression matrix[j, ]
#sampling weights
sw ← vector(size← nrow(expression matrix), prior value)
sw[‘‘Nanog”]← Macs pval
sw[‘‘Oct4”]← Macs pval
#normalize the probabilities
sw ← sw/sum(sw)
rout ← RF(x= sw(sorted), y= xj, importance= TRUE, mtry= round(sqrt(p)), ntree= 1000, sw= as.
double(sorted), numsource= 1L)
imp[index, j] ← c(importance(rout)[,2])
#the kth element of this vector will be the importance score placed on gk −> gj
}
The program has been adapted in order to include ChIP-seq datasets for as many transcription factors as
are available although only two will be used for downstream experimentation. To test iRafnet using ChIP-seq
data, different weighting schemes will be applied:
1. using the normalized maximum −10 ∗ log(p− value), which is the smallest p-value reported for each
gene interaction with Oct4 or Nanog,
2. reducing the weight of the interactions reported in the ChIP-seq data,
3. all weights of potential regulators equal (No ChIP-seq data influence).
This is only one potential method to integrate the data. For example, there may also be other strategies
integrating the data at different stages of the program or perhaps after the program has run in order to
identify key regulators.
6.4.2 cMonkey2
To compare outside biclustering methods to integrated versions specifically for GRN prediction, cMonkey2
is a program available that has its own biclustering method as well as the potential to integrate data from
other sources than expression data such as ChIP-seq and PPI networks [19]. Originally, cMonkey did not
receive much use in the wider community, perhaps due to it making use of sequence information, which other
biclustering algorithms tend not to, thus making it difficult to compare and therefore be established as a good
GRN predictor. However, it is now possible to compare results with cMonkey2, which works by enriching
clusters for gene sets which are expected to include additional evidence for co-regulation (ie. genes under the
same regulatory influence from ChIP-chip/seq) in order to find co-regulated modules. The algorithm works
by calculating an enrichment score and, in order to predict the network structure, uses a program called
Inferelator (described below) to predict the network.
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First, the cMonkey2 pipeline needs to be overridden with a new file including the gene enrichment scoring
function. Second, a JSON file is created with groups of genes (gene sets), which is obtained from ChIP-seq
data, in this case from the genes potentially regulated by Nanog and those potentially regulated by Oct4
(including the genes themselves in the gene sets). Given these gene lists that possibly overlap, the enrichment
scoring function determines the amount of overlap between these genes annotated in each set and the genes
in each bicluster for every iteration using Fisher’s exact test. The gene set that results with the smallest
p-value for each bicluster is used for training, and row scores are generated to increase the probability that
genes stay in a bicluster if they are in the enriched set and tries to add more genes from the set if possible.
The authors explain the gene scores are computed by a simple heuristic where they multiply the log10 of
the p-value by 1.0 for genes which are in the bicluster and are members of the enriched set; by 0.5 for genes
which are in the set but are not in the bicluster; and by 0.0 for all other genes.
6.4.3 Inferelator
After biclustering is performed using cMonkey2 to group genes into modules, Inferelator can be used to
predict transcription factors that are most likely regulating the genes present in each bicluster. The program
uses linear regression LASSO [109]. Since the main focus of this project is to predict interactions of select
transcription factors and not necessarily include protein-protein interactions of any gene not also considered
a transcription factor, this program was also selected to compare to iRafnet as it may also be used with and
without ChIP-seq data. The output of cMonkey2 was modified in order for Inferelator to make predictions,
as Inferelator was originally designed for cMonkey and has been minimally updated.
6.5 Evaluation
Testing these programs with ChIP-seq data is an attempt to answer if and how adding samples of RNA-seq
with the application of ChIP-seq data allows for improvement of the GRN prediction accuracy. Furthermore,
it is desirable to know how much the consistency of the interactions improves during each run of the program.
This will determine whether interactions predicted by ChIP-seq alone begin to disappear with the addition
of new samples from expression profiles, and at what point this begins to happen.
These methods will be evaluated in terms of the number of true positives compared to false positives to
determine how confident a researcher can be in a predicted network for a complex organism. This will be
used as opposed to accuracy since with gene regulatory networks, there are a lot of true negative interactions
due to the sparse nature of biological networks [76, 110]. A method that makes no prediction will still
achieve high accuracy since the number of true negative interactions is large in comparison to true positives,
false positives and false negatives. One limitation to the methods is that they make many predictions so
without thresholding in some way the number of false positives compared to true positive interactions will
be high. For example, GENIE3 will predict interactions multiple times with different importance values so
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if there are 100 genes to predict interactions there are (100) ∗ (100 − 1) possible interactions, but GENIE3
can produce a result of 100000 interactions or more if no maximum is specified. To compare against the gold
standard network the number of predictions will be minimized to 250 in order to compare the 248 “known”
interactions. cMonkey2 was selected for generating an initial prediction for the Sox9 and Runx2 networks as
a feature selection method to compare to the other evaluated biclustering methods. The resulting network
was visualized in Cytoscape [111].
To ensure the RNA-seq data selected is appropriate for evaluations, the same analysis will be done for
GENIE3 and Pearson correlation using microarray data that has been used previously to predict the ESC
network [98]. Finally, the predicted GRNs from each method will be compared to each other to determine
how often these methods are making similar predictions to each other using the same sized GRNs. The
methods used to make the comparisons described above are further explained in Chapter 8.
6.6 Microarray and RNA-seq Comparisons
6.6.1 Generation of ROC curves
Rates of true positives, true negatives, false positives and false negatives were calculated as follows:
True positives (TP): True positives are calculated by determining the number of predicted interactions
that are in the list of known interactions, which is done by determining overlap between dataframes in R.
False positives (FP): False positives are the number of predicted interaction that are not in the list of
known interactions from the literature.
False negatives (FN): False negatives are equal to the number of known interactions that are not in the
list of predicted interactions, meaning the program failed to predict this number of interactions.
True negatives (TN): True negatives are calculated by first determining the number of unique genes in the
list of interactions and then calculating all possible combinations of these genes not including self-interactions.
The number of false positives, true positives and false negatives are subtracted from this number.
Ten predicted GRNs will be generated for each method excluding cMonkey2, which will have five predicted
GRNs due to the length of time required to run the program. The true positive rates and false positive rates
will be plotted to generate a Receiver Operator Characteristic (ROC) curve. True positive rates and false
positive rates will be calculated as follows.
True positive rate: = TP(TP+FN)
False positive rate: = 1− TN(TN+FP)
In order to calculate these values, the number of possible interactions that could be predicted from the ESC
literature network is required. Only 126 genes are present in the RNA-seq data so not all 248 interactions
from the literature network have the potential to be predicted by any method. This was also the case for
microarray data with only 60 genes from the literature network. Therefore, only the interactions that could
be produced will be included for comparisons, so that sensitivity (true positive rate) and 1-specificity (false
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positive rate) could reach 1. ROC curves will be plotted using R and the area under the curve (AUROC) will
be calculated using the trapezoidal method in the flux R package. The number of genes used in the RNA-seq
dataset will also be minimized to the same set of genes available in the microarray dataset to determine if
the number of genes used to predict the GRN in this case changes the performance of GENIE3.
6.7 Measuring Consistency of GRN Prediction Methods
The consistency of each algorithm using RNA-seq data will be determined using the top 250 predicted
interactions and determining how many are different on average across all runs of the algorithms. The top
250 interactions were selected for some comparisons for two reasons. The first is that recent evaluations in
literature using this network have used this cut-off [98]. Secondly, the importance values begin to plateau
after roughly 246 interactions in the random forest methods, where the confidence of interactions does not
change as drastically. Therefore, it was assumed that after this point, the consistency of results would change
by greater margins since the order of very similar importance values could shuffle. All 78 samples will be
used to predict the GRNs to ensure there is no difference in the samples that were used by each algorithm.
When comparing an algorithm to itself, each list of predicted interactions will be compared to all other GRNs
predicted. When comparing two different algorithms, the same run from each method will be compared to
generate an average. The importance measures from GENIE3 will be plotted in R to determine if there is a
natural point at which to cut-off the number of possible interactions. Furthermore, using randomly selected
subsets of RNA-seq samples, the average number of differences will be calculated between 10 runs of GENIE3
in order to determine if more samples correlates with a decrease in the number of differences between two
predicted GRNs. In order to investigate the consistency of results produced by GENIE3 depending on the
number of samples used, the 78 samples will first be split into distinct subsets of equal size. Six GRNs will
be predicted using sample sizes from 6 to 13 since a maximum of six GRNs can be made using 13 distinct
samples. Secondly, the number of overlapping interactions will be plotted for each sample size. Results of
these comparisons are presented in Section 8.3.
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Chapter 7
Evaluation of Biclustering Methods using RNA-seq
Data from Skeletal Tissue
Performance analysis of current biclustering algorithms was recently conducted on microarray data [47,
49]. The first group of researchers measured the performance of 12 biclustering algorithms by evaluating
each bicluster on artificial datasets generated from six different models as well as evaluating the genes of
biclusters discovered in expression data of rat peripheral and brain regions. The second and most recent
study focused on the ability of 15 biclustering or clustering methods to distinguish various sample types
rather than their performance in discovering various bicluster patterns in the data. It was found that the
groups of genes discovered by CTWC, FABIA, ISA, Plaid, SAMBA and hierarchical clustering were enriched
with GO terms and performed acceptably for both distinct tissues and breast tumours. Furthermore, CTWC,
Plaid, SAMBA, hierarchical clustering, constant MSBE and FABIA methods best distinguished the sample-
types in the expression matrix containing multiple tissues. Overall, Plaid was found to be a robust method
when tested on the five heterogeneous tissues used consisting of expression data with bicluster structures
with small overlaps on their genes and samples. Plaid was also found to work well with the rat peripheral
and brain regions as well as the multi-tissue samples studied by Hochreiter et al., who proposed FABIA
as a biclustering algorithm [50]. FABIA uses a similarity measurement in combination with the Munkres
algorithm to estimate the sample differentiation and when it was compared to Plaid it was out-performed
when handling multiple tissues, but the best option when handling tumours from breast tissue alone. Due to
the results of this most recent paper correlating to the performance analysis of other evaluations described,
biclustering method evaluation in this thesis has been narrowed down to SAMBA, Plaid and FABIA. These
three algorithms were selected for evaluations using skeletal tissue because of their accessibility as well as to
test algorithms that have differences in performance rank when handling different tissue samples in previous
studies. If skeletal tissues have gene expression typical of tissue subtypes then FABIA would be expected to
marginally outperform Plaid and SAMBA due to high tissue gene expression similarities. If gene expression
were distinct enough between the skeletal tissues, Plaid or SAMBA would be predicted to outperform FABIA.
An appropriate method should not necessarily separate all the tissues, but be able to identify patterns unique
or similar across the skeletal tissues. Each algorithm tested was also applicable to RNA-seq data though
the previous studies tested their ability to handle microarray results. Therefore, in this chapter, we discuss
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the results of comparing these three biclustering methods using skeletal tissues to determine if any of the
methods are able to produce potentially biologically relevant results.
7.1 Results
Figure 7.1 shows the results of tissue sample differentiation. FABIA outperformed SAMBA according to
the tissue separation metric, with an average separation of 90% in the best run, but was unable to group all
three replicates of immature cartilage and bone as distinct tissue types. Plaid was able to distinguish between
all tissue types in at least one bicluster. This means there were three separate biclusters each containing
all three replicates of one tissue to give a tissue separation score of 100%. Mature and immature cartilage
were grouped together in the remaining biclusters with only one bicluster containing bone, which did not
share an expression pattern across genes in the bicluster with other tissues. Biclusters 4 and 6 only contained
select replicates from mature and immature cartilage. SAMBA produced biclusters with an average tissue
differentiation of 63% and discovered more localized expression patterns across two or all three tissue types.
There were fewer genes contained in each bicluster than those found using Plaid and FABIA.
Figure 7.1: Results of tissue differentiation analysis for Plaid, FABIA and SAMBA biclustering algo-
rithms. Plaid was able to detect local gene expression patterns distinct to each tissue (IMM=Immature
cartilage, MAT=Mature cartilage, BON=Bone). FABIA was able to distinguish all mature cartilage
replicates while SAMBA was unable to discover any localized expression patterns unique to a single
tissue.
There was significant enrichment observed in all six biclusters produced by FABIA containing terms
particular to bone and cartilage development similar to terms found in biclusters from Plaid and SAMBA. Two
biclusters contained terms associated with wound healing such as coagulation, platelet derived growth factor
binding and other blood related terms. One bicluster from each of the other two methods also produced terms
of this nature mixed with other, more general terms, including wound healing and coagulation. Plaid also
produced enriched biclusters although the bicluster containing only mature cartilage produced no enriched
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terms and many terms that were enriched were not specific to skeletal tissue. Figure 7.2 shows a comparison
between the number of enriched terms in biclusters produced by Plaid and FABIA. The complete tables of
GO terms for all three methods can be found in Appendix 2.
Plaid was able to produce multiple biclusters containing Runx2 (bicluster 1 and 4), but no cluster con-
tained Sox9 in the run selected with a tissue separation score of 100%. Runx2 was present in biclusters
separating bone from both other tissues. Sox9 was sometimes, but not always, present in a bicluster. Sox9
and Runx2 are required in biclusters. This is because in order to make a predicted GRN with these tran-
scription factors as the main drivers of genes in the GRN, they and genes sharing similar expression patterns
are required to make predictions for interactions involving Sox9 or Runx2. Therefore, since Plaid does not
consistently produce at least one bicluster containing Sox9, the program cannot be used for feature selection.
Runx2 was present in two biclusters using FABIA (bicluster 1 and 5) with immature or mature cartilage
present in each bicluster. These biclusters could contain genes that are located in both networks driven by
these transcription factors that share activity in mature cartilage. FABIA also produced distinct biclusters
that contained Sox9 (bicluster 4) and Runx2 (bicluster 1). Both of these clusters were annotated with terms
for cartilage and bone development respectively. Sox9 did not appear in any of the biclusters found using
SAMBA including those annotated with cartilage development terms. Runx2 was contained in only one
bicluster (bicluster 4) including terms associated with bone development in the presence of cartilage tis-
sue including “endochondral ossification”, “replacement ossification” and “biomineral tissue development”.
However, all three replicates of bone were not present in this cluster, and they contained replicates of both
immature and mature cartilage.
All of the biclusters produced by SAMBA produce significantly enriched terms associated with bone and
cartilage tissue. The GO terms enriched within SAMBA biclusters were occasionally more specific then Plaid
and FABIA resulting in terms such as “collagen type IX” and “FACIT” collagen - which includes collagen
types IX, XII, XIV, XIX and XXI [112] - as well as more general terms such as “limb morphogenesis”.
The expression patterns of the genes within the collagen associated biclusters show up-regulation in the
clustered mature cartilage tissue. There were, however, other terms consistently present in biclusters using
all techniques containing bone tissue including those associated with cell migration, motility and locomotion.
The bone samples in the RNA-seq dataset were from neural crest cells, which are migratory cells, which
explains these terms. Cartilage samples were from the limb, which is a possible explanation for terms like
“limb morphogenesis”.
7.2 Discussion
Since not all replicates for a tissue were present in a single bicluster for some cases across all three
methods, this suggests that there is a chance that these patterns are not generalizable for all samples of
these tissues and may be due to differences between the biological replicates. Also, more general terms
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appeared interchangeably between biclusters containing bone and cartilage separately and may not be the
best indication of making distinction between the developmental processes. However, the biclusters annotated
with GO terms related to wound healing are potentially important for bone and cartilage development. One
example would be terms annotated with platelet derived growth factor binding. Not only important for
wound healing, this is a potent activator of cells with a mesenchymal origin and differentiation of these cells
potentially results in skeletal tissue formation [113]. Vasculature remodelling is also characteristic of bone
formation [5]. So perhaps FABIA is more sensitive at picking up particular patterns involving these processes.
If mature cartilage does have expression that is similar to bone or immature cartilage as well as gene
expression that is in between the other tissues in the biclusters, it may not be the case that all the tissues
would be separated, or separating the tissues into distinct biclusters would not be useful. This is because in
these cases, a pattern should be seen in large portions of the genes where expression in immature cartilage is
high when expression in bone is low (or vice versa) and expression in mature cartilage is somewhere between.
Therefore, it would be expected that biclusters would usually contain at least two tissues. It appears that
SAMBA is best at selecting patterns that are observed across all three tissues. If SAMBA had been able to
identify Sox9 in at least one bicluster, it would have also been a viable means of feature selection to compare
to cMonkey2 in Section 9.1. However, perhaps this suggests that there are other transcription factors playing
a important role in skeletal tissues. Since there has to be something controlling expression of Sox9 in mature
cartilage and bone to keep Sox9 down-regulated, perhaps some of these transcription factors are present in the
biclusters produced by SAMBA or Plaid. FABIA and Plaid, however, do separate at least one of the tissues.
Plaid can separate all three, which seems unlikely to be a desirable outcome if gene expression is behaving as it
was described above. Using Plaid, Runx2 was grouped in a bicluster separating bone from both other tissues,
which would be expected as expression of Runx2 facilitates the development of bone from undifferentiated
mesenchymal cells. However, if Runx2 plays a role in mature cartilage formation it would also be expected to
appear in a bicluster containing mature cartilage tissue, which is in bicluster 4 along with immature cartilage.
This may suggest that Plaid is not useful for biclustering these tissues without minimizing the number of
genes prior to biclustering, potentially minimizing noise in gene expression Plaid may be sensitive to. Both
methods are able to separate mature cartilage. If the Sox9 and Runx2 GRNs were truly additive, where the
Runx2 network formed in the presence of the Sox9 network to create a mixture of gene expression between
both networks, then mature cartilage having distinct gene expression from immature cartilage, in particular,
would not be expected. The alternative hypothesis, that the Runx2 network in bone is completely separate
from the Sox9 network, could explain if mature cartilage had unique expression compared to bone. However,
this does not explain the unique expression compared to gene expression observed in immature cartilage. The
genes found by FABIA in the bicluster only containing mature cartilage includes genes with high expression
in mature cartilage compared to the other two tissues, such as Col10a1, which were grouped using model-
based clustering as well. Therefore, FABIA separating mature cartilage from the other tissues, in this case, is
appropriate. It will be of interest to further explore the annotations unique to biclusters containing a single
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tissue type to make further judgement of biclustering algorithm performance.
From the model-based clustering presented in Section 5.2, a large portion of gene expression in mature
cartilage falls somewhere between immature and bone. It also shows a comparable number of instances where
expression in mature cartilage is more similar to bone or more similar to immature cartilage gene expression
as opposed to an average between the two. There was also one cluster where mature cartilage showed a group
of highly expressed genes not indicative of an additive GRN, and appeared to be the combination of the GRNs
driving development, when interacting, producing synergistic changes to gene expression. Therefore, since
mature cartilage gene expression is not always similar to immature cartilage or bone, it has unique gene
expression patterns, which could be an explanation for Plaid and FABIA being able to separate these tissue
types. Another possible reason for this separation could be the variation of the biological replicates. From
the PCA in Section 4.1, the variation in the samples of mature cartilage is higher than the other tissues. This
could indicate the pattern is more easily identified in mature cartilage. The biclustering algorithms may be
able to pick up on this more overt variation when it shows a conserved pattern across mature cartilage while
the gene expression does not share the same pattern in the other two tissues. Therefore, the separation of
mature cartilage samples can be explained and does not necessarily mean these biclustering methods perform
poorly.
7.3 Conclusion
RNA-seq data from cartilage and bone tissue was used to evaluate the performance of three biclustering
algorithms and their ability to separate tissue types as well as molecular processes enriched in each bicluster.
Based on these metrics, the Plaid biclustering algorithm was able to separate tissue types, but was unable
to produce clusters with terms enriched for either cartilage or bone development. It also produces larger
biclusters than the other two techniques. The larger bicluster size may explain why there are no significant
terms enriched as Plaid may be more sensitive to noise. Therefore, although it has the potential to separate
tissue types, there are more genes used to separate the tissues that may either not be well described using
GO terms. Furthermore, it did not always produce a bicluster containing Sox9 or Runx2 at least once
suggesting the method could be sensitive to noise in real biological data if the number of genes has not
been minimized by another method beforehand, so this method alone is likely inappropriate. FABIA was
able to find multiple biclusters with local gene expression patterns that contained transcription factors Sox9
and Runx2. FABIA was unable to separate the tissues completely although it was able to separate mature
cartilage, which shares a lot of similar gene expression with either immature cartilage or bone. This may be
due to gene expression unique to mature cartilage, which also provides evidence that the Sox9 and Runx2
GRNs are not completely additive. Therefore, the results from FABIA will be used to construct preliminary
networks for Sox9 and Runx2. It is also important to note that cMonkey2 has not been compared to these
methods, so the biclustering results presented will also be compared to cMonkey2 as it was found to perform
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more proficiently than other popular methods on GRN prediction.
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Figure 7.2: Gene Ontology terms shown for FABIA bicluster containing only mature cartilage sam-
ples. The number of enriched terms are compared between Plaid and FABIA. In clusters separating
mature cartilage, Plaid did not have any enriched terms while FABIA had terms such as “biomineral-
ization”.
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Chapter 8
Comparisons of GRN Prediction Method Performance
ESC RNA-seq data has not been previously used to perform an evaluation of GRN prediction performance
as opposed to microarray data, which has been done in [98]. Therefore, it was necessary to determine if RNA-
seq data would behave similarly to microarray data when used to predict GRNs. In the case of the microarray
data with 60 genes, there is a potential for 3540 (60 ∗ 59) interactions to create a complete network. This
is what was used previously to measure GRN inference performance although not with the integration of
ChIP-seq [98]. Once duplicate genes were removed from the array, there was a total of 8127 genes left on
the array with 60 genes in total from the ESC network in the literature, so the number of genes had to be
minimized to these 60 in order to compare to the literature network. When GENIE3 is run with 126 genes,
the maximum number of interactions is 15750, which is the number of interactions possible given each of the
126 genes potentially interacting with 125 other genes. This program does not take into consideration that
some of the interactions could be self-regulated and so the sensitivity of this algorithm never reaches 100%
with the mouse literature network. Then, to generate ROC curves, these interactions were removed when
comparing to the GRNs predicted by these programs.
8.1 Microarray and RNA-seq Comparisons
GRN prediction from RNA-seq and microarray was performed. 78 samples were used from each data set
selected randomly for each run of GENIE3. A comparison between the first 250 predicted interactions using
126 genes from the RNA-seq dataset and 60 genes from the microarray dataset were used. The number of
true positive interactions seems comparable, since the AUROC was 0.818 and 0.816 using the microarray and
RNA-seq data respectively, although the microarray data contained 90 samples versus 78 RNA-seq samples,
and it only predicted interactions for 60 genes instead of 126. The AUROC was calculated again after the
RNA-seq dataset was minimized to the genes intersecting with the genes in the microarray data leaving 58
genes total, to confirm that the RNA-seq data produced similar AUROC values to ESC microarray data.
This was done since the RNA-seq datasets have not been used specifically for GRN prediction before. This
reduced performance slightly with a AUROC of 0.798. Increasing the number of samples that the microarray
could use to all 90 of the samples available did not change the AUROC, which remained at 0.818, shown in
Figure 8.1.
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Figure 8.1: Number of true positives retrieved by GENIE3 with different numbers of samples used
to predict the GRN. The number of TP in the top 250 predictions are shown.
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Figure 8.2: True positive results for GENIE3 using microarray data.
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Figure 8.3: Number of true positives retrieved by GENIE3 with different numbers of samples used
to predict the GRN. The number of TP in the top 250 predictions are shown.
70
Figure 8.2 and 8.3 shows the number of true positives predicted in the top 250 interactions using microarray
data or RNA-seq resulted in similar numbers overall. However, more predictions for transcription factor
binding were discovered using the microarray data compared to the number of other interactions, which
was opposite to when the RNA-seq data was used. Using RNA-seq resulted in a lower or equal numbers of
predicted transcription factor interactions in almost all the other GRN prediction methods evaluated and
presented in Section 8.2.
8.2 Sample Size
When the number of samples was decreased to 6 randomly selected for each run of the methods, GENIE3
achieved a AUROC of 0.801 using the RNA-seq data, which is a drop of 0.015. It is possible that increasing
the number of runs would have increased the AUROC even more to make it equivalent to using 78 samples
since there are more selections of distinct samples for GRN prediction using only 6 of the 78 samples. When
using all 78 samples, there is only one option for GRN prediction, which is including all 78 samples to make
a prediction. With 10 runs, a maximum of 60 samples were used to predict each GRN since only six samples
are selected randomly for each run. However, it is clear that adding another 72 samples to 6 samples did not
increase the performance of the method overall when considering different cut-offs. However, with a cut-off of
250 top interactions, the number of true positives did improve from 6 to 10 samples. The rate of true positives
discovered is compared to the number of interactions considered, as the number of false positives remained
consistent. In Figure 8.5, with 6 samples, Spearman correlation had a comparable number of true positives
to using 78 samples with fluctuation using numbers of samples between these values. iRafnet performed
the worst out of all of the methods with a trend that was relatively flat with no improvement from 6 to 78
samples, shown in Figure 8.6. Furthermore, it was not able to detect as many true positive interactions in the
top predicted interactions, with few transcription factor interactions making it inappropriate for predicting a
GRN controlled by transcription factor activity. Figure 8.4 shows Pearson correlation had more true positive
interactions than GENIE3 in the top 250 predicted interactions where GENIE3 predicted 15 true positives
on average after reaching 60 samples where Pearson’s correlation was able to predict over 20 true positives.
Pearson’s and Spearman correlation also outperformed GENIE3 when using a smaller number of samples.
However, from the AUROC, the performance was better overall than Pearson’s and Spearman’s correlation
with both iRafnet and GENIE3 ultimately able to discover the most true positive interactions compared to
the total number of predictions made.
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Figure 8.4: Pearson Correlation to predict GRN from RNA-seq
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Figure 8.5: Spearman Correlation to predict GRN from RNA-seq
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Figure 8.6: iRafnet performance with no influence of ChIP-seq. Since it is not possible for influences
between the same gene, performance is lower than GENIE3
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Figure 8.7: ROC for GENIE3, iRafnet, Pearson’s and Spearman correlation. GENIE3 outperformed
the other methods
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8.3 Consistency of Predicted Interactions
A table of the top 250 interactions for each method was constructed and compared across the GRN
prediction methods to determine how similar the results of each program were, and is shown if Table 8.1.
The most consistent methods when using all 78 samples to predict a GRN are Pearson’s and Spearman
correlation. Both of these methods result in the same top 250 predictions for every run of the program. They
are also the programs that share the most interactions between them. The other methods, even while using
the same samples to make the predictions are predicting many different interactions from each other.
Table 8.1: Average Number of Different Interactions Between Predicted GRNs
Spearman Pearson GENIE3 iRafnet Inferelator (cMonkey2)
Spearman 0 59 (+/- 0) 192.5 (+/-0.45) 248.9 (+/-0.1) 234 (+/-2.70)
Pearson 59 (+/- 0) 0 189.9 (+/-0.46) 247.9 (+/- 0.1) 234.8 (+/-2.31)
GENIE3 192.5 (+/-0.45) 189.9 (+/-0.46) 30.69 (+/-0.32) 247.63 (+/- 0.07) 240.82 (+/-0.44)
iRafnet 248.9 (+/-0.1) 247.9 (+/- 0.1) 247.63 (+/- 0.07) 23.48 (+/-0.26) 248.02 (+/-0.34)
Inferelator (cMonkey2) 234 (+/-2.70) 234.8 (+/-2.31) 240.82 (+/-0.44) 248.02 (+/-0.34) 217 (+/-6.45)
The more samples are used the less variable the results of the program. The average number of differences
were plotted in Figure 8.8 for GENIE3 according to sample size with as many GRNs made from distinct
samples made. For example, with 6 samples, 26 distinct GRNs could be predicted from the 78 samples of
RNA-seq data. This was done up to 39 samples where only 2 GRNs could be predicted with distinct samples
for each. As the number of samples increased, the average number of differences decreased until the number
of samples was increased from 26 to 39. When 39 samples are used to construct 2 GRNs, the average number
of differences between them is within the standard error of the predictions using 26 samples to construct 3
distinct GRNs. This shows that increasing from 26 to 39 distinct samples no longer increases the consistency
of the predicted interactions.
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Figure 8.8: Average number of different predictions made with GENIE3
A recommended cut-off for the importance measure is not provided by random forest GRN prediction
methods. However, depending on the number of samples used to infer a GRN, the importance measure will
plateau quickly, shown in Figure 8.9. There is initially a spike where the importance values are quite high
relatively compared to others and this difference gradually plateaus with no obvious value at which to stop
considering the predicted interactions accurate. The plateau begins when the importance measure is equal
to 0.04. An importance value any less than that means that interactions below the top 250 interactions have
very little change in their importance measures.
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Figure 8.9: The value of importance measures from GENIE3 for different numbers of interactions.
The number of samples used to predict the GRN was increased from 18 samples to all 78 samples
(indicated by the legend). The more samples used, the more interactions had higher importance
measures, but the importance measures quickly plateaued and do not change a significant amount
from 1000 to 2000 interactions.
8.4 cMonkey2 and iRafnet Performance using ChIP-seq
8.4.1 iRafnet With and Without ChIP-seq
This method, described in Section 6.4.1, was initially run without any influence of ChIP-seq where all
potential regulators were given a weight of 1 including Nanog and Oct4 for each gene j. Performance was below
GENIE3 when comparing the rate of true positives and false positives in the top 250 predicted interactions.
The method uses a weight of zero for each gene j when it is under consideration as the researchers assume
that a gene is not able to influence its own expression, but some of these interactions are reported in the
literature network. Although iRafnet is the only method that can take this into account, once the influence
of Nanog and Oct4 are included using ChIP-seq data, performance drops instead of improving. The number
of promoter binding events, in particular, is less for iRafnet with or without ChIP-seq data as the predicted
interactions for Nanog and Oct4 have a lower placement in the list of predicted interactions.
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8.4.2 cMonkey2 With and Without ChIP-seq
Without ChIP-seq, cMonkey performance was comparable to GENIE3 results at sample sizes 40 and 78
although the result varied more depending on the number of samples used to predict the GRNs shown in
Figure 8.10. One aspect this evaluation does not take into consideration is the transcription factors that are
in the same bicluster as other genes, which are not accounted for using Inferelator. It is assumed that the
transcription factors in a bicluster could be influencing other genes in that same bicluster, but they are not
reported in Inferelator results. As such, many true positives could be missed using this evaluation. However,
since the GRN is only limited to 250 interactions, there are only so many interactions that would be picked
up, possible only for one or two transcription factors. Since ChIP-seq was used for Nanog and Oct4, the
number of true positive interactions identified in biclusters for each number of samples were identified in
Figure 8.13 and Figure 8.12.
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Figure 8.10: cMonkey2 results with no influence of ChIP-seq
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Figure 8.11: cMonkey2 results with ChIP-seq
80
10 20 30 50 60 70 80
0
10
20
30
40
50
Number of True Positive Interactions Predicted in Biclusters from CMonkey2
40
number_of_samples
tru
e_
po
si
tiv
es
TF-binding (ChIP-seq)
TF-binding
Other (ChIP-seq)
Other
All (ChIP-seq)
All
Figure 8.12: Number of true positives for Oct4 in biclusters
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Figure 8.13: Number of true positives for Nanog in biclusters
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ChIP-seq was not able to improve the rate of true positive predictions using Inferelator for most sets
of samples although significantly higher peaks in Figure 8.11 were observed between 20 and 30 samples as
well as at 46 samples and 72 samples. Taking the potential interactions occurring in bicluster modules also
did not improve with the use of ChIP-seq. However, using ChIP-seq did not decrease the number of true
positive interactions overall. All true positive interactions for Nanog and Oct4 were predicted consistently
within the biclusters when using more than 10 samples without ChIP-seq data so it was not necessary for
the information provided by ChIP-seq to be utilized.
8.5 Discussion of GRN Prediction Evaluation
It was determined that the ESC RNA-seq data could be used for the purpose of evaluating GRN prediction
methods. The AUROC was much better than 0.5 and as such, performed better than randomly predicting
interactions with GENIE3, iRafnet and correlation-based methods. The number of samples used did little
to change the AUROC, which leads to the conclusion that the RNA-seq data would be appropriate for GRN
prediction, but could suggest two other possibilities. It is possible that i) the samples for microarray and
RNA-seq ESC data are equally good for predicting the ESC GRN or ii) the samples are not appropriate for
predicting the GRN using either microarray or RNA-seq.
It is difficult to determine, using the ROC curves, that all of these programs will never find a large
portion of the currently known interactions without taking a lot of possible interactions into consideration.
This was a similar case with the microarray data. However, one difference noted between both types of
data, was that using the microarray data resulted in more predicted promoter binding events in the top 250
predicted interactions. This might suggest that the topology of the network predicted using microarray data
would be different than when using RNA-seq, depending on the cut-off used. One limitation of the true
positive rate using correlation based methods is that the methods predict an association, but the direction
of the interaction will not be specified. However, this may be applied to some predictions after the fact if
there is a database of transcription factor available for the organism as well as PPI information. Although
these methods perform above random, given there are N ∗ (N − 1) potential interactions where N is the
number of genes, the sparsity of the network means that a low number of true positive interactions will
indicate the method predicts interactions better than random guessing. However, having 10248 or
19
248 true
positive interactions does not provide much confidence for the quality of the other interactions that have
been predicted.
Although all of the methods perform better than random, the number of true positives in 250 predicted
interactions is less than 20 in total out of 248, which is likely why AUROC is reported much more in
publication than the actual number of correct interactions predicted using different cut-offs. It also appears
that increasing the number of samples may not increase true positive predictions in a linear or exponential
fashion for real biological data. Therefore, due to this flat trend it may not be best to focus on increasing
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the number of samples used with these methods, but using and combining different methods. When using
iRafnet, it was thought that if more weight was placed on several transcription factors, then the chance of
seeing interactions with those transcription factors influencing other genes would increase, but this is not the
case. This is likely due to the number of genes selected in order to generate the trees for each gene j using
random forest. Instead of selecting a random sample of genes at each node, genes are selected according
to sample weights. This means that biasing towards a small subset of genes is not possible unless all other
regulators are discounted. The sample size will be greater than 2 in this case (GENIE3 and iRafnet select
the square root of the number of potential regulators for each sample of genes). However, it is not practical
to take a subset of two (the number of transcription factors where there is ChIP-seq available) in order to
construct the trees. Since this might be the case, 9 other potential regulators were given a weight of 1 and the
rest were always zero. These others were selected based on the interactions in the literature network, selecting
those more commonly in TF-binding relationships. Again, this improved results back to comparable levels
with GENIE3, but no more than that. Perhaps this would improve further if at least the number of ChIP-seq
data from different transcription factors was equal to the number of samples taken at each node, but this
removes the biasing aspect to only a select few transcription factors. However, this still does not completely
explain the decrease in performance when ChIP-seq is added. iRafnet results in a total of 6502 interactions
being predicted where the importance measure is not equal to zero. Therefore, one benefit of using iRafnet as
opposed to GENIE3 is that there is a very obvious place to set a cut-off in the list of predicted interactions.
These interactions were sorted according to highest importance measure and the top 250 interactions were
used for comparison to GENIE3 and Pearson and Spearman correlation. However, both Nanog and Oct4
have all 125 predicted interactions present with importance measures greater than 0 so a cut-off would still
have to be applied in order to produce a useful result if the focus is on select transcription factors.
The challenge remains that there first needs to be some feature selection performed before GENIE3 could
be used to predict a complex organism’s GRN. Furthermore, an appropriate cut-off to predictions is also
necessary. From current results, it seems that in order to achieve good sensitivity, this will result in all
possible predictions for some transcription factors predicted, which is not useful if a researcher has those
particular transcription factors of interest. They would do no worse by generating all possible combinations
of interactions, although in the case of GENIE3 they would be ranked by importance measure. One benefit
to biclustering (by using cMonkey2) is it divides the genes into modules. There are less false positives
associated with the genes, as they will only be associated with the other genes in the module. As such, since
the biclusters contain fewer false positives in comparison to true positives found overall inside the module,
there are fewer interactions to narrow down using other means as long as the transcription factors of interest
are in a minimal number of biclusters. Therefore, genes of interest can be focused on without eventually
predicting all possible interactions one gene has with all the others. However, this also means that if a
gene is left out of a module it may never be associated with the genes in a module, where random forest
methods will eventually predict an interaction even if overall it results in performance no better than random
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guessing. Inferelator also adds more information on top of the biclusters if it is likely genes of interest are
influencing expression external to their assigned module. Inferelator was designed in 2006 and has been
minimally updated in the past three years. Therefore, using other methods to infer interactions within the
biclusters may now be feasible. Originally, cMonkey2 did not use Inferelator and only compared to other
methods based on similarities of the genes in each module including similar sequence motifs and biological
enrichment, but not on predicted interactions as there is no method to predict these interactions other than
knowledge of the transcription factors in each module potentially regulating the other genes in the module.
From the true positives predicted using a low number of samples, Spearman correlation achieves better
performance initially compared to the other methods. This spike in true positive predicted interactions may
be due to the number of runs being limited to 10 or 5 depending on the runtime of each method. During
each run different samples are combined at random so perhaps a better selection of samples was run with
Spearman correlation. The variation in cMonkey2 results may also show evidence for different subsets of
samples resulting in better GRN prediction than others. This may suggest that it is likely that the number
of samples is not as important for making many true positive predictions as it is to use data with as much
variation as possible in order to pick up patterns in gene expression.
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Chapter 9
Application of cMonkey2 to Skeletal Tissues
cMonkey2 was applied to the skeletal tissue RNA-seq dataset due to its ability to find localized patterns,
including those that may be in a single tissue for which there are only three samples. The random forest
methods utilize techniques that require more than three samples. The Sox9 and Runx2 networks were
predicted using cMonkey2 and Inferelator, which resulted in 913 biclusters. Some of these biclusters that were
empty or contained only a single gene, so they were removed before Inferelator was applied. These results were
minimized to only biclusters that contained either Sox9 or Runx2 or the biclusters that Inferelator predicted
could be regulated by Sox9 or Runx2. This left 13 biclusters, which could be expanded to include regulatory
interactions with the other transcription factors in the biclusters, but Figure 9.1 shows the biclusters that
are directly associated with Sox9 or Runx2 expression.
9.1 Comparison of cMonkey2 Predicted Interactions to FABIA
Biclustering Results
cMonkey2 produced biclusters separating mature cartilage from the other skeletal tissues, but was unable
to separate the other two tissues, much like the results from FABIA. Since FABIA seemed to produce the
most biologically relevant results from analyses performed in Chapter 7, it was selected to compare overlap
of genes associated with Runx2 and Sox9 found by each method. Where FABIA was able to produce up to
10 biclusters, with 6 biclusters used to achieve the highest tissue separation score. cMonkey2 produced 13
biclusters in total that either had Sox9 or Runx2 inside them or, using Inferelator, potentially regulating the
genes inside another bicluster. The biclusters produced by FABIA that also contain Sox9 or Runx2 had 852,
772 and 253 genes. These are much larger than the number of genes contained in the biclusters produced by
cMonkey2 shown in Figure 9.1. As such, only 3 genes overlapped between the results produced by cMonkey
and the results from FABIA (Igf1, Fxyd6 and Lgmn). This is not to conclude that cMonkey2 results are not
useful. For example, cMonkey2 biclusters Sox9 with genes that provide instructions for making part of type
IX collagen, Col9a2 and Col9a1, so the results are not necessarily any less biologically accurate. FABIA was
unable to group these genes with Sox9. It will be of interest to further compare the genes present in the
biclusters of these programs, potentially also including Plaid and SAMBA results, to determine if results from
these programs may be combined or if we may be any more confident in the importance of genes appearing
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in at least one bicluster using each program.
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Figure 9.1: Sox9 and Runx2 GRNs visualized with Cytoscape as predicted by cMonkey2. The
diagram shows biclusters potentially regulated by transcription factors within the same bicluster as well
as transcription factors not placed in the bicluster. Biclusters outlined with orange are biclusters that
contain Sox9 while biclusters outlined in purple contain Runx2. The biclusters outlined with neither
colour do not contain these transcription factors, but Runx2 or Sox9 may be regulating the genes that
are inside the biclusters indicated by directed arrows. The black arrows (unknown regulation) means
there is no confidence associated with the interaction since the gene potentially regulating others in
the bicluster is also in the same bicluster. Up and down-regulation interactions are predicted using
Inferelator. To view the genes within each bicluster, this data is also available in Appendix C
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9.2 Limitations of Testing GRN Prediction Methods
Some limitations of predicting GRNs apply to the analysis of both Chapter 8 and Chapter 9. Therefore,
it is likely that the limitations observed with ESC data also apply to skeletal tissue data. One limitation
in this thesis is the network available for evaluation of the GRN prediction methods in vertebrates may not
be complete as GRNs tend to be complex, and interactions that do occur may not alway be identified using
low throughput techniques. Therefore, the low true positive rates in the top 250 interactions may not be an
indication of a method’s ability to make accurate predictions, but the lack of research available to identify more
interactions that are occurring in these networks. To try and counteract this limitation as much as possible,
the genes used to predict interactions had to be in the literature network. Therefore, interactions could only
be predicted between these genes. However, the number of interactions in the literature network (248) versus
what could be predicted using the RNA-seq data (15750) is a lot lower so a lot of interactions could be
missing. Unfortunately, this may not provide indication of a methods ability to discover new interactions,
compared to finding interactions that are already known. However, more true positive interactions discovered
with high confidence may also give reason to believe the other genes predicted–currently considered as “false
positives”–with high confidence may just be novel interactions.
9.2.1 Predicted Interaction Cut-off
All of the methods do not have a defined cut-off. This may also be a reason for the large rate of
inconsistency when attempting to predict a larger network in methods like GENIE3. Since the importance
values beyond 250 are similar, it is likely that multiple runs of the program shuffle these predicted interactions
around, which is why each run of the program results in different predictions depending on the cut-off. This
could explain why other researchers have reported only 3 edges recovered while multiple runs of GENIE3
produced an average of 18 using the same microarray data [98]. This suggests that it is possible the proposed
method does not in fact perform any better than GENIE3 unless perhaps it is more consistent in its results.
To get consistent interactions predicted for the top 248 interactions of the ESC network with GENIE3, more
than 78 samples of RNA-seq data would be required. For novel discoveries this is of particular concern, since
even collecting 78 samples or attempting to find appropriate datasets online when the research is looking at
something new is likely not possible.
9.2.2 Using AUROC for Measuring Performance
The best performing GRN prediction method proposed by the authors in the most recent evaluation
using the ESC network was able to discover 10 true positive edges using ESC microarray data, which is still
very low although when the AUROC appears to perform better than random [98]. Due to the difference
in performance between 10 runs of GENIE3 in this project and the results reported in literature, there is a
question of how good results can be if they are not consistent. Using GENIE3, the best performing GRN
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prediction method, the last true positive interaction for Nanog is around the 5800th predicted interaction.
At this point, if referring to the ROC curves, using a cut-off of 5800 predicted interactions includes all of the
interactions in which Nanog could possibly be involved.
9.2.3 Addition of ChIP-seq: Quality and DNA Binding Locations
From the initial exploration of incorporating ChIP-seq data to gene expression data to predict GRNs,
ChIP-seq does not largely seem to impact the performance of random forest or biclustering. One caveat to
these findings could be the quality of the ChIP-seq data. When using fastQC as a quality check to determine
the quality of the sequences, many required trimming. When the sequence length is originally small before
trimming (25-36bp) any more trimming can have a impact on the number of uniquely aligned sequences to
the genome. The sequences that do not align uniquely are not counted as a gene feature and so cannot
contribute any information about gene expression or likely binding sites in downstream analysis. Therefore,
binding sites may not achieve counts above background.
Another possible limitation might be using a 3000 base pair (bp) cut-off from the transcription factor start
site. This cut-off was used as the ChIPSeeker program labels these as binding events to a promoter while
binding sites further away might be a different kind of regulation. As the focus was on promoter binding
events for comparisons with the ESC literature network, this cut-off was used. However, this cut-off may
exclude possibly important regulatory events. Since the focus is on the 126 genes in ESC, any binding events
outside of these 126 genes are not considered when predicting the GRN, since most of these binding events
were picked up using the cut-off of 3000 bp. There was still potential to increase the number of predicted
interactions, perhaps not all of them, but more than the RNA-seq data alone. If dealing with a larger set of
genes to predict a GRN, it may be useful to reevaluate if the 3000 bp cut-off would be appropriate.
Another limitation would be minimizing the number of genes before GRN prediction with the ChIP-seq
data. There still may be a benefit to incorporating ChIP-seq data when the number of genes used to predict
a network is large. In this thesis, the genes in the ESC RNA-seq samples were minimized to those known to
take part in the network, which is not possible with uncharacterized networks, although there is the option of
using clustering and biclustering to minimize the number of genes. The way cMonkey operates, for example,
is it groups genes that have the potential to interact with the transcription factors for which there is ChIP-seq
data. Since, for these evaluations, the genes were already minimized to only include genes known to be in
the ESC literature network, the options for grouping particular genes together had already been minimized.
If more genes not known to be in the network were included, and less likely to be involved, the ChIP-seq
data may have proven more useful.
9.2.4 Auto-Regulation
One limitation across all of the methods tested is their inability to accurately predict auto-regulation,
which is the regulation of a gene’s expression by itself. For example, both Oct4 and Nanog have binding
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sites that allow for changes in expression of themselves. These interactions have been confirmed and are
in the literature ESC network. This is detected by ChIP-seq, but cannot be picked up in expression data
since the expression of a gene is always going to be the most highly correlated with their own expression
and so these interactions are left out of the prediction, meaning when evaluating using the ROC, these
interactions are never found. Hence, they cannot be taken into consideration if sensitivity is to ever equal
1. With the binding site information, the expression data did increase the confidence of these interactions
so this is one benefit of using iRafnet. But in comparison to the other methods, its performance was poorer
overall although it outperformed correlation-based methods. However, with Nanog and Oct4, there are only
2 possible occurrences of auto regulation, and it is not obvious that the addition of the ChIP-seq data would
be helpful with ChIP-seq data for more transcription factors.
9.2.5 Sox9 and Runx2 Literature Networks
New gene expression and ChIP-seq data for bone and cartilage tissue has recently become available
[114, 115]. Therefore, it will be necessary to update the literature networks not only based on our data, but
other data available in order to determine if any datasets, including the RNA-seq data used in this thesis,
are potential outliers. It is possible that the current datasets compared to the RNA-seq data from skeletal
tissues is an outlier or it could be that the RNA-seq data is not appropriate for GRN prediction. Predicting
the GRNs with other datasets is another means that could increase the confidence for the current GRN
prediction. If multiple datasets are resulting in very different lists of predicted interactions, they may not
be appropriate for GRN prediction or it may be necessary to average the predictions across the datasets.
The more agreement there is among the predictions using different datasets suggests more confidence can be
placed in the predicted network.
9.3 Future Directions
From comparisons between the microarray and RNA-seq data, the two datasets are just as useful as each
other for GRN prediction, but whether the resulting predictions made by either are good is less clear. It
might be interesting to test a dataset with the same genes from another tissue other than ESC and see if
the same top interactions would be predicted. This may provide insight as to whether the interactions the
methods are able to identify in the top interactions can be attributed to a GRN that is functioning in one
type of cell compared to another tissue that are not pluripotent with no self-renewal. With simulated data
it is possible to confirm that a particular GRN is functioning as it was placed in the data artificially. With
actual biological data however, it is generally assumed that the GRN is functioning and has the potential to
be picked up by the GRN prediction methods. Another method to test this might be to randomly swap gene
expression values among the data to get rid of relationships in the gene expression and run all of the methods
again. If the number of predictions does not drop significantly in the top interaction or if the AUROC remains
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high or above random, this may suggest that the datasets are not appropriate for predicting the relationships
specifically found in a GRN.
A second objective would be to improve how to compare biclustering techniques to other machine learning
techniques for GRN prediction. The genes within biclusters are associated in some way, but there is only
one confidence value (the residue), which does not indicate whether some of the transcription factors are
more likely to be direct regulators compared to others. This means it is necessary to consider every potential
interaction that could occur between the genes in a bicluster, which increases the number of false positives
(while possibly increasing the number of true positives as well). The ROC is not a proficient way to measure
the performance of these algorithms as it is not necessary that all potential interactions be predicted. Only
97 interactions were ever predicted for Nanog when there could be 126, for example using cMonkey2.
Adding more machine learning methods to this evaluation may provide more or less evidence to support
the usefulness of increasing sample size for a complex organism. It may be necessary to have some means of
predicting with bicluster interactions by attaching a level of confidence to each possible interaction as opposed
to a residual which provides overall confidence based on how correlated all genes are to each other. As long
as it is possible for a GRN prediction method to produce a list of predicted interactions, the current methods
of comparing performance may be used. If these methods can be integrated to predict interactions most
likely in the biclusters, there could be potential for comparing the current biclustering methods more easily
to other GRN prediction methods. It is possible that applying ChIP-seq data after biclustering as opposed
to it influencing the genes grouped together initially could make the addition of ChIP-seq information more
useful as well. One limitation currently for cMonkey2 in higher organisms is the motif database is not in
a format that allows the program to automatically run, and it is necessary to curate your own database or
minimize genes in some other fashion so that only genes that are in the current database are accounted for
[19]. Therefore, it may be necessary to curate a database of sequence data for skeletal dataset in order to
incorporate motif finding if cMonkey2 predictions prove to make sense biologically at this stage. It will also
be of interest to locate other transcription factors with high connectivity with the Sox9 and Runx2 networks.
These transcription factors may also have a significant influence on the expression of Sox9 and Runx2 as
there has to be other gene expression that is influencing the down-regulation of Sox9 in order to mature
cartilage and bone to develop.
9.3.1 Evolution of Gene Regulatory Networks
Gene regulatory networks tend to have complex structures and it is a current challenge to determine
which connections in a GRN are modified and how they are modified in order to produce a novel phenotype.
It is thought that the co-option of older GRNs can lead to the development of novel structures [39]. Examples
of this phenomenon include beetle horn formation resulting from the co-opting of the appendage formation
GRN [39]. Not all genes in the networks required for appendage formation are required for the development
of the beetle horn although knockdown of key parts of the network suggest that parts of the network are
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necessary for beetle horn formation. Another GRN for echinoderm larval skeleton development could have
been co-opted from an ancestral GRN that directed the formation of their adult skeleton [116]. The GRN
in this case for adult was already well understood so co-expression studies showed genes active in similar
manners during both processes. In other, less related species like the sea cucumber, it has been shown
that it is likely this GRN underwent further remodelling. The GRNs defining skeletal tissue development in
vertebrates may be an example of GRN co-option leading to the generation of new morphologies [8].
9.3.2 Gene Regulatory Networks Evolution in Skeletal Tissues
The distinct characteristics of the Sox9 and Runx2 GRNs have recently been explained from an evolu-
tionary perspective [8]. It is hypothesized that cartilage is a much older tissue than bone, meaning that
the GRN(s) characterizing the development of this tissue have been established for a longer period of time
before bone appeared in evolutionary history. One possibility is that bone evolved separately from cartilage
meaning the gene expression and the GRN that defines bone does not necessarily have any relation to the
genes expressed in cartilage. Another option is that bone development evolved gradually through co-option
of the Runx2 GRN that was established in mature cartilage [8, 117]. It is further hypothesized that a mixture
of the GRNs in immature cartilage and bone characterizes mature cartilage development, meaning the tissue
arose somewhere between the process of bone co-opting the Runx2 portion of the Sox9/Runx2 GRN mixture
in mature cartilage. Learning more about the topology of these networks will aid in determining regulation
and function of the genes in these networks and elucidate the evolution of skeletogenic mechanisms.
Potentially, biclustering may be adapted to include other information. To do so, biclustering algorithms
currently used will have to be adapted in order to handle the sequence data contained with the data used
to construct the gene expression matrix that is currently used to bicluster. cMonkey2 can use sequence
information currently, but only from a database and does not focus on mutation across the same gene, but
on potential regulator binding sites [19]. Using synonymous (change of a nucleotide that does not change
the amino acid sequence produced) and non-synonymous (change of a nucleotide that does change the amino
acid sequence produced) mutations will group genes by different degrees of conservation within a single tissue
as well as across tissues. It would be interesting to determine how results correspond to results using gene
expression profiles to determine genes potentially in a network. Since evolution of the GRNs will be a main
focus of my research in the future, the incorporation of sequence information in terms of synonymous and
non-synonymous mutations in genes would be useful.
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Chapter 10
Conclusions
The limited knowledge currently available describing the regulation of skeletal tissue development could
be further elucidated with the accurate measure of gene expression using RNA-seq technology. Using this
gene expression data to predict possible GRNs driving the development of bone and cartilage tissue could
potentially identify genes not known to be involved in these processes as well as confirm hypothesized key
regulators of the networks as well as others. The first objective of this thesis was to determine if there
is evidence of two interacting GRNs in mature cartilage by analyzing gene expression. Furthermore, since
there is some information available in literature about genes potentially regulated by transcription factors
Sox9 and Runx2, it was necessary to determine if this information agreed with the RNA-seq data from the
skeletal tissues since minimal agreement between these data sources could provide justification for predicting
new networks. Results of model-based clustering, as well as differential expression and simple comparisons
of gene expression across bone, immature and mature cartilage show evidence that if there are two GRNs
driving bone and cartilage formation, they are likely both active in mature cartilage. It was determined that
there are less uniquely expressed genes in mature cartilage compared to immature cartilage and bone. Gene
expression in mature cartilage was usually an average of gene expression in immature cartilage and bone,
or had similar gene expression to one of the tissues. This suggested that most genes in the GRN driving
mature cartilage development, were under control of both Runx2 and Sox9 GRNs. It also appears that the
number of genes in mature cartilage that have expression more like immature cartilage or bone are nearly
even, suggesting one GRN is not necessarily the dominant GRN with more activity in mature cartilage.
However, since there are genes expressed that are unique to mature cartilage, suggesting that the Sox9 and
Runx2 GRNs are not entirely additive. The expression of both Sox9 and Runx2 may influence some genes
to increase in expression according to differential expression results as well as clustering results. To confirm
these results it will be required that more data from other sources be analyzed in the same manner, or
more samples added to the current RNA-seq dataset to confirm if the current set of data is an outlier and
unreliable for biological interpretation. It was also determined that the Sox9 and Runx2 networks in the
literature available for this project did not contain many overlapping genes with those considered expressed
using the RNA-seq data from bone, immature and mature cartilage. Therefore, the analysis of other datasets
that have become available for determining a potential Sox9 or Runx2 GRN will be useful for strengthening
evidence either for or against a relationship between the Sox9 and Runx2 GRNs.
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The second part of the thesis focused on predicting new Sox9 and Runx2 GRNs, given that the genes in
literature reported as being regulated by these transcription factors did not agree with the RNA-seq data
available for skeletal tissues. This required that the number of samples used to predict the GRNs be enough
to predict interactions in the GRNs better than random. Initial predictions of GRNs functioning in skeletal
tissues are useful for future research comparing genes conserved and expressed among vertebrates. Challenges
associated with predicting a GRN include the large number of samples required to predict interactions. Since
the number of samples available is small, it was necessary to determine if these samples would be enough on
their own, or if results of GRN prediction using these samples could be improved by either adding more data
or using a particular method over others. Random forest methods outperformed correlation-based methods,
but increasing sample size did little to improve performance, with a maximum of 90 samples of microarray
data and 78 samples of RNA-seq data for ESC in mouse. Furthermore, neither using a strict cut-off nor
considering many different cut-offs up to the total possible interactions lead to significantly improved results
with any method. Other techniques to improve results such as ensemble techniques combining methods
or results from different data sets to have more variable samples may have a greater impact to results.
The consistency of results across methods was highly variable with machine learning methods while fairly
consistent when comparing correlation-based methods. Increasing the number of samples has the potential
to improve consistency within a single method, but using all 78 samples of RNA-seq data still resulted in a
large range in predictions between methods.
Furthermore, with the ChIP-seq data used, there was no evidence of improvement using the ESC data
although there were limitations due to the number of genes already being minimized. From biclustering
results, the addition of ChIP-seq did not do anything to improve the number of interactions predicted,
because they are all predicted regardless of the use of ChIP-seq data. Therefore, it was not possible to reduce
sample size with the addition of ChIP-seq data using the methods tested. Machine learning methods were
found to outperform correlation-based methods although both have limitations such as requiring a cut-off
to predicted interactions. The only method that did not require a cut-off was cMonkey2, a biclustering
method capable of discovering modules of related genes. As cMonkey2 can find patterns within datasets
with small sample sizes as well as not predicting all possible interactions for a transcription factor without
the application of a cut-off, it was selected to make an initial prediction for the Sox9 and Runx2 GRNs.
Biclustering using other methods was also done, since the number of genes used to predict Sox9 and Runx2
GRNs needs to be minimized before predictions are made. It was also done to observe how the skeletal
tissues separated into different biclusters based on patterns in gene expression and discover more evidence
of interacting GRNs. The method that had results similar groupings of the tissues to cMonkey, FABIA, was
compared to cMonkey2. It seems that biclustering methods that do not separate all the tissues into distinct
biclusters may be more biologically relevant since the Sox9 and Runx2 GRNs are likely active to some extent
in all three tissues. Therefore, using biclustering methods like cMonkey, FABIA and SAMBA, which do not
separate all the tissue may ultimately be more useful moving forward with testing the predicted GRNs in
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skeletal tissue. Identifying a proficient means of analyzing expression data from skeletal tissue to construct
GRNs would contribute to the further study of skeletal development using comparison across multiple species.
Ultimately, comparisons can also be made between the molecular mechanisms of normal tissue development
and degenerative skeletal conditions. This will allow for properties of skeletal tissue differentiation to be
utilized for future therapies.
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Appendix A
Differential Expression
Table A.1: Differential expression results for the genes most up-regulated in each tissue compared
to the other two tissues. Table shows the log2 fold changes, and the genes are sorted based on the
minimum log2 fold change. Gene counts for each tissue for each gene are also shown for all three
replicates.
Genes most up-
reg. (Mature)
logFC
(IMM)
logFC.2
(BONE)
MinFC MAT1 MAT2 MAT3
2200002D01Rik 4.810602 4.325495 4.325495 14 30 169
Abtb1 2.307323 2.758312 2.307323 228 375 1437
AI661453 9.731659 4.970652 4.970652 75 95 169
Apba2 2.772514 4.933579 2.772514 159 106 136
Apod 4.274054 3.931457 3.931457 322 15 66
Arap2 3.509914 2.544457 2.544457 201 250 312
Arsi 2.588097 9.106185 2.588097 1247 1096 3483
Atp6v0a4 3.1244 6.211701 3.1244 75 75 195
Cabp1 4.020776 3.629571 3.629571 15 57 81
Catsper4 7.432629 9.854591 7.432629 32 61 276
Ccdc80 5.824458 5.684647 5.684647 1540 987 4317
Cdh19 5.452143 6.11394 5.452143 118 47 154
Cds1 5.896676 6.0197 5.896676 296 247 955
Col10a1 11.939181 10.279139 10.279139 11410 12681 61834
Comp 2.103194 10.501231 2.103194 10482 6615 25962
Corin 6.377141 4.145676 4.145676 227 63 254
Cpa6 2.50223 5.649675 2.50223 303 179 632
Cttnbp2 2.36133 3.008105 2.36133 363 204 213
Cyp11a1 7.433346 9.15161 7.433346 6 26 195
Dach1 3.456439 4.079639 3.456439 206 107 154
Ddn 6.099884 6.647466 6.099884 96 54 147
Dkk2 5.313394 3.635593 3.635593 1208 133 114
Dusp5 4.505456 2.622123 2.622123 198 444 507
Eps8l2 2.773986 8.710346 2.773986 181 211 1235
Fbln5 7.485709 3.688678 3.688678 591 173 162
Fcer2a 3.02806 6.071101 3.02806 84 45 77
Gcnt2 5.115782 3.634691 3.634691 357 141 367
Gm15712 2.210871 4.338054 2.210871 130 119 261
Gm27249 7.861018 7.86304 7.861018 15 14 66
Hhip 4.563887 4.216572 4.216572 1476 593 29
Hoxa11 5.850657 9.840089 5.850657 353 11 0
Ihh 8.42466 5.636227 5.636227 2030 940 3303
Isg20 5.472439 8.376665 5.472439 15 17 103
Itga1 2.534262 4.371699 2.534262 365 97 456
Itga7 6.422603 6.859952 6.422603 165 229 702
Itgb8 3.270052 3.406617 3.270052 146 118 162
Kirrel3 3.674392 2.740369 2.740369 69 148 349
Klhl31 5.004721 3.320505 3.320505 106 191 184
Lemd1 6.390953 7.092974 6.390953 36 28 110
Lipg 5.799712 5.297901 5.297901 100 65 110
103
Lypd6 4.83222 4.829945 4.829945 313 49 26
Mbp 3.727502 3.015208 3.015208 282 46 217
Mcoln3 7.906811 5.478464 5.478464 84 20 209
Nfasc 4.339463 10.013455 4.339463 54 89 268
Nhej1 2.580367 2.866777 2.580367 195 205 621
Nim1k 2.307411 5.40575 2.307411 914 602 724
Nt5dc1 4.575578 3.411777 3.411777 437 316 1345
Parm1 5.082532 2.677354 2.677354 1164 411 603
Pde11a 5.848737 6.284956 5.848737 149 73 228
Prkg2 2.115171 3.531984 2.115171 1872 1197 2182
Prom1 4.241879 4.582153 4.241879 752 226 577
Prss50 9.18596 6.790912 6.790912 24 40 169
Pth1r 3.707333 3.359919 3.359919 16229 34093 92554
Rapgef3 2.424302 2.248307 2.248307 120 226 261
Rasgrf2 5.045018 3.404607 3.404607 139 85 129
Rbms3 2.348274 2.144482 2.144482 971 774 621
Rgs7bp 3.013869 2.952551 2.952551 250 207 375
RP24-222G3.1 4.275858 8.023105 4.275858 103 108 132
RP24-475O6.1 5.918157 3.898769 3.898769 21 57 125
Rpl39l 2.714879 2.858102 2.714879 283 181 55
Rspo3 3.66622 5.536452 3.66622 2179 580 382
Serinc5 4.309275 3.44221 3.44221 4940 1206 3461
Sidt2 2.183537 2.022157 2.022157 1710 1219 2557
Slc17a9 2.762031 3.11076 2.762031 382 1235 5780
Slc35g1 2.995354 4.103005 2.995354 185 66 478
Slc43a2 4.415567 2.987216 2.987216 97 86 246
Slco2b1 9.611415 3.167916 3.167916 44 53 217
Stmn2 8.643946 3.812662 3.812662 772 79 18
Stra6 5.582603 3.876393 3.876393 52 24 33
Syna 9.80765 6.559881 6.559881 43 72 242
Thrb 4.601468 4.164985 4.164985 268 133 268
Tmie 2.374371 3.537102 2.374371 132 185 364
Tnmd 10.822619 5.357013 5.357013 527 22 169
Ttll3 3.098853 4.059393 3.098853 544 687 1569
Wnt11 3.069925 4.804596 3.069925 278 56 125
Wnt5b 3.636137 3.751825 3.636137 427 370 955
Zfp185 3.866001 3.874776 3.866001 376 17 169
Znhit6 2.329638 2.533332 2.329638 598 754 3259
Genes most up-
reg. (Immature)
logFC (Ma-
ture)
logFC.1
(Bone)
MinFC IMA1 IMA2 IMA3
C4b 9.249958 9.754976 9.249958 252 272 508
Car9 7.37604 8.014918 7.37604 180 858 54
Trhr2 7.147005 9.51244 7.147005 43 10 185
5730596B20Rik 6.166898 8.51908 6.166898 58 25 38
1700049E15Rik 6.952792 5.77329 5.77329 55 126 32
Trabd2b 5.57442 8.84187 5.57442 1018 1216 1606
4933400C23Rik 5.807299 5.541725 5.541725 28 28 39
Fmod 5.507848 7.248587 5.507848 3168 15227 751
Plekha4 4.921619 7.574858 4.921619 93 73 236
Xlr3c 4.910256 8.079711 4.910256 22 6 60
Gm17225 4.905818 8.075264 4.905818 56 29 5
Lin7a 4.773595 5.010597 4.773595 221 924 114
RP23-198G19.1 4.644177 6.483578 4.644177 383 351 803
Sfrp5 4.564137 9.568965 4.564137 139 422 379
104
Serpina3n 4.472844 10.781695 4.472844 901 640 581
Snph 4.458046 5.71735 4.458046 72 54 75
Gm27202 4.283741 9.502154 4.283741 77 51 110
Hist1h1e 4.21974 5.114965 4.21974 150 126 99
Ucma 4.182678 8.812778 4.182678 189 293 60
Gm13111 4.13892 9.263066 4.13892 67 56 79
Smoc1 4.016777 7.231947 4.016777 291 994 908
Scn9a 3.957163 7.702003 3.957163 106 23 289
RP23-448H3.2 3.949846 4.836995 3.949846 17369 23260 11316
Gm26945 3.947416 10.849907 3.947416 189 170 249
Gm14776 5.085592 3.903751 3.903751 141 195 195
Edn2 5.777074 3.90223 3.90223 25 44 39
Lrrc75b 3.883743 5.447106 3.883743 225 147 984
Trank1 3.84283 5.596119 3.84283 18 78 42
Fam198a 3.810586 3.853473 3.810586 388 134 348
Gm16152 3.680431 5.791181 3.680431 116 112 326
4930545L23Rik 4.194338 3.670655 3.670655 113 102 9
Chdh 4.428763 3.668352 3.668352 40 35 120
Gdf5 4.576696 3.663428 3.663428 93 411 87
Gm25224 3.658465 6.995592 3.658465 73 64 17
Sapcd2 3.48673 4.272382 3.48673 283 543 482
Rbpjl 3.480056 9.808766 3.480056 13 8 17
Fbxo2 3.474793 5.591904 3.474793 82 107 77
Mybl1 3.449473 5.444433 3.449473 243 168 163
Pthlh 3.400384 7.428276 3.400384 332 462 76
Vwa1 3.343207 5.533101 3.343207 200 1176 67
Hoxd4 3.321618 7.799469 3.321618 197 374 102
Chst3 3.295191 4.328497 3.295191 84 287 49
Mfsd2a 3.23883 5.624131 3.23883 57 150 25
Flrt1 3.197749 5.260034 3.197749 175 98 127
2600014E21Rik 3.183158 8.853394 3.183158 268 260 27
Gm16150 3.179214 4.457532 3.179214 88 83 123
Hist1h2ap 3.168437 3.492985 3.168437 896 1096 1346
Gm16326 4.556545 3.159546 3.159546 19 21 57
Fam19a2 3.147345 4.846471 3.147345 101 339 74
Adhfe1 3.136526 3.727971 3.136526 98 47 61
Ephx1 3.414469 3.118784 3.118784 19 97 30
Aim1 4.114407 3.116736 3.116736 55 172 46
Il1rapl1 3.109017 3.7959 3.109017 73 165 134
Col19a1 3.098795 8.033677 3.098795 30 22 34
Unc80 3.085252 7.021364 3.085252 167 121 114
Hist1h1d 3.077059 3.912552 3.077059 23 41 32
Cbr2 3.040547 7.64866 3.040547 150 73 188
1700006J14Rik 3.016552 3.241811 3.016552 121 93 20
Hist1h2ao 3.016257 4.788247 3.016257 144 112 297
Clmn 3.013547 3.99686 3.013547 1088 1529 1037
Prph 4.038076 3.011818 3.011818 18 46 26
Gm16183 3.004755 5.306423 3.004755 205 64 598
Osmr 2.981151 5.183422 2.981151 443 473 100
BC006965 2.939796 8.337577 2.939796 1608 470 6280
Mak 2.896029 6.342479 2.896029 47 73 47
Inhba 2.895669 3.71397 2.895669 92 714 88
Syne4 2.890169 3.699997 2.890169 337 419 546
Rdh12 3.257836 2.874022 2.874022 98 86 34
105
Casc5 2.81594 3.563772 2.81594 492 499 450
Rgma 2.787285 4.593662 2.787285 151 121 141
Hist1h2ae 3.230079 2.772671 2.772671 168 152 46
Rap1gap 2.7693 4.033521 2.7693 271 106 131
Lrig3 2.748966 4.242207 2.748966 988 1440 1797
Cfap44 3.993681 2.740413 2.740413 68 163 117
RP23-204I16.3 2.714684 6.706832 2.714684 84 32 178
Tbx5 2.70007 10.711909 2.70007 753 1194 1509
Meg3 2.6913 7.929196 2.6913 59621 61080 122676
Ppp1r9a 2.687894 4.375313 2.687894 4834 3596 4133
BC039771 2.623559 2.957934 2.623559 240 267 252
Fxyd6 2.620406 4.260963 2.620406 744 1861 199
Rab36 3.284063 2.60221 2.60221 47 24 36
Matn4 2.569946 7.79374 2.569946 4685 2079 14224
Mtap7d3 2.559913 6.685392 2.559913 1897 1144 2320
Cpm 2.532306 5.345226 2.532306 1127 2339 221
Fan1 2.531 2.99462 2.531 130 101 112
Hoxd9 2.523183 10.549144 2.523183 396 1218 202
6430550D23Rik 2.516636 3.023248 2.516636 76 48 152
Ndufa4l2 2.515878 2.769244 2.515878 257 741 328
B4galnt4 2.489832 4.128476 2.489832 156 185 195
Iqgap3 2.476717 3.374537 2.476717 331 658 328
Mirg 2.475712 7.173399 2.475712 3692 3702 5337
Sox11 2.46664 3.117145 2.46664 5568 10757 5154
H1fx 2.45962 2.758729 2.45962 196 222 417
Gm26603 2.740352 2.450303 2.450303 531 524 400
Rin3 2.44015 2.645907 2.44015 609 561 1273
Fam19a5 2.43538 2.438948 2.43538 124 225 125
Psrc1 2.434505 2.879373 2.434505 200 210 264
Chadl 2.433461 6.255045 2.433461 384 355 1258
Nckap5 2.425943 4.648875 2.425943 410 294 1731
Sox8 2.421676 5.808876 2.421676 587 468 706
Dnm1 2.687658 2.420465 2.420465 410 842 2091
Cdca2 2.42033 3.39143 2.42033 605 566 1182
Prkcz 2.419146 2.872238 2.419146 217 325 677
P4ha3 2.417101 3.263347 2.417101 818 277 1124
Prdm16 2.412959 3.8947 2.412959 335 338 424
Aspm 2.41162 2.766846 2.41162 370 477 178
Mxd3 2.386008 3.645875 2.386008 173 216 322
Arsj 2.363737 6.417907 2.363737 383 185 182
Plcb1 2.362116 2.982614 2.362116 753 1154 200
Zgrf1 2.361901 3.616637 2.361901 611 444 879
C530008M17Rik 2.329135 3.908319 2.329135 398 557 291
Cntn2 2.30023 3.253513 2.30023 190 174 111
Usp51 2.279624 2.417398 2.279624 167 91 202
Enkd1 2.252749 3.467269 2.252749 282 258 731
Nfix 2.245716 2.253558 2.245716 1059 1354 3041
Gpc6 2.201415 2.407498 2.201415 5055 8699 3027
Gabre 2.201119 2.545379 2.201119 147 207 378
Aff2 2.196276 4.154827 2.196276 181 218 340
Arhgef39 2.192644 3.153019 2.192644 310 300 162
Ikzf4 2.180516 2.318342 2.180516 217 235 270
Itpr3 2.431129 2.180217 2.180217 182 219 361
RP23-23C9.1 2.466135 2.16361 2.16361 77 70 52
106
Ninj1 2.347599 2.157327 2.157327 492 939 377
Map1a 2.142191 6.21035 2.142191 561 452 1714
Sox5 2.132289 5.648823 2.132289 4120 3008 4891
Rian 2.117474 5.605464 2.117474 182 91 310
Limch1 3.424258 2.113269 2.113269 1102 623 1168
Cep135 2.101704 2.901145 2.101704 358 325 551
RP24-338G10.1 2.091957 2.194718 2.091957 221 179 496
Rad51ap1 2.089535 3.529236 2.089535 3799 4413 2856
Trerf1 2.088411 4.665902 2.088411 566 581 1259
Wdr90 2.08618 3.698569 2.08618 473 440 621
Kif22 2.051434 2.404828 2.051434 339 402 643
Fam53b 2.045293 2.486744 2.045293 237 283 258
Lphn3 2.042898 4.320772 2.042898 462 353 1062
Mroh2a 2.03119 2.856586 2.03119 273 369 803
Dlk1 2.010515 4.470405 2.010515 4485 5108 3010
Brca2 2.005431 2.645235 2.005431 506 366 564
Tube1 2.005067 2.400683 2.005067 193 140 221
Genes most up-
reg. (Bone)
logFC.1
(IMM)
logFC.2
(Mature)
MinFC BON1 BON2 BON3
Lhx8 9.136745 9.071637 9.071637 503 583 568
AI606473 9.311965 9.048097 9.048097 56 94 63
Lppr5 7.723725 7.460771 7.460771 20 23 27
Gpr50 9.755557 7.380689 7.380689 87 110 94
Dlx1 7.114804 7.074487 7.074487 31 214 167
Dlx2 10.488019 6.834576 6.834576 49 171 264
Pax3 6.448011 6.592669 6.448011 1475 29 69
Pitx1 7.663759 5.89066 5.89066 276 231 235
BC064078 5.884778 8.370188 5.884778 61 30 42
Tmem132d 8.860258 5.705026 5.705026 50 62 44
Tnfaip8l3 5.684269 5.148943 5.148943 23 19 19
Cd1d2 4.993531 5.484816 4.993531 37 19 33
Crym 12.475711 4.973768 4.973768 587 716 614
Msx1 4.967471 4.856061 4.856061 1232 1175 911
Lhx6 4.70797 5.003821 4.70797 96 108 92
Hist2h3c2 5.897839 4.641575 4.641575 177 125 130
Ovol2 8.662749 4.610689 4.610689 27 42 66
Chgb 7.869674 4.593058 4.593058 134 238 128
Gal 11.428436 4.38991 4.38991 329 322 277
Clec2g 11.014425 4.359401 4.359401 254 204 238
Bcl2a1a 7.53391 4.354274 4.354274 13 25 24
Grm4 10.491861 4.341922 4.341922 238 136 112
Syt6 10.862196 4.331178 4.331178 240 214 172
Arl4d 6.406811 4.316271 4.316271 394 369 333
Ccdc121 5.430921 4.27946 4.27946 52 38 38
Madcam1 8.294017 4.266542 4.266542 10 51 44
Mmp8 5.648194 4.215696 4.215696 20 54 27
5031410I06Rik 5.270554 4.215152 4.215152 13 35 30
Car1 7.359612 4.180348 4.180348 27 15 14
Ramp1 7.053807 4.154912 4.154912 45 45 48
Drd1a 5.511976 4.048314 4.048314 32 41 30
Aifm3 4.213354 4.012438 4.012438 18 67 44
Ranbp3l 7.280341 4.010069 4.010069 1424 2188 1593
Gm16332 6.602178 3.979735 3.979735 52 31 40
Fetub 10.201013 3.956426 3.956426 107 178 111
107
Cdh12 4.498081 3.941303 3.941303 9 34 23
Mepe 8.423785 3.903966 3.903966 43 38 35
Gprin3 6.122325 3.74407 3.74407 147 173 109
Lingo3 4.349777 3.706382 3.706382 57 40 37
Fhod3 5.604989 3.669986 3.669986 311 558 350
Calcr 8.71084 3.666315 3.666315 18 63 60
Pcbd1 6.097716 3.660692 3.660692 330 329 256
Wif1 3.79022 3.604383 3.604383 3097 3464 3472
Bhlha15 4.253196 3.575559 3.575559 83 100 78
2310030G06Rik 6.584264 3.550023 3.550023 80 104 102
Clec4a2 7.652997 3.537115 3.537115 58 190 174
Insc 11.092047 3.52579 3.52579 1020 847 769
Sall1 5.580406 3.491765 3.491765 34 56 55
Rab38 4.17576 3.440497 3.440497 39 13 36
Cmbl 6.604614 3.429892 3.429892 184 179 171
Kcnj3 10.411635 3.380355 3.380355 140 157 161
Cdh23 4.270056 3.363996 3.363996 183 96 87
Srgn 7.244619 3.346306 3.346306 221 277 290
Fat3 5.825276 3.335312 3.335312 1528 1257 1339
Car3 10.000694 3.315939 3.315939 11527 8698 7192
Cd59a 4.176947 3.309338 3.309338 407 419 333
Gstm6 5.085284 3.280339 3.280339 108 69 88
Slc2a12 5.805997 3.249088 3.249088 321 286 324
Cd1d1 8.359185 3.245766 3.245766 905 832 962
Col1a2 7.363067 3.164504 3.164504 648095 727263 598100
Plekha2 4.999655 3.115288 3.115288 171 161 200
Ctsh 4.964961 3.113365 3.113365 771 916 638
Ccl9 4.109489 3.076699 3.076699 319 1051 857
Mob3b 6.138554 3.066977 3.066977 409 558 496
Foxf1 4.240281 2.971339 2.971339 63 39 52
2010300C02Rik 4.704031 2.942642 2.942642 214 208 154
Prex1 3.759317 2.898032 2.898032 3530 3493 3353
Satb2 9.145641 2.881265 2.881265 3161 2658 2501
Olfml3 5.910038 2.86078 2.86078 6343 6368 5897
Gpr133 9.851301 2.828861 2.828861 1605 1418 1692
Ibsp 10.804709 2.825338 2.825338 290255 269321 234039
Dner 9.627539 2.82529 2.82529 709 119 182
Fyn 4.836725 2.811189 2.811189 2378 4191 3765
RP23-388I22.1 2.799335 3.715813 2.799335 311 298 276
Scn3a 10.0203 2.795545 2.795545 1085 575 607
Smad6 2.950231 2.784969 2.784969 685 658 655
Tdrp 9.43823 2.779462 2.779462 303 270 270
Dcn 6.528736 2.766027 2.766027 3066 4783 4304
Dkk1 9.309895 2.753702 2.753702 2032 1620 2540
Sparc 3.298517 2.751291 2.751291 117578 136556 116792
Ncf1 7.888247 2.720026 2.720026 695 802 622
Kazald1 2.711625 3.189502 2.711625 5946 5801 4817
Pard6g 3.231024 2.700203 2.700203 2140 2380 2666
Dapk2 8.328763 2.672389 2.672389 756 921 770
Ifitm5 7.713749 2.66909 2.66909 5328 5934 5751
Aldh1b1 7.433072 2.645313 2.645313 306 263 169
Serpinf1 3.797382 2.609135 2.609135 854 1189 1008
Prcp 3.700088 2.608368 2.608368 1995 1130 997
Cd109 4.285435 2.598995 2.598995 1412 2924 2377
108
Shb 3.031154 2.595782 2.595782 247 277 248
Ccdc149 4.174977 2.559771 2.559771 160 143 134
Rassf4 3.136354 2.529738 2.529738 1053 1047 1042
Hrc 6.388662 2.526006 2.526006 1833 1790 1386
Magi2 4.157514 2.503774 2.503774 578 526 456
Hpcal1 3.393296 2.497773 2.497773 785 491 588
Kctd12b 7.226238 2.495244 2.495244 697 655 552
Ddx59 3.435503 2.478726 2.478726 412 416 368
Tmem119 6.840728 2.439901 2.439901 6488 6845 6968
Bmp4 4.79948 2.38646 2.38646 506 333 293
Ptprr 5.227636 2.373628 2.373628 185 224 188
Ttc7 2.348966 2.700116 2.348966 605 681 827
Phex 9.119497 2.347742 2.347742 5037 4701 3690
Cgref1 3.532644 2.32064 2.32064 5082 7422 5323
Ell2 4.420378 2.317539 2.317539 2048 2737 2523
Frmd4b 3.487581 2.309628 2.309628 1199 1018 943
Dlx3 9.169601 2.272572 2.272572 1848 1855 1703
Ust 3.1538 2.263212 2.263212 828 777 793
Gm15417 2.243336 2.701654 2.243336 89 75 61
Pdgfrl 3.555791 2.238034 2.238034 1237 1834 1098
Hist1h1c 2.228665 2.479309 2.228665 1219 1422 1313
Smim14 3.540073 2.220217 2.220217 4141 4548 4152
Fam109b 2.27056 2.205267 2.205267 744 534 622
Ano1 5.236643 2.15554 2.15554 1373 1819 1591
2810025M15Rik 3.215811 2.145351 2.145351 1373 1262 1261
Sema3b 3.614571 2.132613 2.132613 1268 1614 1298
Stk17b 3.705852 2.130371 2.130371 1047 945 1082
Mylk 2.12619 2.165814 2.12619 1121 685 1170
Cd63 2.676787 2.126146 2.126146 33402 22627 24819
BC027582 4.189821 2.111899 2.111899 160 142 160
Sh3bgrl2 4.195357 2.109408 2.109408 565 613 498
Ankrd6 3.574807 2.097861 2.097861 776 743 869
Galm 2.083556 2.308364 2.083556 331 304 313
Slc7a2 2.661316 2.082962 2.082962 1387 1811 2053
Inpp4a 2.673503 2.051824 2.051824 697 672 680
Cadm1 4.06709 2.038146 2.038146 5659 5047 5394
Fam46a 2.369924 2.020256 2.020256 12272 9854 9493
Pls3 4.50806 2.017227 2.017227 3651 4598 5573
Fras1 4.727238 2.009784 2.009784 1099 1061 1142
Sh3pxd2b 4.424895 2.006615 2.006615 3237 3047 3045
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Appendix B
Gene Ontology Enrichment Analysis
Table B.1: Gene Ontology results for genes present in FABIA biclusters. N is the number of genes
with the associated GO term in a bicluster while X is the total number of genes in the background set
that are associated with the GO term.
N X p-value P adj attrib ID attrib name
6 6 3.5879704167483001E-7 1E-3 GO:0005833 hemoglobin
complex
6 6 3.5879704167483001E-7 1E-3 GO:0090193 positive regula-
tion of glomeru-
lus development
7 8 2.2327690834081999E-7 <0.001 GO:0090192 regulation of
glomerulus
development
8 14 4.77256147161806E-6 0.02 GO:0060351 cartilage devel-
opment involved
in endochondral
bone morpho-
genesis
8 14 4.77256147161806E-6 0.02 GO:0071622 regulation of
granulocyte
chemotaxis
11 21 2.35595435838962E-7 <0.001 GO:0090184 positive regula-
tion of kidney
development
11 22 4.3529425554940897E-7 2E-3 GO:0005201 extracellular
matrix struc-
tural con-
stituent
16 33 1.7340661223660601E-9 <0.001 GO:0031225 anchored com-
ponent of
membrane
10 21 2.62306671942031E-6 6.0E-3 GO:0001968 fibronectin
binding
14 31 5.7654916834889098E-8 <0.001 GO:0050840 extracellular
matrix binding
12 27 6.4706181619242598E-7 2E-3 GO:0048706 embryonic skele-
tal system de-
velopment
13 30 3.1474432892403899E-7 <0.001 GO:0004930 G-protein cou-
pled receptor
activity
10 24 1.1533808418117801E-5 3.5E-2 GO:0030858 positive regula-
tion of epithe-
lial cell differen-
tiation
110
13 32 7.78067056032933E-7 2E-3 GO:0002687 positive regula-
tion of leukocyte
migration
10 25 1.77757359173968E-5 4.7E-2 GO:0035137 hindlimb mor-
phogenesis
13 33 1.18524393038482E-6 2E-3 GO:0031214 biomineral tis-
sue development
17 44 3.7462488736548198E-8 <0.001 GO:0050900 leukocyte mi-
gration
51 135 2.2957966272059699E-21 <0.001 GO:0005578 proteinaceous
extracellular
matrix
23 60 1.74891005222263E-10 <0.001 GO:0051216 cartilage devel-
opment
11 29 1.22854581467478E-5 3.8E-2 GO:0090183 regulation of
kidney develop-
ment
59 162 1.35130950603293E-23 <0.001 GO:0031012 extracellular
matrix
13 35 2.60235311068536E-6 5.0E-3 GO:0005518 collagen binding
24 69 7.3450057453294495E-10 <0.001 GO:0009897 external side of
plasma mem-
brane
29 85 2.1194797756309901E-11 <0.001 GO:0001501 skeletal system
development
14 41 3.4344891183182701E-6 8.0E-3 GO:0005581 collagen trimer
14 41 3.4344891183182701E-6 8.0E-3 GO:0030500 regulation of
bone mineral-
ization
16 47 7.2056049050454499E-7 2E-3 GO:0050921 positive regula-
tion of chemo-
taxis
20 59 3.2038768068600297E-8 <0.001 GO:0030326 embryonic limb
morphogenesis
20 59 3.2038768068600297E-8 <0.001 GO:0035113 embryonic
appendage
morphogenesis
131 423 4.3109749969765002E-43 <0.001 GO:0005576 extracellular re-
gion
14 43 6.5082582472223003E-6 2.1E-2 GO:0070167 regulation of
biomineral tis-
sue development
14 44 8.8111631760993594E-6 3.2E-2 GO:0002685 regulation
of leukocyte
migration
19 61 3.2484767129804101E-7 <0.001 GO:0008201 heparin binding
14 45 1.18067970808607E-5 3.7E-2 GO:0005261 cation channel
activity
16 53 4.3885048707458198E-6 1.8E-2 GO:0048520 positive regula-
tion of behavior
24 80 2.09951814383663E-8 <0.001 GO:0001503 ossification
111
30 104 1.0318648253535001E-9 <0.001 GO:0030198 extracellular
matrix organi-
zation
30 104 1.0318648253535001E-9 <0.001 GO:0043062 extracellular
structure orga-
nization
21 73 3.53964994121251E-7 1E-3 GO:0035107 appendage mor-
phogenesis
21 73 3.53964994121251E-7 1E-3 GO:0035108 limb morpho-
genesis
16 59 2.0013644891332301E-5 4.9E-2 GO:0045778 positive regula-
tion of ossifica-
tion
17 63 1.18996775816344E-5 3.7E-2 GO:0050731 positive regula-
tion of peptidyl-
tyrosine phos-
phorylation
18 67 7.0775972883762301E-6 2.1E-2 GO:0010811 positive reg-
ulation of
cell-substrate
adhesion
24 90 2.5117119768673201E-7 <0.001 GO:0006935 chemotaxis
20 75 2.5054901416722E-6 5.0E-3 GO:0019838 growth factor
binding
24 92 3.9206102571434899E-7 2E-3 GO:0042330 taxis
20 77 3.90443286163468E-6 9.0E-3 GO:0044420 extracellular
matrix compo-
nent
20 78 4.8411182914754799E-6 0.02 GO:0005539 glycosaminoglycan
binding
30 119 3.2649974110267698E-8 <0.001 GO:0030278 regulation of os-
sification
28 113 1.3921588684794499E-7 <0.001 GO:0007186 G-protein cou-
pled receptor
signaling path-
way
25 102 8.1057553084648204E-7 2E-3 GO:0098552 side of mem-
brane
88 379 2.7566695942264198E-19 <0.001 GO:0005615 extracellular
space
52 224 8.5508887718875607E-12 <0.001 GO:0005509 calcium ion
binding
24 102 2.9319960013772302E-6 7.0E-3 GO:0010810 regulation of
cell-substrate
adhesion
33 141 4.7898474205072297E-8 <0.001 GO:0004888 transmembrane
signaling recep-
tor activity
23 98 4.9262353237078297E-6 0.02 GO:0010632 regulation of ep-
ithelial cell mi-
gration
112
25 107 2.0983869853906501E-6 3.0E-3 GO:1901681 sulfur com-
pound binding
24 103 3.5230385454192999E-6 8.0E-3 GO:1901342 regulation of
vasculature
development
22 97 1.41589662353361E-5 0.04 GO:0001763 morphogenesis
of a branching
structure
50 225 1.17336323651596E-10 <0.001 GO:0009986 cell surface
39 178 2.06037378564837E-8 <0.001 GO:0038023 signaling recep-
tor activity
45 207 2.1529714974322501E-9 <0.001 GO:0030335 positive regula-
tion of cell mi-
gration
24 110 1.1785391692014299E-5 3.6E-2 GO:0030336 negative regula-
tion of cell mi-
gration
47 218 1.2525925793602099E-9 <0.001 GO:0040017 positive regula-
tion of locomo-
tion
45 210 3.4820502943171001E-9 <0.001 GO:2000147 positive regu-
lation of cell
motility
32 149 6.2158656397240396E-7 2E-3 GO:1903034 regulation of
response to
wounding
45 215 7.5625168653703296E-9 <0.001 GO:0051272 positive regula-
tion of cellular
component
movement
24 114 2.22204521078299E-5 0.05 GO:2000146 negative reg-
ulation of cell
motility
36 176 4.4276581877016699E-7 2E-3 GO:0031226 intrinsic compo-
nent of plasma
membrane
27 132 1.21424719792932E-5 3.7E-2 GO:0090287 regulation of
cellular response
to growth factor
stimulus
73 369 2.4026686373510698E-12 <0.001 GO:0007155 cell adhesion
73 370 2.7594225501547202E-12 <0.001 GO:0022610 biological adhe-
sion
28 139 1.1394645048131599E-5 3.5E-2 GO:0001525 angiogenesis
27 134 1.6201751110553799E-5 4.2E-2 GO:0002521 leukocyte differ-
entiation
68 348 2.5690810149361599E-11 <0.001 GO:0030334 regulation of cell
migration
38 192 5.1169269546806001E-7 2E-3 GO:0016337 single organ-
ismal cell-cell
adhesion
43 220 1.31643145784269E-7 <0.001 GO:0004872 receptor activity
113
35 180 2.21239386069635E-6 4.0E-3 GO:0002009 morphogenesis
of an epithelium
42 217 2.4479838940406002E-7 <0.001 GO:0098609 cell-cell adhe-
sion
54 284 8.6737138171379996E-9 <0.001 GO:0009888 tissue develop-
ment
68 363 1.81628206128766E-10 <0.001 GO:2000145 regulation of cell
motility
78 422 1.4968795464761001E-11 <0.001 GO:0007275 multicellular or-
ganismal devel-
opment
38 202 1.90683069495833E-6 3.0E-3 GO:0043269 regulation of ion
transport
40 219 2.2290845680791602E-6 4.0E-3 GO:0048729 tissue morpho-
genesis
50 277 1.7468167543148699E-7 <0.001 GO:0009887 organ morpho-
genesis
33 182 2.0046224245379201E-5 4.9E-2 GO:0010721 negative regula-
tion of cell de-
velopment
38 211 5.6478636866460197E-6 0.02 GO:0098602 single organism
cell adhesion
68 386 2.7673116354531601E-9 <0.001 GO:0051270 regulation of
cellular compo-
nent movement
70 398 1.7103270037821999E-9 <0.001 GO:0040012 regulation of lo-
comotion
81 469 2.0356370248101E-10 <0.001 GO:0045597 positive regula-
tion of cell dif-
ferentiation
104 624 3.82294555661716E-12 <0.001 GO:0048513 organ develop-
ment
53 311 5.0201339470734897E-7 2E-3 GO:0016477 cell migration
137 849 1.02681139658503E-14 <0.001 GO:2000026 regulation of
multicellular
organismal
development
57 339 2.9292882963249899E-7 <0.001 GO:0048731 system develop-
ment
99 607 4.9406140125825799E-11 <0.001 GO:0051094 positive regula-
tion of develop-
mental process
46 276 5.3622746657438103E-6 0.02 GO:0030155 regulation of cell
adhesion
60 363 2.6084530774391699E-7 <0.001 GO:0003008 system process
181 1186 5.2757987970103801E-17 <0.001 GO:0051239 regulation of
multicellular
organismal
process
55 334 9.4607517169920205E-7 2E-3 GO:0048870 cell motility
62 378 2.1669469423054601E-7 <0.001 GO:0040011 locomotion
114
41 248 2.1190235060926699E-5 0.05 GO:0022891 substrate-
specific trans-
membrane
transporter
activity
44 268 1.2719409848960899E-5 3.8E-2 GO:0022857 transmembrane
transporter
activity
55 340 1.67944037993881E-6 3.0E-3 GO:0045596 negative regula-
tion of cell dif-
ferentiation
104 663 1.5986855395387201E-10 <0.001 GO:0051240 positive regula-
tion of multicel-
lular organismal
process
49 306 8.3362324199080006E-6 2.7E-2 GO:0022892 substrate-
specific trans-
porter activity
78 495 3.2491208085246497E-8 <0.001 GO:0051241 negative regula-
tion of multicel-
lular organismal
process
124 812 1.3056943189054199E-11 <0.001 GO:0045595 regulation of cell
differentiation
115 753 8.2862733266854805E-11 <0.001 GO:0009653 anatomical
structure mor-
phogenesis
186 1278 2.5313466974863399E-15 <0.001 GO:0032501 multicellular
organismal
process
185 1271 3.0671443286448801E-15 <0.001 GO:0044707 single-
multicellular
organism pro-
cess
69 449 5.6159199638347598E-7 2E-3 GO:0051093 negative regula-
tion of develop-
mental process
69 453 7.85210333196869E-7 2E-3 GO:0002682 regulation of
immune system
process
162 1130 1.0812178585085701E-12 <0.001 GO:0050793 regulation of
developmental
process
73 490 8.8006547814048801E-7 2E-3 GO:0022603 regulation of
anatomical
structure mor-
phogenesis
74 504 1.2997384598505499E-6 2E-3 GO:0060284 regulation of cell
development
125 891 3.0445818161631501E-9 <0.001 GO:0030154 cell differentia-
tion
115
88 645 2.9713311152811499E-6 7.0E-3 GO:0044459 plasma mem-
brane part
171 1310 6.4579882330220096E-10 <0.001 GO:0005886 plasma mem-
brane
168 1308 3.3641739239291601E-9 <0.001 GO:0048856 anatomical
structure devel-
opment
160 1246 9.1688720551134707E-9 <0.001 GO:0048869 cellular develop-
mental process
264 2177 6.7922345161723396E-12 <0.001 GO:0032502 developmental
process
95 721 5.32287189955161E-6 0.02 GO:0042127 regulation of cell
proliferation
252 2082 3.5325358310107399E-11 <0.001 GO:0044767 single-organism
developmental
process
204 1664 2.2798827897708201E-9 <0.001 GO:0031224 intrinsic compo-
nent of mem-
brane
221 1825 1.0959036746228901E-9 <0.001 GO:0044421 extracellular re-
gion part
188 1629 1.1841806460117201E-6 2E-3 GO:0016021 integral compo-
nent of mem-
brane
6 6 6.4899999999999995E-7 1E-3 GO:0005833 hemoglobin
complex
6 6 6.4899999999999995E-7 1E-3 GO:0072124 regulation of
glomerular
mesangial cell
proliferation
5 5 6.9999999999999999E-6 1.8E-2 GO:0003071 renal system
process involved
in regulation
of systemic
arterial blood
pressure
7 8 4.4299999999999998E-7 <0.001 GO:0090192 regulation of
glomerulus
development
6 8 1.5400000000000002E-5 3.3E-2 GO:0098801 regulation of re-
nal system pro-
cess
6 8 1.5400000000000002E-5 3.3E-2 GO:1901722 regulation of cell
proliferation in-
volved in kidney
development
8 12 1.9599999999999999E-6 3.0E-3 GO:0050919 negative chemo-
taxis
14 22 5.3700000000000001E-10 <0.001 GO:0008038 neuron recogni-
tion
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7 11 1.42E-5 0.03 GO:0043395 heparan sulfate
proteoglycan
binding
7 11 1.42E-5 0.03 GO:0072215 regulation of
metanephros
development
8 13 4.6800000000000001E-6 9.0E-3 GO:0071772 response to
BMP
8 13 4.6800000000000001E-6 9.0E-3 GO:0071773 cellular response
to BMP stimu-
lus
11 18 7.5600000000000002E-8 <0.001 GO:0007156 homophilic cell
adhesion via
plasma mem-
brane adhesion
molecules
8 14 1.0000000000000001E-5 2.4E-2 GO:0048070 regulation of
developmental
pigmentation
9 16 3.2200000000000001E-6 4.0E-3 GO:0007413 axonal fascicu-
lation
8 15 1.9700000000000001E-5 3.7E-2 GO:0048521 negative regula-
tion of behavior
9 17 6.2700000000000001E-6 1.4E-2 GO:0043394 proteoglycan
binding
11 21 6.4300000000000003E-7 1E-3 GO:2000351 regulation of
endothelial
cell apoptotic
process
10 20 3.6799999999999999E-6 4.0E-3 GO:0003014 renal system
process
10 20 3.6799999999999999E-6 4.0E-3 GO:1904036 negative regula-
tion of epithe-
lial cell apop-
totic process
9 19 2.0100000000000001E-5 3.9E-2 GO:0045992 negative reg-
ulation of
embryonic
development
16 35 2.1299999999999999E-8 <0.001 GO:0072562 blood micropar-
ticle
10 22 1.08E-5 2.4E-2 GO:0030501 positive regu-
lation of bone
mineralization
10 22 1.08E-5 2.4E-2 GO:0070169 positive regula-
tion of biomin-
eral tissue devel-
opment
13 29 6.0999999999999998E-7 1E-3 GO:0090183 regulation of
kidney develop-
ment
117
11 25 5.7300000000000002E-6 1.3E-2 GO:0034754 cellular hor-
mone metabolic
process
14 33 5.1500000000000005E-7 1E-3 GO:0031214 biomineral tis-
sue development
56 135 1.2899999999999999E-23 <0.001 GO:0005578 proteinaceous
extracellular
matrix
15 36 2.67E-7 <0.001 GO:0010595 positive regula-
tion of endothe-
lial cell migra-
tion
12 29 4.6800000000000001E-6 9.0E-3 GO:0098742 cell-cell adhe-
sion via plasma-
membrane
adhesion
molecules
19 46 8.02E-9 <0.001 GO:0045669 positive reg-
ulation of
osteoblast dif-
ferentiation
14 34 8.0100000000000004E-7 1E-3 GO:0030193 regulation of
blood coagula-
tion
14 34 8.0100000000000004E-7 1E-3 GO:1900046 regulation of
hemostasis
16 39 1.3799999999999999E-7 <0.001 GO:1904035 regulation of
epithelial cell
apoptotic pro-
cess
18 44 2.3899999999999999E-8 <0.001 GO:0008083 growth factor
activity
11 27 1.4100000000000001E-5 2.9E-2 GO:0014068 positive reg-
ulation of
phosphatidyli-
nositol 3-kinase
signaling
12 30 7.1400000000000002E-6 1.8E-2 GO:0004930 G-protein cou-
pled receptor
activity
17 43 1.0700000000000001E-7 <0.001 GO:0070167 regulation of
biomineral tis-
sue development
11 28 2.12E-5 0.04 GO:0001944 vasculature de-
velopment
11 28 2.12E-5 0.04 GO:0050715 positive regula-
tion of cytokine
secretion
62 162 8.9099999999999994E-24 <0.001 GO:0031012 extracellular
matrix
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16 41 3.15E-7 <0.001 GO:0030500 regulation of
bone mineral-
ization
14 36 1.8300000000000001E-6 3.0E-3 GO:0050818 regulation of co-
agulation
17 45 2.35E-7 <0.001 GO:0008037 cell recognition
15 40 1.35E-6 2E-3 GO:0042445 hormone
metabolic
process
13 35 7.7999999999999999E-6 1.9E-2 GO:0005518 collagen binding
15 41 1.95E-6 3.0E-3 GO:0005581 collagen trimer
15 41 1.95E-6 3.0E-3 GO:0048592 eye morphogen-
esis
15 41 1.95E-6 3.0E-3 GO:0050707 regulation of cy-
tokine secretion
12 33 2.2500000000000001E-5 0.04 GO:0030509 BMP signaling
pathway
21 59 3.0600000000000003E-8 <0.001 GO:0045778 positive regula-
tion of ossifica-
tion
19 54 1.72E-7 <0.001 GO:1904018 positive regula-
tion of vascu-
lature develop-
ment
14 40 7.8299999999999996E-6 0.02 GO:0007160 cell-matrix ad-
hesion
14 40 7.8299999999999996E-6 0.02 GO:0014066 regulation of
phosphatidyli-
nositol 3-kinase
signaling
15 43 3.89E-6 4.0E-3 GO:0001570 vasculogenesis
15 43 3.89E-6 4.0E-3 GO:0090596 sensory organ
morphogenesis
24 69 5.3700000000000003E-9 <0.001 GO:0009897 external side of
plasma mem-
brane
13 38 2.1999999999999999E-5 0.04 GO:0014910 regulation of
smooth muscle
cell migration
21 62 8.2700000000000006E-8 <0.001 GO:0010594 regulation of en-
dothelial cell mi-
gration
25 74 5.14E-9 <0.001 GO:0007411 axon guidance
132 423 6.5999999999999997E-39 <0.001 GO:0005576 extracellular re-
gion
25 75 7.0399999999999997E-9 <0.001 GO:0097485 neuron projec-
tion guidance
16 48 3.6899999999999998E-6 4.0E-3 GO:0045766 positive regula-
tion of angio-
genesis
23 70 3.84E-8 <0.001 GO:0001667 ameboidal-type
cell migration
119
20 61 3.0899999999999997E-7 <0.001 GO:0060560 developmental
growth involved
in morphogene-
sis
17 52 2.4899999999999999E-6 4.0E-3 GO:0001936 regulation of
endothelial cell
proliferation
45 141 3.8399999999999999E-14 <0.001 GO:0004888 transmembrane
signaling recep-
tor activity
18 56 1.6700000000000001E-6 3.0E-3 GO:0061041 regulation of
wound healing
17 53 3.3500000000000001E-6 4.0E-3 GO:0050673 epithelial cell
proliferation
14 44 2.72E-5 4.7E-2 GO:0019199 transmembrane
receptor protein
kinase activity
14 44 2.72E-5 4.7E-2 GO:0050772 positive regula-
tion of axono-
genesis
19 60 1.11E-6 2E-3 GO:0010634 positive regula-
tion of epithelial
cell migration
26 83 1.5399999999999999E-8 <0.001 GO:0048754 branching mor-
phogenesis of an
epithelial tube
25 80 3.0799999999999998E-8 <0.001 GO:0001503 ossification
29 93 2.57E-9 <0.001 GO:0061138 morphogenesis
of a branching
epithelium
28 90 5.1300000000000003E-9 <0.001 GO:0006935 chemotaxis
30 97 1.6999999999999999E-9 <0.001 GO:0001763 morphogenesis
of a branching
structure
26 84 2.0400000000000001E-8 <0.001 GO:0007178 transmembrane
receptor protein
serine/thre-
onine kinase
signaling path-
way
24 78 8.1199999999999999E-8 <0.001 GO:0005539 glycosaminoglycan
binding
16 52 1.19E-5 2.9E-2 GO:0048514 blood vessel
morphogenesis
27 88 1.35E-8 <0.001 GO:0001568 blood vessel de-
velopment
23 75 1.6199999999999999E-7 <0.001 GO:0048562 embryonic
organ morpho-
genesis
28 92 8.8800000000000008E-9 <0.001 GO:0042330 taxis
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23 76 2.1199999999999999E-7 <0.001 GO:0051924 regulation of
calcium ion
transport
16 53 1.5500000000000001E-5 3.3E-2 GO:0048520 positive regula-
tion of behavior
108 379 6.1699999999999998E-28 <0.001 GO:0005615 extracellular
space
52 178 2.2499999999999999E-14 <0.001 GO:0038023 signaling recep-
tor activity
33 113 1.37E-9 <0.001 GO:0007186 G-protein cou-
pled receptor
signaling path-
way
26 89 7.6500000000000003E-8 <0.001 GO:0050770 regulation of ax-
onogenesis
21 72 1.3999999999999999E-6 2E-3 GO:0010817 regulation of
hormone levels
17 59 1.6799999999999998E-5 3.4E-2 GO:0030326 embryonic limb
morphogenesis
17 59 1.6799999999999998E-5 3.4E-2 GO:0035113 embryonic
appendage
morphogenesis
18 63 1.0900000000000001E-5 2.5E-2 GO:0050920 regulation of
chemotaxis
19 67 7.0099999999999998E-6 1.8E-2 GO:0031589 cell-substrate
adhesion
29 103 3.3899999999999999E-8 <0.001 GO:1901342 regulation of
vasculature
development
25 89 3.1399999999999998E-7 <0.001 GO:2000027 regulation of or-
gan morphogen-
esis
29 104 4.29E-8 <0.001 GO:0030198 extracellular
matrix organi-
zation
29 104 4.29E-8 <0.001 GO:0043062 extracellular
structure orga-
nization
17 61 2.72E-5 4.6E-2 GO:0008201 heparin binding
22 79 1.88E-6 3.0E-3 GO:0045667 regulation
of osteoblast
differentiation
61 225 5.5199999999999998E-15 <0.001 GO:0009986 cell surface
27 98 1.6400000000000001E-7 <0.001 GO:0010632 regulation of ep-
ithelial cell mi-
gration
20 73 7.1999999999999997E-6 1.8E-2 GO:0035107 appendage mor-
phogenesis
20 73 7.1999999999999997E-6 1.8E-2 GO:0035108 limb morpho-
genesis
121
18 66 2.1999999999999999E-5 0.04 GO:0045995 regulation of
embryonic
development
37 138 1.9500000000000001E-9 <0.001 GO:0035239 tube morpho-
genesis
22 82 3.7000000000000002E-6 4.0E-3 GO:0050795 regulation of be-
havior
23 86 2.3700000000000002E-6 3.0E-3 GO:0050839 cell adhesion
molecule bind-
ing
20 75 1.1199999999999999E-5 2.7E-2 GO:0019838 growth factor
binding
21 79 7.1899999999999998E-6 1.8E-2 GO:0001649 osteoblast dif-
ferentiation
57 220 3.67E-13 <0.001 GO:0004872 receptor activity
31 119 8.28E-8 <0.001 GO:0030278 regulation of os-
sification
54 210 2.1699999999999998E-12 <0.001 GO:2000147 positive regu-
lation of cell
motility
25 96 1.4899999999999999E-6 2E-3 GO:0035295 tube develop-
ment
20 77 1.7200000000000001E-5 3.4E-2 GO:0044420 extracellular
matrix compo-
nent
53 207 4.1899999999999997E-12 <0.001 GO:0030335 positive regula-
tion of cell mi-
gration
22 85 7.0199999999999997E-6 1.8E-2 GO:0001501 skeletal system
development
46 180 1.2199999999999999E-10 <0.001 GO:0002009 morphogenesis
of an epithelium
55 218 3.09E-12 <0.001 GO:0040017 positive regula-
tion of locomo-
tion
91 369 7.0099999999999997E-19 <0.001 GO:0007155 cell adhesion
91 370 8.5100000000000004E-19 <0.001 GO:0022610 biological adhe-
sion
26 102 1.44E-6 2E-3 GO:0098552 side of mem-
brane
55 219 3.7600000000000001E-12 <0.001 GO:0048729 tissue morpho-
genesis
54 215 5.93E-12 <0.001 GO:0051272 positive regula-
tion of cellular
component
movement
21 83 1.6500000000000001E-5 3.4E-2 GO:0050679 positive regula-
tion of epithelial
cell proliferation
27 107 1.1200000000000001E-6 2E-3 GO:1901681 sulfur com-
pound binding
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54 217 8.7600000000000006E-12 <0.001 GO:0098609 cell-cell adhe-
sion
23 93 9.9399999999999997E-6 2.2E-2 GO:0045765 regulation of an-
giogenesis
25 104 7.1099999999999997E-6 1.8E-2 GO:0070372 regulation of
ERK1 and
ERK2 cascade
53 224 1.0700000000000001E-10 <0.001 GO:0005509 calcium ion
binding
59 253 1.7100000000000001E-11 <0.001 GO:0007167 enzyme linked
receptor pro-
tein signaling
pathway
80 348 7.8299999999999998E-15 <0.001 GO:0030334 regulation of cell
migration
45 192 3.8799999999999998E-9 <0.001 GO:0016337 single organ-
ismal cell-cell
adhesion
63 277 1.0899999999999999E-11 <0.001 GO:0009887 organ morpho-
genesis
89 398 1.2800000000000001E-15 <0.001 GO:0040012 regulation of lo-
comotion
32 139 1.0699999999999999E-6 2E-3 GO:0001525 angiogenesis
81 363 3.0799999999999999E-14 <0.001 GO:2000145 regulation of cell
motility
25 109 1.7099999999999999E-5 3.4E-2 GO:0010770 positive regu-
lation of cell
morphogenesis
involved in
differentiation
30 131 2.61E-6 4.0E-3 GO:0030855 epithelial cell
differentiation
32 140 1.2699999999999999E-6 2E-3 GO:0040013 negative regula-
tion of locomo-
tion
47 211 1E-8 <0.001 GO:0098602 single organism
cell adhesion
68 311 1.1000000000000001E-11 <0.001 GO:0016477 cell migration
91 422 6.3900000000000001E-15 <0.001 GO:0007275 multicellular or-
ganismal devel-
opment
33 149 1.84E-6 3.0E-3 GO:1903034 regulation of
response to
wounding
62 284 9.9799999999999994E-11 <0.001 GO:0009888 tissue develop-
ment
44 200 4.3999999999999997E-8 <0.001 GO:0010769 regulation of
cell morphogen-
esis involved in
differentiation
123
83 386 1.3E-13 <0.001 GO:0051270 regulation of
cellular compo-
nent movement
38 175 5.2300000000000001E-7 1E-3 GO:0050678 regulation of ep-
ithelial cell pro-
liferation
27 124 2.1800000000000001E-5 0.04 GO:0051271 negative regula-
tion of cellular
component
movement
34 158 2.57E-6 4.0E-3 GO:0005887 integral compo-
nent of plasma
membrane
28 130 1.91E-5 3.5E-2 GO:0010959 regulation
of metal ion
transport
101 490 4.2100000000000002E-15 <0.001 GO:0022603 regulation of
anatomical
structure mor-
phogenesis
70 334 4.2500000000000002E-11 <0.001 GO:0048870 cell motility
28 132 2.5700000000000001E-5 4.4E-2 GO:0090287 regulation of
cellular response
to growth factor
stimulus
78 378 6.9399999999999999E-12 <0.001 GO:0040011 locomotion
37 176 1.6899999999999999E-6 3.0E-3 GO:0031226 intrinsic compo-
nent of plasma
membrane
57 276 5.2199999999999998E-9 <0.001 GO:0030155 regulation of cell
adhesion
96 478 1.1700000000000001E-13 <0.001 GO:0006928 movement of
cell or subcellu-
lar component
120 607 2.2200000000000001E-16 <0.001 GO:0051094 positive regula-
tion of develop-
mental process
59 290 5.04E-9 <0.001 GO:0004871 signal trans-
ducer activity
50 245 6.9499999999999994E-8 <0.001 GO:0051962 positive regula-
tion of nervous
system develop-
ment
32 157 1.6500000000000001E-5 3.4E-2 GO:0045785 positive regula-
tion of cell adhe-
sion
34 169 1.2099999999999999E-5 2.9E-2 GO:0007399 nervous system
development
159 849 2.7900000000000002E-19 <0.001 GO:2000026 regulation of
multicellular
organismal
development
124
67 339 1.57E-9 <0.001 GO:0048731 system develop-
ment
121 633 2.3499999999999999E-15 <0.001 GO:0007166 cell surface re-
ceptor signaling
pathway
91 469 4.2800000000000003E-12 <0.001 GO:0045597 positive regula-
tion of cell dif-
ferentiation
126 663 9.0000000000000003E-16 <0.001 GO:0051240 positive regula-
tion of multicel-
lular organismal
process
34 171 1.5800000000000001E-5 3.4E-2 GO:0007169 transmembrane
receptor pro-
tein tyrosine
kinase signaling
pathway
36 184 1.2999999999999999E-5 2.9E-2 GO:0045666 positive regula-
tion of neuron
differentiation
64 332 1.04E-8 <0.001 GO:0060089 molecular trans-
ducer activity
209 1186 3.09E-22 <0.001 GO:0051239 regulation of
multicellular
organismal
process
44 228 2.1299999999999999E-6 3.0E-3 GO:0050769 positive regula-
tion of neuroge-
nesis
138 753 7.04E-16 <0.001 GO:0009653 anatomical
structure mor-
phogenesis
35 181 2.2200000000000001E-5 0.04 GO:0005911 cell-cell junction
39 202 7.9500000000000001E-6 0.02 GO:0043269 regulation of ion
transport
56 293 1.2100000000000001E-7 <0.001 GO:0010720 positive regula-
tion of cell de-
velopment
57 303 1.6400000000000001E-7 <0.001 GO:0022604 regulation of cell
morphogenesis
194 1130 3.6300000000000001E-19 <0.001 GO:0050793 regulation of
developmental
process
45 242 4.6099999999999999E-6 8.0E-3 GO:0048598 embryonic mor-
phogenesis
60 325 1.5300000000000001E-7 <0.001 GO:0008285 negative regula-
tion of cell pro-
liferation
214 1271 3.1299999999999998E-20 <0.001 GO:0044707 single-
multicellular
organism pro-
cess
125
215 1278 2.7400000000000001E-20 <0.001 GO:0032501 multicellular
organismal
process
142 812 1.42E-14 <0.001 GO:0045595 regulation of cell
differentiation
111 624 5.6199999999999999E-12 <0.001 GO:0048513 organ develop-
ment
60 329 2.3799999999999999E-7 <0.001 GO:0045664 regulation of
neuron differen-
tiation
46 253 6.7599999999999997E-6 1.4E-2 GO:0010975 regulation of
neuron projec-
tion develop-
ment
75 424 2.6799999999999998E-8 <0.001 GO:0051960 regulation of
nervous system
development
48 271 8.9500000000000007E-6 2.1E-2 GO:0003006 developmental
process involved
in reproduction
123 721 6.7500000000000001E-12 <0.001 GO:0042127 regulation of cell
proliferation
212 1310 6.7099999999999997E-18 <0.001 GO:0005886 plasma mem-
brane
86 495 5.7800000000000003E-9 <0.001 GO:0051241 negative regula-
tion of multicel-
lular organismal
process
70 401 1.37E-7 <0.001 GO:0008284 positive regula-
tion of cell pro-
liferation
63 363 7.3300000000000001E-7 1E-3 GO:0003008 system process
102 601 7.3199999999999995E-10 <0.001 GO:0005102 receptor binding
67 389 4.3000000000000001E-7 <0.001 GO:0050767 regulation of
neurogenesis
86 504 1.39E-8 <0.001 GO:0060284 regulation of cell
development
108 645 4.8899999999999997E-10 <0.001 GO:0044459 plasma mem-
brane part
207 1308 2.55E-16 <0.001 GO:0048856 anatomical
structure devel-
opment
80 472 6.2800000000000006E-8 <0.001 GO:0010562 positive regula-
tion of phospho-
rus metabolic
process
80 472 6.2800000000000006E-8 <0.001 GO:0045937 positive regu-
lation of phos-
phate metabolic
process
126
75 443 1.7499999999999999E-7 <0.001 GO:0048646 anatomical
structure forma-
tion involved in
morphogenesis
58 340 3.5899999999999999E-6 4.0E-3 GO:0045596 negative regula-
tion of cell dif-
ferentiation
54 318 8.9700000000000005E-6 2.1E-2 GO:0031344 regulation of cell
projection orga-
nization
60 355 3.3100000000000001E-6 4.0E-3 GO:0032101 regulation of re-
sponse to exter-
nal stimulus
76 453 2.11E-7 <0.001 GO:0002682 regulation of
immune system
process
49 290 2.6699999999999998E-5 4.5E-2 GO:0048468 cell develop-
ment
74 449 6.2900000000000003E-7 1E-3 GO:0051093 negative regula-
tion of develop-
mental process
270 1825 1.15E-17 <0.001 GO:0044421 extracellular re-
gion part
141 891 4.8800000000000002E-11 <0.001 GO:0030154 cell differentia-
tion
56 347 2.8399999999999999E-5 4.7E-2 GO:0043068 positive reg-
ulation of
programmed
cell death
188 1246 1.1E-12 <0.001 GO:0048869 cellular develop-
mental process
71 445 3.5999999999999998E-6 4.0E-3 GO:0098589 membrane
region
206 1381 1.9300000000000001E-13 <0.001 GO:0007165 signal transduc-
tion
65 407 9.1300000000000007E-6 2.1E-2 GO:0001934 positive regula-
tion of protein
phosphorylation
306 2177 5.3899999999999998E-17 <0.001 GO:0032502 developmental
process
64 402 1.19E-5 2.9E-2 GO:0030030 cell projection
organization
68 428 6.7599999999999997E-6 1.4E-2 GO:0042327 positive regula-
tion of phospho-
rylation
289 2082 4.3699999999999996E-15 <0.001 GO:0044767 single-organism
developmental
process
165 1128 4.9299999999999995E-10 <0.001 GO:0032879 regulation of lo-
calization
127
116 785 1.74E-7 <0.001 GO:0048584 positive regula-
tion of response
to stimulus
91 615 4.0600000000000001E-6 5.0E-3 GO:0009967 positive regula-
tion of signal
transduction
80 540 1.5400000000000002E-5 3.3E-2 GO:0070887 cellular response
to chemical
stimulus
230 1664 1.8999999999999999E-11 <0.001 GO:0031224 intrinsic compo-
nent of mem-
brane
99 682 3.5099999999999999E-6 4.0E-3 GO:0023056 positive regula-
tion of signaling
86 594 1.7900000000000001E-5 3.5E-2 GO:0030054 cell junction
222 1629 2.0399999999999999E-10 <0.001 GO:0016021 integral compo-
nent of mem-
brane
184 1338 6.3799999999999999E-9 <0.001 GO:0023051 regulation of
signaling
99 698 9.7100000000000002E-6 2.2E-2 GO:0010647 positive regula-
tion of cell com-
munication
164 1199 7.98E-8 <0.001 GO:0009966 regulation of
signal transduc-
tion
94 672 2.9099999999999999E-5 4.7E-2 GO:0048585 negative regula-
tion of response
to stimulus
209 1578 1.09E-8 <0.001 GO:0048583 regulation of re-
sponse to stimu-
lus
184 1380 6.9899999999999997E-8 <0.001 GO:0010646 regulation of cell
communication
107 783 2.19E-5 0.04 GO:0051174 regulation of
phosphorus
metabolic pro-
cess
106 779 2.8799999999999999E-5 4.7E-2 GO:0019220 regulation of
phosphate
metabolic pro-
cess
284 2270 3.2700000000000001E-9 <0.001 GO:0044425 membrane part
148 1123 3.7000000000000002E-6 4.0E-3 GO:0065008 regulation of bi-
ological quality
296 2388 3.3799999999999999E-9 <0.001 GO:0048522 positive regula-
tion of cellular
process
316 2616 1.35E-8 <0.001 GO:0048518 positive regula-
tion of biological
process
128
211 1721 4.16E-6 5.0E-3 GO:0031988 membrane-
bounded vesicle
513 4706 5.6799999999999999E-8 <0.001 GO:0065007 biological regu-
lation
227 1884 5.6999999999999996E-6 1.3E-2 GO:0031982 vesicle
494 4552 3.58E-7 <0.001 GO:0050789 regulation of bi-
ological process
264 2251 6.2700000000000001E-6 1.3E-2 GO:0048519 negative regula-
tion of biological
process
473 4341 5.9500000000000002E-7 1E-3 GO:0050794 regulation of
cellular process
248 2128 2.2900000000000001E-5 0.04 GO:0048523 negative regula-
tion of cellular
process
446 4108 3.63E-6 4.0E-3 GO:0005515 protein binding
530 5038 7.7100000000000007E-6 1.9E-2 GO:0044699 single-organism
process
5 7 4.69142170614867E-7 2E-3 GO:0003009 skeletal muscle
contraction
4 6 1.13484012416261E-5 1.9E-2 GO:0010919 regulation of in-
ositol phosphate
biosynthetic
process
8 25 4.1201915895595998E-7 2E-3 GO:0006941 striated muscle
contraction
9 37 1.02944750126797E-6 2E-3 GO:0022900 electron trans-
port chain
26 135 1.9657624069355098E-14 <0.001 GO:0005578 proteinaceous
extracellular
matrix
27 162 2.4446271205530899E-13 <0.001 GO:0031012 extracellular
matrix
10 61 1.17170901212455E-5 1.9E-2 GO:0008201 heparin binding
12 85 7.8190713793110795E-6 8.0E-3 GO:0001501 skeletal system
development
11 78 1.89666081314572E-5 0.03 GO:0005539 glycosaminoglycan
binding
54 423 2.4993065086753099E-20 <0.001 GO:0005576 extracellular re-
gion
34 379 8.3209272376592193E-9 <0.001 GO:0005615 extracellular
space
31 363 1.23880253390561E-7 1E-3 GO:0003008 system process
24 284 4.2906296063349796E-6 5.0E-3 GO:0009888 tissue develop-
ment
31 422 3.2641730427692599E-6 5.0E-3 GO:0007275 multicellular or-
ganismal devel-
opment
74 1278 6.9187352222183001E-9 <0.001 GO:0032501 multicellular
organismal
process
129
73 1271 1.2949234596072499E-8 <0.001 GO:0044707 single-
multicellular
organism pro-
cess
16 135 2.1707391859897501E-8 <0.001 GO:0005578 proteinaceous
extracellular
matrix
18 162 7.7580819920006808E-9 <0.001 GO:0031012 extracellular
matrix
33 423 4.9683535800453898E-11 <0.001 GO:0005576 extracellular re-
gion
18 277 2.1841155519159701E-5 3.3E-2 GO:0009887 organ morpho-
genesis
35 624 7.8721408172260394E-8 <0.001 GO:0048513 organ develop-
ment
6 6 4.2696212005413998E-10 <0.001 GO:0005833 hemoglobin
complex
4 4 5.7589967481140203E-7 1E-3 GO:0031838 haptoglobin-
hemoglobin
complex
4 5 2.8166523046157098E-6 1.2E-2 GO:0030825 positive regula-
tion of cGMP
metabolic pro-
cess
4 6 8.2652613645796707E-6 2.4E-2 GO:0019825 oxygen binding
11 35 1.3784435788083099E-9 <0.001 GO:0072562 blood micropar-
ticle
7 24 2.6678800903408201E-6 9.0E-3 GO:0055008 cardiac muscle
tissue morpho-
genesis
7 25 3.6183358864521802E-6 1.4E-2 GO:0006941 striated muscle
contraction
9 33 1.7998755857775201E-7 <0.001 GO:0031214 biomineral tis-
sue development
8 30 1.0729523558841999E-6 5.0E-3 GO:0060415 muscle tissue
morphogenesis
8 31 1.41175994688806E-6 6.0E-3 GO:0050840 extracellular
matrix binding
7 29 1.0683093490522701E-5 2.9E-2 GO:1902930 regulation of
alcohol biosyn-
thetic process
10 49 7.0848483836871199E-7 1E-3 GO:0006936 muscle contrac-
tion
13 66 2.3065524115908601E-8 <0.001 GO:0003012 muscle system
process
24 135 2.2657022113402799E-13 <0.001 GO:0005578 proteinaceous
extracellular
matrix
9 52 1.08356105859414E-5 2.9E-2 GO:0048514 blood vessel
morphogenesis
26 162 2.6557523844903202E-13 <0.001 GO:0031012 extracellular
matrix
130
17 104 3.1159503426712301E-9 <0.001 GO:0030198 extracellular
matrix organi-
zation
17 104 3.1159503426712301E-9 <0.001 GO:0043062 extracellular
structure orga-
nization
59 423 3.5118516382437701E-26 <0.001 GO:0005576 extracellular re-
gion
15 97 5.8545233404851597E-8 <0.001 GO:0001763 morphogenesis
of a branching
structure
14 93 2.3101454673117499E-7 <0.001 GO:0061138 morphogenesis
of a branching
epithelium
12 80 1.78374075793079E-6 7.0E-3 GO:0001503 ossification
43 379 1.16790296976662E-15 <0.001 GO:0005615 extracellular
space
25 219 1.52313300195994E-9 <0.001 GO:0048729 tissue morpho-
genesis
29 284 9.8801921614063904E-10 <0.001 GO:0009888 tissue develop-
ment
18 180 2.3363883670357698E-6 9.0E-3 GO:0002009 morphogenesis
of an epithelium
38 422 8.3831069985444898E-11 <0.001 GO:0007275 multicellular or-
ganismal devel-
opment
21 224 9.5773383273316003E-7 4.0E-3 GO:0005509 calcium ion
binding
18 196 7.8351232586422001E-6 2.1E-2 GO:0007389 pattern specifi-
cation process
30 363 6.9885917786189801E-8 <0.001 GO:0003008 system process
19 225 1.4692909506585101E-5 3.3E-2 GO:0009986 cell surface
20 242 1.1994125843516999E-5 3.1E-2 GO:0048598 embryonic mor-
phogenesis
85 1271 6.1626609906293902E-16 <0.001 GO:0044707 single-
multicellular
organism pro-
cess
22 277 8.2355556050856005E-6 2.1E-2 GO:0009887 organ morpho-
genesis
85 1278 8.6109456999171402E-16 <0.001 GO:0032501 multicellular
organismal
process
21 271 1.93512443454791E-5 4.2E-2 GO:0003006 developmental
process involved
in reproduction
26 369 1.07445293819627E-5 2.9E-2 GO:0007155 cell adhesion
26 370 1.12736718339205E-5 2.9E-2 GO:0022610 biological adhe-
sion
50 753 3.6248440059090802E-9 <0.001 GO:0009653 anatomical
structure mor-
phogenesis
131
41 633 2.33795832965117E-7 <0.001 GO:0007166 cell surface re-
ceptor signaling
pathway
32 490 4.8638755667330899E-6 1.6E-2 GO:0022603 regulation of
anatomical
structure mor-
phogenesis
39 624 1.1883162478938699E-6 6.0E-3 GO:0048513 organ develop-
ment
36 607 1.05583387628627E-5 2.6E-2 GO:0051094 positive regula-
tion of develop-
mental process
71 1308 6.5828610286661696E-9 <0.001 GO:0048856 anatomical
structure devel-
opment
106 2177 9.6779568692902494E-11 <0.001 GO:0032502 developmental
process
63 1186 1.4342743777632399E-7 <0.001 GO:0051239 regulation of
multicellular
organismal
process
100 2082 1.10950940201248E-9 <0.001 GO:0044767 single-organism
developmental
process
46 849 6.1535790751483699E-6 1.9E-2 GO:2000026 regulation of
multicellular
organismal
development
58 1130 1.63958943701026E-6 6.0E-3 GO:0050793 regulation of
developmental
process
87 1825 3.9086324583793002E-8 <0.001 GO:0044421 extracellular re-
gion part
67 1381 1.5274223757993801E-6 6.0E-3 GO:0007165 signal transduc-
tion
61 1246 3.9571887771131096E-6 1.5E-2 GO:0048869 cellular develop-
mental process
61 1310 1.9603235582128199E-5 4.3E-2 GO:0005886 plasma mem-
brane
172 5038 1.6879121263806799E-5 3.6E-2 GO:0044699 single-organism
process
5 23 4.9745376934006201E-6 1.2E-2 GO:0042562 hormone bind-
ing
5 28 1.38862542500497E-5 2.3E-2 GO:0050715 positive regula-
tion of cytokine
secretion
5 33 3.2050548484478999E-5 0.05 GO:0031214 biomineral tis-
sue development
7 53 2.0345766863567202E-6 5.0E-3 GO:0050673 epithelial cell
proliferation
8 70 1.13693401348119E-6 2E-3 GO:0007267 cell-cell signal-
ing
132
9 81 3.0041699300035198E-7 <0.001 GO:0044700 single organism
signaling
9 82 3.3429194861118402E-7 <0.001 GO:0023052 signaling
8 88 6.5383891616087396E-6 1.8E-2 GO:0050714 positive regula-
tion of protein
secretion
12 135 3.6213547326273002E-8 <0.001 GO:0005578 proteinaceous
extracellular
matrix
13 162 3.2261875621453698E-8 <0.001 GO:0031012 extracellular
matrix
29 423 1.5069389485097999E-15 <0.001 GO:0005576 extracellular re-
gion
8 102 1.95630768602668E-5 3.1E-2 GO:0010810 regulation of
cell-substrate
adhesion
10 131 2.17879990417622E-6 5.0E-3 GO:0030855 epithelial cell
differentiation
11 152 1.1176808295683201E-6 2E-3 GO:0050708 regulation of
protein secre-
tion
11 157 1.54082368252879E-6 3.0E-3 GO:0045785 positive regula-
tion of cell adhe-
sion
9 141 3.06226303888987E-5 4.8E-2 GO:0004888 transmembrane
signaling recep-
tor activity
11 178 5.2505061088622402E-6 1.2E-2 GO:0038023 signaling recep-
tor activity
12 225 8.7494228194370304E-6 2.1E-2 GO:0009986 cell surface
14 277 2.7671275564476198E-6 6.0E-3 GO:0009887 organ morpho-
genesis
18 379 2.2382476326744001E-7 <0.001 GO:0005615 extracellular
space
13 284 1.8774360373409099E-5 3.1E-2 GO:0009888 tissue develop-
ment
15 339 6.1000040317212299E-6 1.7E-2 GO:0048731 system develop-
ment
28 753 1.1642168786244801E-8 <0.001 GO:0009653 anatomical
structure mor-
phogenesis
22 663 4.0670727714736701E-6 7.0E-3 GO:0051240 positive regula-
tion of multicel-
lular organismal
process
22 672 5.0636702248074002E-6 1.2E-2 GO:0048585 negative regula-
tion of response
to stimulus
20 607 1.3437935700659501E-5 2.3E-2 GO:0051094 positive regula-
tion of develop-
mental process
133
51 2177 1.73711264822752E-8 <0.001 GO:0032502 developmental
process
25 891 1.5535640447557098E-5 0.03 GO:0030154 cell differentia-
tion
31 1186 4.6699759883394602E-6 7.0E-3 GO:0051239 regulation of
multicellular
organismal
process
33 1308 4.4320725455098598E-6 7.0E-3 GO:0048856 anatomical
structure devel-
opment
32 1271 6.8882026593448999E-6 1.9E-2 GO:0044707 single-
multicellular
organism pro-
cess
32 1278 7.7412473531242206E-6 2.1E-2 GO:0032501 multicellular
organismal
process
31 1246 1.2975467263716299E-5 2.3E-2 GO:0048869 cellular develop-
mental process
46 2082 9.4015002598449898E-7 1E-3 GO:0044767 single-organism
developmental
process
36 1578 1.40580725229098E-5 2.3E-2 GO:0048583 regulation of re-
sponse to stimu-
lus
Table B.2: Gene Ontology results for genes present in Plaid biclusters
N X p-value P adj attrib ID attrib name
15 18 1.32373623125089E-5 2.2E-2 GO:0015988 energy cou-
pled proton
transmem-
brane transport,
against elec-
trochemical
gradient
15 18 1.32373623125089E-5 2.2E-2 GO:0015991 ATP hydrolysis
coupled proton
transport
14 17 3.4174022449091097E-5 4.9E-2 GO:0042743 hydrogen per-
oxide metabolic
process
20 28 2.8336208197659299E-5 4.3E-2 GO:0016504 peptidase acti-
vator activity
24 34 6.1148714894831102E-6 1.1E-2 GO:1902600 hydrogen ion
transmembrane
transport
23 34 2.8717314646217301E-5 4.3E-2 GO:0030193 regulation of
blood coagula-
tion
134
23 34 2.8717314646217301E-5 4.3E-2 GO:1900046 regulation of
hemostasis
30 45 2.76428956831763E-6 3.0E-3 GO:0019003 GDP binding
29 45 1.11460639671914E-5 1.7E-2 GO:0006818 hydrogen trans-
port
29 45 1.11460639671914E-5 1.7E-2 GO:0015992 proton trans-
port
35 55 2.1348354636556E-6 2E-3 GO:0015078 hydrogen ion
transmembrane
transporter
activity
48 78 1.28938065803611E-7 <0.001 GO:0098800 inner mitochon-
drial membrane
protein complex
36 61 1.8373080376874198E-5 3.3E-2 GO:0061134 peptidase regu-
lator activity
36 62 3.01971438818212E-5 4.6E-2 GO:0010594 regulation of en-
dothelial cell mi-
gration
40 69 1.16637683833662E-5 1.8E-2 GO:0009897 external side of
plasma mem-
brane
55 98 1.18184095341188E-6 2E-3 GO:0010632 regulation of ep-
ithelial cell mi-
gration
51 92 4.6735541671739796E-6 8.0E-3 GO:0015077 monovalent
inorganic cation
transmembrane
transporter
activity
46 83 1.36580454243054E-5 2.5E-2 GO:0008064 regulation of
actin poly-
merization or
depolymeriza-
tion
46 83 1.36580454243054E-5 2.5E-2 GO:0030832 regulation of
actin filament
length
57 105 3.2071739366463902E-6 5.0E-3 GO:0098798 mitochondrial
protein complex
63 117 1.43495121972022E-6 2E-3 GO:0044455 mitochondrial
membrane part
70 132 8.1200775357918205E-7 <0.001 GO:0043209 myelin sheath
53 101 2.5378189508670001E-5 4.1E-2 GO:0007162 negative regula-
tion of cell adhe-
sion
63 121 6.3383919330692801E-6 1.1E-2 GO:0044391 ribosomal sub-
unit
53 102 3.6256347802155599E-5 0.05 GO:0098552 side of mem-
brane
99 194 5.8594911117478399E-8 <0.001 GO:0000323 lytic vacuole
99 194 5.8594911117478399E-8 <0.001 GO:0005764 lysosome
135
72 141 3.5786909701652E-6 5.0E-3 GO:0022890 inorganic cation
transmembrane
transporter
activity
85 169 1.10572630343214E-6 <0.001 GO:0008324 cation trans-
membrane
transporter
activity
63 126 3.33351935090832E-5 4.8E-2 GO:0032535 regulation of
cellular compo-
nent size
85 171 2.0595086570090898E-6 2E-3 GO:0032970 regulation of
actin filament-
based process
111 226 1.30928486559545E-7 <0.001 GO:0005773 vacuole
710 1537 1.4736681496055E-34 <0.001 GO:0043230 extracellular or-
ganelle
710 1537 1.4736681496055E-34 <0.001 GO:1903561 extracellular
vesicle
708 1533 2.08254310182311E-34 <0.001 GO:0065010 extracellular
membrane-
bounded or-
ganelle
708 1533 2.08254310182311E-34 <0.001 GO:0070062 extracellular ex-
osome
91 187 2.8863958076295201E-6 5.0E-3 GO:0007264 small GTPase
mediated signal
transduction
100 207 1.44188234123197E-6 2E-3 GO:0030335 positive regula-
tion of cell mi-
gration
821 1825 1.4245802710451599E-35 <0.001 GO:0044421 extracellular re-
gion part
777 1721 5.5356669608676697E-34 <0.001 GO:0031988 membrane-
bounded vesicle
101 210 1.65287269400123E-6 2E-3 GO:2000147 positive regu-
lation of cell
motility
77 160 2.6967290849820602E-5 4.1E-2 GO:0032956 regulation of
actin cytoskele-
ton organization
184 386 2.2069265984688799E-10 <0.001 GO:0051270 regulation of
cellular compo-
nent movement
173 363 7.9690413834354295E-10 <0.001 GO:2000145 regulation of cell
motility
104 218 1.87014329539657E-6 2E-3 GO:0040017 positive regula-
tion of locomo-
tion
165 348 3.1889988017941999E-9 <0.001 GO:0030334 regulation of cell
migration
835 1884 2.3516004352205102E-33 <0.001 GO:0031982 vesicle
136
187 398 6.9202112931759804E-10 <0.001 GO:0040012 regulation of lo-
comotion
147 312 3.9042401971170998E-8 <0.001 GO:0005912 adherens junc-
tion
102 217 5.3743770888666702E-6 0.01 GO:0098609 cell-cell adhe-
sion
101 215 6.16434450561136E-6 1.1E-2 GO:0051272 positive regula-
tion of cellular
component
movement
85 181 3.3331382211468397E-5 4.8E-2 GO:0005911 cell-cell junction
148 317 7.2367329399200505E-8 <0.001 GO:0070161 anchoring junc-
tion
90 192 2.16186585900075E-5 3.5E-2 GO:0016337 single organ-
ismal cell-cell
adhesion
127 273 7.8313454932435203E-7 <0.001 GO:0005743 mitochondrial
inner membrane
131 282 5.7935545194756695E-7 <0.001 GO:0005925 focal adhesion
131 284 9.3637145201601097E-7 <0.001 GO:0005924 cell-substrate
adherens junc-
tion
92 199 3.4362398209543899E-5 5.0E-2 GO:0005525 GTP binding
161 351 8.3873338609037807E-8 <0.001 GO:0031966 mitochondrial
membrane
131 285 1.1850555314874601E-6 2E-3 GO:0030055 cell-substrate
junction
109 237 8.9632284013221393E-6 1.5E-2 GO:0006812 cation transport
133 290 1.1431085229435899E-6 1E-3 GO:0019866 organelle inner
membrane
173 379 4.1748047087099401E-8 <0.001 GO:0005615 extracellular
space
110 242 1.5619139640524201E-5 2.6E-2 GO:0019725 cellular home-
ostasis
125 276 5.2310312484664401E-6 0.01 GO:0030155 regulation of cell
adhesion
192 428 3.7735789792038701E-8 <0.001 GO:0098796 membrane pro-
tein complex
177 396 1.7770631807072501E-7 <0.001 GO:0005768 endosome
112 251 3.5613640400051103E-5 4.9E-2 GO:2001233 regulation of
apoptotic sig-
naling pathway
200 453 8.6414804294883602E-8 <0.001 GO:0002682 regulation of
immune system
process
210 480 9.6090625643374899E-8 <0.001 GO:0044429 mitochondrial
part
130 297 2.6988580529988501E-5 4.1E-2 GO:0016023 cytoplasmic
membrane-
bounded vesicle
257 594 1.12500786697113E-8 <0.001 GO:0030054 cell junction
137
184 423 9.8210445361880801E-7 <0.001 GO:0005576 extracellular re-
gion
158 369 1.6721624752456401E-5 2.7E-2 GO:0007155 cell adhesion
255 601 1.04579396313669E-7 <0.001 GO:0005102 receptor binding
158 370 1.9956537751939701E-5 3.4E-2 GO:0022610 biological adhe-
sion
911 2270 1.0996142110218999E-18 <0.001 GO:0044425 membrane part
171 404 1.6860100324754798E-5 2.7E-2 GO:1902533 positive regu-
lation of intra-
cellular signal
transduction
205 489 5.2809827087913696E-6 0.01 GO:0031410 cytoplasmic
vesicle
195 467 1.2140946692834701E-5 1.8E-2 GO:0016192 vesicle-
mediated
transport
528 1310 1.20132582108096E-10 <0.001 GO:0005886 plasma mem-
brane
1415 3753 1.73307852914801E-18 <0.001 GO:0044444 cytoplasmic
part
438 1083 4.0087255702780299E-9 <0.001 GO:0005739 mitochondrion
1406 3735 5.6987822727163698E-18 <0.001 GO:0016020 membrane
251 615 5.4028954700448998E-6 0.01 GO:0009967 positive regula-
tion of signal
transduction
263 645 3.4626844087082899E-6 5.0E-3 GO:0044459 plasma mem-
brane part
277 682 2.7307019802821E-6 3.0E-3 GO:0023056 positive regula-
tion of signaling
317 785 9.1143553349305905E-7 <0.001 GO:0048584 positive regula-
tion of response
to stimulus
657 1664 2.9433251516634397E-11 <0.001 GO:0031224 intrinsic compo-
nent of mem-
brane
642 1629 8.0932384314835596E-11 <0.001 GO:0016021 integral compo-
nent of mem-
brane
449 1128 2.8223093608457999E-8 <0.001 GO:0032879 regulation of lo-
calization
280 698 7.8268348981181199E-6 1.3E-2 GO:0010647 positive regula-
tion of cell com-
munication
375 943 5.4426784849398196E-7 <0.001 GO:0031090 organelle mem-
brane
288 722 9.7822417076479903E-6 1.5E-2 GO:1902531 regulation of
intracellular sig-
nal transduction
542 1381 8.1916062617619302E-9 <0.001 GO:0007165 signal transduc-
tion
138
462 1199 1.7352464375871299E-6 2E-3 GO:0009966 regulation of
signal transduc-
tion
414 1074 6.3579294403810503E-6 1.1E-2 GO:0044765 single-organism
transport
457 1190 3.0768837406052E-6 5.0E-3 GO:1902578 single-organism
localization
512 1338 1.11927596059748E-6 1E-3 GO:0023051 regulation of
signaling
603 1586 2.6306585559344101E-7 <0.001 GO:0006810 transport
453 1186 6.7455583076402501E-6 1.2E-2 GO:0051239 regulation of
multicellular
organismal
process
594 1578 1.61548913341542E-6 2E-3 GO:0048583 regulation of re-
sponse to stimu-
lus
426 1123 2.90335153938905E-5 4.3E-2 GO:0065008 regulation of bi-
ological quality
519 1380 1.0039300784261399E-5 1.6E-2 GO:0010646 regulation of cell
communication
624 1674 3.7288856409545701E-6 5.0E-3 GO:0051234 establishment of
localization
684 1869 1.97953542223332E-5 3.4E-2 GO:0051179 localization
9 13 5.7299654383343997E-6 0.02 GO:0070577 lysine-
acetylated
histone binding
10 20 8.4669836566384405E-6 1.6E-2 GO:0003014 renal system
process
18 52 1.86544996826691E-6 3.0E-3 GO:0001936 regulation of
endothelial cell
proliferation
24 86 3.2087375311298901E-6 6.0E-3 GO:0050839 cell adhesion
molecule bind-
ing
26 103 9.5572461894383898E-6 2.1E-2 GO:1901342 regulation of
vasculature
development
33 135 1.3638991061002901E-6 2E-3 GO:0005578 proteinaceous
extracellular
matrix
38 162 6.7165841553267E-7 <0.001 GO:0031012 extracellular
matrix
57 311 7.5814129638389197E-6 1.5E-2 GO:0016477 cell migration
60 334 8.39096234562273E-6 1.6E-2 GO:0048870 cell motility
84 490 9.7163802154988691E-7 1E-3 GO:0022603 regulation of
anatomical
structure mor-
phogenesis
68 401 1.58572554684693E-5 3.3E-2 GO:0008284 positive regula-
tion of cell pro-
liferation
139
78 478 1.5859507448228801E-5 3.3E-2 GO:0006928 movement of
cell or subcellu-
lar component
112 721 2.4089271563461402E-6 4.0E-3 GO:0042127 regulation of cell
proliferation
101 663 1.8433266311205599E-5 3.5E-2 GO:0051240 positive regula-
tion of multicel-
lular organismal
process
133 889 2.0153431272333799E-6 3.0E-3 GO:0042221 response to
chemical
121 812 7.59118924114161E-6 1.5E-2 GO:0045595 regulation of cell
differentiation
125 849 9.6463141056353604E-6 2.1E-2 GO:2000026 regulation of
multicellular
organismal
development
160 1130 4.8232293176944698E-6 1.1E-2 GO:0050793 regulation of
developmental
process
6 33 3.7659508188293199E-6 6.0E-3 GO:0031214 biomineral tis-
sue development
6 43 1.8623267633530901E-5 2.9E-2 GO:0070167 regulation of
biomineral tis-
sue development
Table B.3: Gene Ontology results for genes present in SAMBA biclusters
N X p-value P adj attrib ID attrib name
3 3 6.7242998927886702E-7 <0.001 GO:0005594 collagen type IX
3 4 2.6724838285934402E-6 <0.001 GO:0005593 FACIT collagen
3 5 6.6383615780194199E-6 3.0E-3 GO:0030934 anchoring colla-
gen
4 10 1.15843286945534E-6 <0.001 GO:0001502 cartilage con-
densation
4 13 3.8652502656835102E-6 <0.001 GO:0007338 single fertiliza-
tion
4 13 3.8652502656835102E-6 <0.001 GO:0009954 proximal/distal
pattern forma-
tion
4 19 2.01209171507659E-5 2.1E-2 GO:0035136 forelimb mor-
phogenesis
14 129 5.0438816122287201E-12 <0.001 GO:0005578 proteinaceous
extracellular
matrix
5 45 4.4840710216580199E-5 4.5E-2 GO:0005581 collagen
7 70 2.5393064828789199E-6 <0.001 GO:0009952 anterior/posterior
pattern specifi-
cation
7 70 2.5393064828789199E-6 <0.001 GO:0035107 appendage mor-
phogenesis
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7 70 2.5393064828789199E-6 <0.001 GO:0035108 limb morpho-
genesis
14 156 6.8153585611196698E-11 <0.001 GO:0031012 extracellular
matrix
8 85 7.4702121287196396E-7 <0.001 GO:0001501 skeletal system
development
7 78 5.2867336713415004E-6 2E-3 GO:0061448 connective tis-
sue development
8 100 2.5952039821145798E-6 <0.001 GO:0044420 extracellular
matrix part
8 117 8.4231791647478101E-6 4.0E-3 GO:0003002 regionalization
22 419 6.3456310474107002E-12 <0.001 GO:0005576 extracellular re-
gion
9 180 2.8303743755832499E-5 2.9E-2 GO:0007389 pattern specifi-
cation process
12 264 3.18079672752497E-6 <0.001 GO:0009888 tissue develop-
ment
18 681 2.13676527274008E-5 2.1E-2 GO:0009653 anatomical
structure mor-
phogenesis
21 903 2.6634733783446199E-5 2.9E-2 GO:0050793 regulation of
developmental
process
7 18 2.1476094727665501E-7 1E-3 GO:0001968 fibronectin
binding
6 21 1.2946937821925199E-5 2.2E-2 GO:0005201 extracellular
matrix struc-
tural con-
stituent
8 28 4.3929069402221502E-7 1E-3 GO:0030193 regulation of
blood coagula-
tion
8 28 4.3929069402221502E-7 1E-3 GO:1900046 regulation of
hemostasis
8 30 7.8991383901089397E-7 2E-3 GO:0050818 regulation of co-
agulation
7 31 1.3193597140846101E-5 2.3E-2 GO:0031214 biomineral tis-
sue development
8 40 8.2452037757126004E-6 1.7E-2 GO:0004222 metalloendopeptidase
activity
8 40 8.2452037757126004E-6 1.7E-2 GO:0004930 G-protein cou-
pled receptor
activity
8 40 8.2452037757126004E-6 1.7E-2 GO:0050900 leukocyte mi-
gration
11 56 1.95386553898746E-7 1E-3 GO:0051216 cartilage devel-
opment
8 42 1.2085441137275601E-5 2.1E-2 GO:0061041 regulation of
wound healing
8 43 1.4510308541343901E-5 2.5E-2 GO:0014706 striated muscle
tissue develop-
ment
141
8 44 1.7331763917378299E-5 3.4E-2 GO:0008083 growth factor
activity
9 55 1.25988601871862E-5 2.1E-2 GO:0001894 tissue home-
ostasis
12 79 1.0135086931399E-6 2E-3 GO:0005539 glycosaminoglycan
binding
13 94 1.08054534735346E-6 2E-3 GO:0030198 extracellular
matrix organi-
zation
13 94 1.08054534735346E-6 2E-3 GO:0043062 extracellular
structure orga-
nization
17 135 9.4541102958638404E-8 <0.001 GO:0032844 regulation of
homeostatic
process
15 119 5.4262435116954098E-7 2E-3 GO:0016337 cell-cell adhe-
sion
18 145 4.9013726830135801E-8 <0.001 GO:0004888 transmembrane
signaling recep-
tor activity
23 209 6.67289010910742E-9 <0.001 GO:0051240 positive regula-
tion of multicel-
lular organismal
process
17 156 7.7686259502437504E-7 2E-3 GO:0043269 regulation of ion
transport
13 120 1.7006065703730101E-5 3.2E-2 GO:0030855 epithelial cell
differentiation
19 181 3.0812444769391599E-7 1E-3 GO:0038023 signaling recep-
tor activity
32 327 1.29521023459293E-10 <0.001 GO:0005615 extracellular
space
18 182 1.5342483975595201E-6 3.0E-3 GO:0009986 cell surface
22 235 2.6568263275891399E-7 1E-3 GO:0004872 receptor activity
37 425 1.23012468734406E-10 <0.001 GO:0007275 multicellular or-
ganismal devel-
opment
24 293 8.8137008735018296E-7 2E-3 GO:0007155 cell adhesion
24 293 8.8137008735018296E-7 2E-3 GO:0022610 biological adhe-
sion
24 307 2.0284707701572798E-6 3.0E-3 GO:0003008 system process
77 1160 3.4677998641169598E-15 <0.001 GO:0044707 single-
multicellular
organism pro-
cess
77 1170 5.5889224631680098E-15 <0.001 GO:0032501 multicellular
organismal
process
37 510 1.9252484575454499E-8 <0.001 GO:0048513 organ develop-
ment
142
76 1179 2.8041357960450999E-14 <0.001 GO:0048856 anatomical
structure devel-
opment
30 412 4.5425741071850101E-7 1E-3 GO:0051094 positive regula-
tion of develop-
mental process
46 678 2.33673618506596E-9 <0.001 GO:2000026 regulation of
multicellular
organismal
development
61 959 4.1233346287006103E-11 <0.001 GO:0051239 regulation of
multicellular
organismal
process
26 384 1.0543778273163499E-5 0.02 GO:0022603 regulation of
anatomical
structure mor-
phogenesis
68 1213 6.4148987609711403E-10 <0.001 GO:0005886 plasma mem-
brane
73 1326 2.6425542286391201E-10 <0.001 GO:0044421 extracellular re-
gion part
47 838 5.5272331065761402E-7 2E-3 GO:0030154 cell differentia-
tion
62 1148 2.0425189390607301E-8 <0.001 GO:0048869 cellular develop-
mental process
97 1995 8.9421028787807098E-11 <0.001 GO:0032502 developmental
process
37 656 9.5493325557638202E-6 1.9E-2 GO:0045595 regulation of cell
differentiation
92 1900 4.8776232082356105E-10 <0.001 GO:0044767 single-organism
developmental
process
76 1690 8.1809274391339595E-7 2E-3 GO:0016021 integral compo-
nent of mem-
brane
166 4851 7.5870970957759897E-7 2E-3 GO:0044699 single-organism
process
9 90 2.6095611104555499E-5 4.8E-2 GO:0060249 anatomical
structure home-
ostasis
15 235 1.49552945362614E-5 2.7E-2 GO:0005509 calcium ion
binding
6 6 5.1525771335380004E-10 <0.001 GO:0005833 hemoglobin
complex
4 4 6.5246180787634404E-7 1E-3 GO:0031838 haptoglobin-
hemoglobin
complex
4 6 9.3506809547410406E-6 1.9E-2 GO:0019825 oxygen binding
5 12 1.23327513575794E-5 0.02 GO:0042481 regulation of
odontogenesis
143
5 13 1.9574092493763898E-5 2.7E-2 GO:0002673 regulation of
acute inflamma-
tory response
6 20 1.4235890707758199E-5 2.5E-2 GO:0001958 endochondral
ossification
6 20 1.4235890707758199E-5 2.5E-2 GO:0036075 replacement os-
sification
7 27 7.8177973219071094E-6 1.6E-2 GO:0014068 positive reg-
ulation of
phosphatidyli-
nositol 3-kinase
signaling
8 35 4.8177706637263797E-6 1.5E-2 GO:0072562 blood micropar-
ticle
9 47 5.8351864821531702E-6 1.5E-2 GO:0060560 developmental
growth involved
in morphogene-
sis
9 48 7.0043949536272601E-6 1.5E-2 GO:0010634 positive regula-
tion of epithelial
cell migration
14 78 3.4206640600406898E-8 <0.001 GO:0001503 ossification
9 52 1.3903546707598601E-5 2.3E-2 GO:0010594 regulation of en-
dothelial cell mi-
gration
10 62 8.8777646637907097E-6 1.6E-2 GO:0009897 external side of
plasma mem-
brane
11 74 7.1392045823786001E-6 1.5E-2 GO:0010632 regulation of ep-
ithelial cell mi-
gration
16 112 1.02144336347113E-7 <0.001 GO:0007186 G-protein cou-
pled receptor
signaling path-
way
18 194 1.04256301848236E-5 0.02 GO:0048729 tissue morpho-
genesis
30 372 2.3975053213472402E-7 <0.001 GO:0009605 response to ex-
ternal stimulus
47 689 1.39377935547036E-8 <0.001 GO:0007166 cell surface re-
ceptor signaling
pathway
40 633 1.4468106600721699E-6 2E-3 GO:0042127 regulation of cell
proliferation
45 828 1.66721281603162E-5 2.5E-2 GO:0032879 regulation of lo-
calization
65 1342 7.5511931389333203E-6 1.6E-2 GO:0007165 signal transduc-
tion
104 2386 6.34557268892082E-7 1E-3 GO:0050896 response to
stimulus
12 86 3.4484298389747099E-6 8.0E-3 GO:0006935 chemotaxis
12 87 3.9042783378155103E-6 8.0E-3 GO:0042330 taxis
144
12 87 3.9042783378155103E-6 8.0E-3 GO:1901342 regulation of
vasculature
development
16 165 1.0981528744944701E-5 1.8E-2 GO:0040017 positive regula-
tion of locomo-
tion
24 332 1.27698723525655E-5 1.9E-2 GO:0040011 locomotion
34 578 1.7530025641233999E-5 2.6E-2 GO:0044459 plasma mem-
brane part
92 2241 8.0897328772972403E-6 1.6E-2 GO:0044425 membrane part
146 4019 2.5154927157424001E-6 4.0E-3 GO:0044763 single-organism
cellular process
8 56 1.28600730011157E-5 3.9E-2 GO:0043270 positive regula-
tion of ion trans-
port
12 92 2.3286175626045E-7 <0.001 GO:0034762 regulation of
transmembrane
transport
11 86 9.2054096415440104E-7 3.0E-3 GO:0034765 regulation of ion
transmembrane
transport
9 100 5.6271381796036003E-6 7.0E-3 GO:0015672 monovalent
inorganic cation
transport
8 89 1.92279006335895E-5 2.3E-2 GO:0015077 monovalent
inorganic cation
transmembrane
transporter
activity
12 191 6.6680806332757703E-6 0.01 GO:0007610 behavior
15 330 2.33011197117117E-5 3.4E-2 GO:0043565 sequence-
specific DNA
binding
17 379 7.5400392528364301E-6 1.1E-2 GO:0003700 sequence-
specific DNA
binding tran-
scription factor
activity
17 380 7.8078278140831392E-6 1.2E-2 GO:0001071 nucleic acid
binding tran-
scription factor
activity
5 26 1.90069714410369E-5 3.5E-2 GO:0048706 embryonic skele-
tal system de-
velopment
8 74 5.13898170976169E-6 9.0E-3 GO:0007267 cell-cell signal-
ing
8 82 1.1134832356554401E-5 2.5E-2 GO:0023052 signaling
8 82 1.1134832356554401E-5 2.5E-2 GO:0044700 single organism
signaling
10 137 1.18668378716142E-5 3.0E-2 GO:0007154 cell communica-
tion
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Appendix C
cMonkey2 Results Tables
Table C.1: This presents a tabular view of the information in Figure 9.1. The number of rows and
number of columns in each bicluster are shown as well as the names of the rows (genes) and columns
(condition). k is the bicluster number, while the residue is a representation of the similarity in gene
expression contained in each bicluster. The genes that were predicted by Inferelator as potential
regulators are shown, as well as transcription factors within each bicluster.
nrows ncols rows cols k resid outside weight TFs
35 8 Smdt1, Rab27b,
Manbal, Ube2m,
Cmbl, Actb, Tufm,
Arid3a, Sh3pxd2a,
2010300C02Rik,
Cd59a, Smad6,
Syt6, Fam109b,
Grb2, Mpdu1,
Pitx1, Gaa, Fetub,
Abhd17a, Prex1,
Rab3d, Fam46a,
Frmd4b, Rnaset2b,
Sema4d, Rasgrp2,
Ptprs, Mrps23,
Glrx5, Cd68, Clta,
2810025M15Rik,
Arid1b, Sec31a
MAT2,
MAT3,
MAT1,
BON3,
BON2,
BON1,
IMA1,
IMA3
38 0.1756 Nfat5,
Sox9,
Foxn3
(-0.51384,
-0.26325,
0.18629)
Arid3a,
Smad6,
Pitx1,
Arid1b
24 5 Sec11c, Zfp827,
Cacna1c, Ovca2,
Mkl2, Gpr153,
Sh3rf1, Fam222b,
Ercc6, Sp7,
Plekhm3, Mapk12,
Rassf3, Msi1,
Slc48a1, RP23-
380F8.2, Med7,
AI480526, Snx15,
Tbx3, Cnn2, Btd,
Lppr4, Dlx5
MAT2,
BON1,
IMA1,
MAT3,
IMA2
250 0.1758 Aff1,
Runx1t1,
Erf, Aff3,
Tle4,
Meis2,
Smarcd1,
Runx2,
Atf1,
Smad9,
Bbx
(0.20778,
-0.11947,
-0.11498,
-0.10411,
-0.10078,
-0.084329,
0.078725,
0.054123,
0.049653,
0.043559,
-0.028171)
Mkl2,
Sp7,
Tbx3,
Dlx5
146
25 5 Maea, Coa4,
Dmp1, Vps37a,
Rc3h1, Rnf185,
Ptgr1, Kit, RP23-
346I1.4, Atp6v1b2,
Slc25a11, Dner,
Rps17, RP24-
546N2.4, Gdi2,
Fam102a,
Zfp560, Mrpl22,
Enpp6, Fam214a,
Gadd45b, Atp5h,
D1Ertd622e,
Myo10, Gars
BON1,
IMA1,
MAT3,
IMA3,
MAT1
290 0.1337 Aff1, Aes,
Runx2,
Bbx,
Mef2c,
Irx3,
Meis1,
Mxd1,
Sin3b,
Sox8,
Sox5
(0.15331,
0.14317,
0.13503,
-0.11415,
0.10777,
0.09347,
-0.088752,
0.050765,
0.039792,
-0.036668,
-0.029867)
0
29 5 Akr1b10, Zfp280b,
Gatad2a, Mrpl36,
BC052040, Cdc73,
Tpd52, Fap, Pcsk6,
Slc31a2, Stk24,
Yipf6, Isca2,
Rnf19a, Sf3b5,
Tmx1, Sec23ip,
2700029M09Rik,
Bola3, Zbtb34, Re-
pin1, Srprb, Kirrel,
Gadd45b, Egr1,
Creb3, Kcnma1,
Gbe1, Abhd4
BON3,
BON1,
MAT1,
MAT3,
IMA2
297 0.1215 Cebpb,
Aff3,
Hoxa5,
Plagl1,
Hoxa9,
Sox9,
Pcbd1
(0.093631,
-0.088493,
-0.079995,
-0.058402,
-0.057215,
-0.044339,
0.022497)
Egr1,
Creb3
30 6 Ufl1, Ndufa3,
Plaur, Psat1, Wif1,
Gprc5c, Mrpl17,
2010300C02Rik,
Tdg, Fgf13, Myo10,
Slc37a2, Aes,
Scamp3, Gnb2l1,
Wbp1l, Mcoln1,
Aamp, Vma21,
Sema4d, Pcyt1a,
Cebpb, Ddx59,
Sike1, Ramp1,
Trp53bp2, Zd-
hhc9, Atp5h, Pcnx,
2810025M15Rik
MAT3,
MAT1,
BON3,
BON2,
BON1,
IMA2
332 0.1495 Lhx8,
Pitx1,
Foxa3,
Aff3,
Arhgef12,
Arid3a,
Hoxa9,
Msx1,
Sox9,
Smad6,
Ostf1
(0.12165,
0.10557,
-0.095115,
-0.087054,
0.070036,
0.061415,
-0.054262,
0.053118,
-0.052594,
0.050472,
0.036797)
Tdg,
Aes,
Cebpb
147
33 5 Igf1, Runx2,
Fam129a, Arap3,
Tfdp2, Sepp1,
Tgfb3, Zfp282,
Ech1, Zfp532,
1700037H04Rik,
Prkar2b, Cgnl1,
Rars2, Dtna,
Arhgap28, Dach2,
Akip1, Pacs2,
Lacc1, Samd14,
Vamp5, Lrrfip2,
Sec62, Rbp1,
Adamtsl1, Ahcy,
Celf2, Efna1,
Hs3st3b1, Atp9a,
Gas2, Bcar3
BON3,
BON1,
MAT2,
MAT3,
IMA3
343 0.1834 0 0 Runx2,
Tfdp2
26 9 Stil, Nuf2, Esco2,
Rock1, Loxl3,
Cyr61, Taf5l,
Maml2, Scube3,
Cenpk, Cytl1,
Kcna6, Spsb4,
Fgfrl1, Fam57a,
Vrk1, Cpm,
Cyp26b1, Mbnl1,
Sox5, Papss2,
Anln, Enpp2,
Clcn5, Zfp131,
Peg3
MAT2,
MAT3,
MAT1,
BON3,
BON2,
BON1,
IMA1,
IMA3,
IMA2
345 0.1841 Creb3l1,
Hoxa5,
Ezh2,
Zbtb16,
Hoxd9,
Msx1,
Sox9
(-0.23248,
0.1899,
0.17186,
-0.13872,
0.10672,
-0.097227,
0.06576)
Sox5
20 6 Fxyd6, Abhd11,
Ddhd2, Nin,
2700097O09Rik,
Dok1, Sfrp5,
Hk2, Tecpr2,
1110051M20Rik,
Sulf2, Zfp318,
Ssx2ip, Hoxd4,
Ercc6l2, Rab23,
Zfp367, Mcmbp,
Nacc2, Zfp101
MAT3,
MAT1,
BON3,
BON2,
BON1,
IMA1
549 0.1521 Runx2,
Creb3,
Hif1a,
Arid5b,
Smc1a,
Aff3,
Dlx3,
Aff1,
Mbd2,
Hoxd8,
Aes,
Sox8,
Taf12
(-0.17095,
-0.15654,
0.14414,
-0.090853,
0.064771,
0.059541,
-0.058945,
-0.055944,
-0.050454,
0.047497,
-0.042976,
0.03527,
-0.024977)
Hoxd4
148
26 8 Ncoa2, Gnas,
Msh6, Pde4dip,
1700021K19Rik,
Igf2os,
Gm24187, Sel1l,
3110079O15Rik,
Fam73b, Spsb1,
Art3, Fam57a,
Cep41, Map2,
Ap4e1, Sox9,
Fam101a,
Gm24270, Cs-
galnact1, Hoxa5,
Hoxc6, Itih5l-ps,
Fancb, Gm23935,
Dact3
MAT3,
MAT1,
BON3,
BON2,
BON1,
IMA1,
IMA3,
IMA2
592 0.1616 Hoxa9,
Foxa3,
Hoxd9,
Id3,
Cebpb,
Hoxa10
(0.24734,
0.23389,
0.18733,
-0.12054,
-0.0989,
0.063471)
Ncoa2,
Sox9,
Hoxa5,
Hoxc6
37 6 Colgalt2, Gnas,
Islr, Mcoln2,
Pde3a, Art3, Il16,
Hoxa10, Runx3,
Zbtb20, Hoxc6,
Tmbim1, Clcc1,
Comp, Lrp8,
Pds5b, Car12,
Wscd2, Myh14,
Plod2, Plekhb1,
Sox9, Fbln2, Gfpt2,
Prelp, Hoxa9, Cs-
galnact1, Matn1,
Matn3, Acan,
Col9a2, Col9a1,
Itih5l-ps, C1qtnf3,
Diap3, Trim47,
Ncmap
MAT3,
BON3,
BON2,
BON1,
IMA1,
IMA3
690 0.1185 Foxn3,
Aff3,
Foxa3,
Aes,
Msx1,
Zfand3,
Hoxd9,
Pitx1,
Lhx8,
Ikzf2
(-0.16009,
0.13877,
0.11165,
-0.10233,
-0.090299,
-0.085989,
0.082594,
-0.077011,
-0.06043,
-0.039318)
Hoxa10,
Runx3,
Hoxc6,
Sox9,
Hoxa9
20 7 Gm15654,
Map1a, Gm26870,
Gm10800, Foxp4,
Gm10801, Slc6a8,
Mfn1, Cep192,
Gm21738, Fam73b,
Gm10719,
Gm10722,
Gm10718,
Gm10717, Rrp12,
Trpv4, Taf5l,
Trip10, Gm10720
MAT2,
MAT3,
MAT1,
BON3,
BON2,
BON1,
IMA2
770 0.1611 Tuba1a,
Tdg,
Sox9,
Mlx, Aes,
Kat2a
(-0.32683,
-0.28026,
0.19034,
-0.17917,
-0.092253,
0.073017)
Foxp4
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31 4 Dgcr8, Fnip2,
Prdm11,
AU019823,
Slc16a3, Prkdc,
Rps19-ps3, Nol8,
Cep95, Tex9,
Sfi1, Nfkbiz,
Rrp12, Ivns1abp,
4930523C07Rik,
Heatr3, G2e3,
Tacc3, Erf, Stk4,
Slc1a5, Hhat,
Trim24, Carf,
Birc5, Ccdc25,
Map7d2, Fance,
Ift172, Rbp4, Uhrf2
BON2,
MAT2,
MAT3,
MAT1
780 8.58E-
2
Runx2,
Arid4a,
Ets2,
Erg, Gsc,
Arhgef12,
Kat2a,
Hmgn3,
Taf1a,
Arid1a,
Ewsr1
(-0.17486,
0.12582,
-0.12206,
0.0913, -
0.079742,
-0.077608,
0.074218,
-0.063882,
0.05556,
-0.049714,
0.020405)
Erf,
Trim24
27 4 Lgmn, Npnt,
Arhgap12, Vim,
Intu, Ttc17,
Dnaja3, Mxd1,
Cd200, Guca1a,
Slc10a3, An-
txr2, Tspan11,
Chn2, Strn,
Cdk2ap2, Runx2,
Pex7, Nol11,
Kitl, Zfp36l1,
Msrb2, Trp53inp2,
Slc25a20, Ptprm,
Dctn6, Mrpl46
BON2,
MAT2,
MAT3,
MAT1
820 7.4E-2 0 0 Mxd1,
Runx2
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